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Abstract 
Deracemisation is the conversion of a racemic mixture into a single enantiomer, with 
theoretical chemical yields and e.e's of 100%. The high yields and e.e's are the main 
advantage of deracemisation reactions over the more classical kinetic resolutions, 
where a 50% chemical yield is the maximum obtainable. 
RS-a-Amino acids bearing a - or 7-substituent were prepared using standard 
methods for a-amino acid synthesis. The RS-a-amino acids where subjected to a 
cyclical oxidation-reduction deracemisation reaction using D-amino acid oxidase 
from T. variabilis and hydride reducing agents. The enzyme was found to tolerate the 
- and 7-substituted a-amino acids as substrates and the use of NaCNBH 3 for the 
deracemisation of acyclic a-amino acids has been demonstrated for the first time. 
Screening of a library of organisms was undertaken to identify novel oxidase 
enzymes for use in the deracemisation reaction. The screen revealed five organisms 
that were able to oxidise L-phenylalanine to phenylpyruvic acid, indicating possible 
L-amino acid oxidase activity. However, when screening for monoamine oxidase the 
assay methods employed lacked the sensitivity to identify conversion of benzylamine 
to benzaldehyde. 
The cyclic oxidation-reduction sequence used for the deracemisation of RS-a-amino 
acids has been extended to encompass racemic amines for the first time. The 
deracemisation of RS-a-methylbenzylamine, using an enantioselective monoamine 
oxidase and ammonia:borane as reducing agent, has been shown to proceed with 
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(R)-AMBA, 77% yield, 93% e.e. 
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In the past few decades, the search for general methods for the synthesis of 
enantiomerically pure a-amino acids and amines has been a major goal of synthetic 
organic chemists. a-Amino acids are used widely in the pharmaceutical industry, as 
building blocks for physiologically active molecules' and as active compounds in 
their own right. Non-proteinogenic a-amino acids also play an important role in the 
investigation of enzyme mechanisms. 
Enantiomerically pure amines bearing a stereogenic centre at the a-position are often 
used in asymmetric synthesis as chiral auxiliaries or catalysts. However, they are also 
vital building blocks for therapeutic targets within the pharmaceutical industry. 2 
In the case of pharmaceutical compounds, generally only one enantiomer of a target 
molecule is active, with the other showing no, or even detrimental, biological activity. 
Therefore the need to prepare compounds in an enantiopure form arises from both 
commercial and safety issues. 
1.1. Synthesis of optically active a-amino acids 
Asymmetric synthesis is a valuable tool in the preparation of enantiomerically pure 
compounds. It relies on the reactive centre(s) experiencing some stereodiscriminating 
environment in the transition state. Often an achiral starting material is involved, with 
chirality introduced through a chiral auxiliary or catalyst. 
There are three main strategies for the retrosynthesis of an a-amino acid 
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Figure 1.1.1: retrosynthetic strategy for a-amino acids 
1.1.1. Asymmetric alkylation reactions 
Various methods for asymmetric alkylation are reported in the literature, most of 
which are based on nucleophilic or electrophilic glycine equivalents. 6 ' 7 Some of the 
most established nucleophilic glycine equivalents include Schollkopf's bis-lactim 
ethers 1,8  Williams' oxazinones 2,9 and Seebach's imidazolidinones 310  (figure 1.1.2). 
In all these cases the heterocyclic template is necessarily more rigid than the acyclic 
counterpart, and therefore imparts a higher degree of asymmetric induction. 
Me 
Men". N 	 _____ 
Me 	 Ph 
MeONX 	
PhXN 	 <N 
P 	 1 Boc 
1 	 2 	 3 
valine derived bis-lactim ether 	oxazinones 	 irnidazolidinones 
Figure 1.1.2: nucleophilic glycine equivalents 
Schollkopf's bis-lactim ethers have been used to prepare natural and unnatural 
a-amino acids 5a-e with greater than 90% e.e. (figure 1.1.3).8  Hydrolysis of the 
Introduction 
alkylated bis-lactim ether to the desired amino acid proceeds without significant 
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Figure 1.1.3: alkylation of Schollkopf s bis-lactim ether 
Other methods of introducing asymmetry to a molecule have included the use of 
imine glycinates based on natural molecules such as camphor 611  and 
hydroxypinanones 712  (figure 1.1.4), where asymmetry is introduced through the 
inherent chirality of the auxiliary. The enantiomeric excesses observed range from 
moderate to good, depending on the size of the alkylating group, solvent, base and 
counter ion employed. 
Me Me 










Figure 1.1.4: chiral imine glycinates 
As is the case with other areas of organic chemistry, the general trend in asymmetric 
alkylation is to employ catalytic methods as opposed to auxiliary methods. The 
advantages of using catalytic methods are numerous, e.g., the number of steps in the 
reaction is reduced by the elimination of both the attachment and the removal of the 
auxiliary, and recycling of the catalyst is often achievable, both contributing to a 
3 
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reduction in the overall cost of the system. Phase-transfer catalysts based on the 
natural alkaloids cinchonine and cinchonidine, such as the catalyst 10,13  have been 
successfully employed in the enantioselective preparation of a-amino acids 
derivatives 9a-f from the achiral imine glycinate 8 (figure 1.1 •5)•14  In recent years 
these chiral PTCs have been used in solid phase synthesis with good results.15' 16 
CO2tBU 	R-Hal 	 CO2BU 
Ph 	
) 	 __ Ph 	) 
	
>=N >N "R 
Ph 	 10m01%10 	Ph 
>94% e.e. 






e PhCH2 - 
f Ph2CH- 
10 
Figure 1.1.5: chiral phase-transfer catalysis 
Many of the nucleophilic equivalents described above can be transformed into the 
corresponding electrophilic equivalent, through simple halogenation followed by 
displacement of the halogen by a nucleophilic species (figure 1.l.6).1719  Such 
methodology can allow access to the opposite enantiomer of an amino acid, and can 
be used to introduce R groups that are not accessible via electrophilic addition. 
Ph 	 NBS 	Ph 0 0 	 Ph 0 
PhXN PhX NIBr PhXTONR  
I 	 I 	 I 
P P P 
2 	 11 	 12 
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Me 	 N 	c2c 	Mey.L..fN 




Figure 1.1.6: preparation of electrophilic glycine equivalents 
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1.1.2. Asymmetric amination reactions 
In the synthesis of optically active ct-amino acids, the asymmetric amination reaction 
offers a complimentary approach to asymmetric alkylation reactions. A greater 
variation in the nature of the R group is tolerated compared with the alkylation 
methodologies described in section 1.1.1. The amination reaction can occur under 
electrophilic or nucleophilic conditions. The type of nitrogen compound employed 
influences the stereospecificity of the reaction and is a useful strategy for obtaining 
both enantiomers of an a-amino acid in optically pure form. Some examples of 
electrophilic aminating reagents are di-tert-butyl-azodicarboxylate (DBAD) 15,20 
benzenediazonium tetrafluoroboronate 1621  and 2,4,6-tri-iso-propylbenzenesulfonyl 
azide (trisyl azide) 1722  (figure 1.1.7). Nucleophilic nitrogen is most commonly 







15 	 16 	 17 
Figure 1.1.7: electrophilic nitrogen species 
DBAD has found widespread use as an electrophilic aminating reagent as it shows 
high diastereofacial selectivity and is commercially available as a stable, crystalline 
solid. However, the need for reductive cleavage of the N-N bond can limit the 
functionality tolerated in the side chain. When introducing an amine group to a highly 
functionalised system, trisyl azide is often used as the source of nitrogen, e.g. in the 
synthesis of the natural cyclic tripeptide, K-13 (18).23 
OH a








Asymmetric amination reactions are generally performed via the electrophilic 
amination of chiral enolates. The two most common enolate auxiliaries used are 
Oppolzer's sulfonamide24 and Evans' carboximides 19.25  The Evans' auxiliaries are 
also used in nucleophilic amination reactions via bromination of the chiral enolate, 26 
providing access to the opposite enantiomer of the a-amino acid without the need for 
a new auxiliary (figure 1.1.8). 
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Figure 1.1.8: amination using Evans' auxiliaries 
The removal of the Evans' auxiliaries is generally performed using lithium hydroxide 
and in most cases occurs without significant racemisation at the a-centre. However, 
when the side chain is particularly bulky, e.g. t-butyl group, hydrolysis using lithium 
peroxide is the favoured method, as LiOH often results in competing cleavage of the 
urethane carbonyl group. 
1.1.3. Asymmetric hydrogenation 
Catalytic asymmetric hydrogenation is potentially one of the most efficient and 
convenient methods for preparing a-amino acids. 27 A popular approach is to use 
rhodium catalysts with chiral phosphine ligands. There have been many examples of 
chiral phosphine ligarids reported in the literature in recent years, 2830 examples of 
which can be seen in figure 1.1.9. 
31 
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27 	 28 
Figure 1.1.9: chiral phosphine ligands for catalytic asymmetric hydrogenation 
By using the opposite enantiomeric ligand the opposite stereoselectivity can be 
achieved. As with many catalytic hydrogenations, optimisation is an empirical 
process, and sometimes even subtle differences in the ligand can produce dramatic 
differences in the e.e. obtained. 30 A challenge presented to chemists in the last few 
years has been to prepare I3,-disubstituted a-amino acids in enantiomerically pure 
form. These compounds are of interest in the design of peptide and peptidomimetic 
therapeutics as the f3-substitution introduces conformational constraints to the peptide. 
The DuPhos and BPE ligands developed by Burk et al. have now been shown to give 
e.e.'s of >98% in such reactions (figure 1.1.10),' with the added advantage that 
hydrogenation occurs regioselectively. 












Figure 1.1.10: synthesis of 3j-disubstituted a-amino acids 
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A complimentary approach to asymmetric hydrogenation using chiral ligands is to 
employ a chiral alkene followed by hydrogenation over a palladium catalyst as shown 
in figure 1.1.11.32  This type of reaction often employs the templates seen in the 
alkylation methodologies (§ 1.1.1). 
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Figure 1.1.11: hydrogenation using a chiral auxiliary 
1.2. Synthesis of optically active chiral amines 
The synthesis of optically active chiral amines follows three main retrosynthetic 
strategies (figure 1.2.1). 
NH 
1 ,2-nucleophilic addition 





==== 	A 	reduction R R R R 
NH2 	 0 
R L R, 	 R 1 R. 	transamination 
Figure 1.2.1: retrosynthetic strategy for chiral amines 
1.2.1. 1,2-Nucleophilic addition to a C=N double bond 
The synthesis of chiral amines via 1,2-nucleophilic addition has been the subject of a 
large number of publications in recent years. The methodology is attractive in that it 
offers a direct and synthetically flexible route to optically active chiral amines. A brief 
1.11 
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overview of the relevant strategies is given and further detailed information is 
available in a recent comprehensive review. 33 
The types of C=N double bonds commonly employed in 1 ,2-nucleophilic additions 
are imines (RHC=NR'), hydrazones (RHC=NNRRu),  oxime ethers (RHC=NOR') and 
nitrones (RHC=N(0)R'). Oxime ethers are the least favoured substrates due to their 
lower electrophilic reactivity and their propensity to form E/Z mixtures. The most 
attractive method of introducing chirality is through external ligand-induced 
stereoselectivity, as this avoids the attachment and removal of a chiral auxiliary and 
holds the potential for recycling the chiral ligand. There have been a number of 
attempts at making this methodology catalytic, however the enantioselectivity of such 




R'Li Me OMe 
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R = Ph, (E)-PhCH=CH, 1- and 2-naphthyl 




Figure 1.2.2: catalytic asymmetric addition to an imine 
There have been only a few examples of these catalytic methods published. The bulk 
of the literature is focused on chirality built into the C=N double bond (figure 
I 35 .2.3).' 36 
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asymmetric induction through auxiliary on a nitrone 36 
Figure 1.2.3: asymmetric induction through auxiliary control 
1.2.2. Reduction methodologies 
1.2.2.1. Asymmetric hydrogenation 
The asymmetric hydrogenation of prochiral imines is similar to the hydrogenation 
methods described for the synthesis of a-amino acids (§ 1.1.3). Some of the more 
common metal catalysts employed are rhodium, iridium, ruthenium and titanium, 
usually complexed with chiral diphosphine ligands in situ. However, the reduction of 
imines is not as easily accomplished as the reduction of other functional groups, such 
as alkenes and ketones. 37 A number of factors contribute to the difficulty of imine 
hydrogenation: orbital overlap between the imine and metal centre is less effective 
than in the corresponding olefin-metal centre overlap; the amine products may 
"poison" the catalyst and a smaller thermodynamic gain is realized from reduction of 
C=N bonds (-60 kJ.moi 1 ) relative to C=C bonds (-130 kJ.mor). 
Various strategies have been developed in an attempt to improve the rate of 
hydrogenation and the enantioselectivity of catalytic asymmetric hydrogenations of 
imines. Many of these fall in the field of ligand design, for example the optimization 
of tridendate diphosphine ligands with C2 symmetry (figure 1 .2.4).38  Although 
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enantioselectivity is low, fine-tuning of the ligands should improve the selectivity of 
the hydrogenation. 
	
Me 	 Me 
Me 	N' catalyst* 	Me 	
kOMe b—Me b—Me 
47 	 48 
Me 	 Me 	 Me4..(( L...( Me YfN-jy 
PR2 	 0.. R=Ph 	PR2R2P 
49 	 50 
Catalyst* 	 Yield! % 	e.e.! % 
{Ir[(R,R)-49](COD)}C10 4 	87 	40(S) 
[Ir(COD)C1] 2/2 C10412 (S,S)-49 	65 	34(R) 
{Rh[(R,R)-49](NBD)}C10 4 	0 	- 
[Ir(COD)C1] 2(R,R)-50 	 5 	- 
[Ir(COD)C1} 2/2 C10412 (R,R)-50 	31 	55(8) 
[Ir(COD)C1] 2/2 C10412 (S,5)-50 	37 	53(R) 
{Rh[(R,R)-50](NBD)}C10 4 	9 	41(5) 
COD = 1,5-cyclooctadiene 
NBD = norbornadiene 
Figure 1.2.4: optimisation of tridentate diphosphine ligands 
During investigations into the diastereoselective hydrogenation of chiral imines, a 
group at DSM Research noted that hydrogenation of one enantiomer of a racemic 
imine proceeded faster than hydrogenation of its opposite enantiomer. This led to 




















RR' R 	R' RR' NH2 
Me"Ph 53 54 53 	 52 
52 
aR=Ph,R'=Me 67%,83%e.e. 
bRPh,R'=H 86%, 19%e.e. 
c R = 2-MeO-C6H4 R' = Me 72%, 98% e.e. 
Figure 1.2.5: kinetic resolution by rhodium/diphosphine catalysed hydrogenation 
The level of enantio selectivity was generally good but was dependent on the imine 
structure and the chiral ligand employed. 
The first example of transfer hydrogenation of imines was reported in 1996 as an 
alternative to high pressure and high temperature systems (figure 1 .2.6). ° The yields 
and enantioselectivities in these reactions were excellent, although still dependent on 
empirical evaluation of the catalyst. The advantage of these systems over standard 
hydrogenation procedures is that an increase in imine reactivity is observed and the 
CN/C=O chemoselectivity is approximately 98:1. This allows for the reduction of an 
imine in the presence of a C=O functional group. Unfortunately, acyclic imines suffer 
from lower enantioselectivity, partially due to syn-anti isomerisation. 
The authors quote in the text the use of (S,5)-BDPP as chiral ligand, yielding the S-imine. However, 
the published reaction schemes show (R,R)-BDPP yielding the R-imine. Figure 1.2.5 is based on the 





















Ar' = p-cymene 
Figure 1.2.6: transfer hydrogenation of cyclic imines 
1.2.2.2. Hydride transfer 
Chemo- and stereoselective reductions of imines by hydride transfer reagents have 
received much attention in recent years. 4 ' Most of the common metal hydride 
reducing agents prefer the reduction of a carbonyl group to that of an imino group due 
to the lower electrophilicity of the imino group. 42 The number of imino selective, 
asymmetric methods reported in the literature to date is small, and only moderate 













)CI MeO (NH 
Me 
72% yield, 80% e.e. 
55 
Figure 1.2.7: asymmetric reduction by the chiral reducing agent 58 
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1.2.3. Reductive amination reactions 
Asymmetric reductive amination of ketones can be achieved in one of two ways: 
i) addition of a prochiral ketone to a prochiral amine followed by asymmetric 
reduction (§ 1.2.2); or ii) addition of a prochiral ketone to a chiral amine (auxiliary) 
followed by reduction using a non-selective reducing agent. a-Methylbenzylamine 
(52, AMBA) is a cheap chiral amine that is commercially available in both 
enantiomeric fonns and is therefore a popular choice as a chiral auxiliary. Reductive 
amination using AMBA as the auxiliary has been used in the synthesis of 
pharmaceutically important benzocyclic amines, e.g. 1 -aminoindane, 62 (figure 
1 .2.8).46  Commercially available (+)- or (-)-norephedrine has also been employed as a 
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Me 
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(R,R)-92% d.e. (R)-20% yield H2NMe >99% e.e. 
52 60 61 62 
Figure 1.2.8: asymmetric reductive amination of benzocyclic compounds 
1.3. Biocatalysis 
An alternative approach to the conventional chemical synthesis of enantiomerically 
pure compounds lies in the area of biocatalysis. Enzymes are attractive catalysts for 
synthetic chemists in that they are inherently chiral, being produced using naturally 
occurring L-amino acids, they operate under mild conditions and they usually exhibit 
high levels of chemo- and regiospecificity. 
14 
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1.3.1. Kinetic resolutions 
The process of resolution whereby one enantiomer is more readily transfonned into 







(5)-A 	 OR 
slow 
A = substrate 
P = product 
Figure 1.3.1: kinetic resolution 
The first kinetic resolution recorded was by Pasteur in 1858, when he discovered that 
ammonium tartrate fermented in the presence of Penicillium glaucam resulted in 
faster metabolism of the D-enantiomer compared to the L-enantiomer. 48 Today either 
chemo- or biocatalysis can be used to bring about such resolutions, with reports of 
biocatalytic resolutions greatly outnumbering the chemocatalytic methods. The 
hydrolase enzymes, such as lipases and proteases, are the most popular class of 
enzyme in reported resolution processes. The biological function of these enzymes is 
the hydrolysis of ester and amide bonds respectively. Hydrolysis of a-amino acid 
esters is a common method for the kinetic resolution of amino acids. 49 However, in 
organic solvents these enzymes will catalyse the transfer of an acyl group from a 
suitable acyl donor to an acceptor alcohol or amine (figure 1.3.2). 
R'OH 	 OH 
0 
0 
Enz-Ser-OH + A _R' 	











Figure 1.3.2: mechanism of lipase-catalysed acyl transfer to an alcohol acceptor 
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Due to the versatility and simplicity of lipase-catalysed resolutions, a number of 
kinetic resolutions are now carried out on an industrial scale. 5° One such process is 
the resolution of racemic primary amines using Candida antarctica lipase and ethyl 
acetate as the acyl donor. 3 This method is used to resolve ct-methylbenzylamine, with 
50% recovery of the S-enantiomer and an e.e. of 90%. Chiral amines have also been 
kinetically resolved using an co-transaminase (figure 1.3.3). 51  It was found that the 
enzyme was inhibited by the acetophenone product, which resulted in a decrease in 
the yield of the reaction. The problem was overcome by using a bi-phasic system, 
which offered two advantages: i) the inhibitory product acetophenone can be 
extracted from the aqueous phase and ii) AMBA forms an imine with cyclohexanone 
and exists primarily in the organic phase, therefore allowing the organic phase to act 



















5 1 % yield 
phosphate buffer 	
95% e.e. 
Figure 1.3.3: kinetic resolution of AMBA using co-transaminase 
However, no matter how efficient the resolution, classical kinetic resolutions suffer 
from some major disadvantages: the maximum yield that can be obtained is only 
50%; separation of the product from the unreacted starting material can be 
problematic; for kinetic reasons, the enantiomeric purity is depleted at 50% 
16 
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conversion52 (which is the optimum point for separation from a preparative point of 
view). 
1.3.2. Deracemisation 
Deracemisation can be defined as a process that leads to the formation of a single 
enantiomer from a racemic mixture, with theoretical yields and enantiomeric excesses 
of 100%. 53 Over the years, various research groups have attempted to realise this goal, 
almost all relying on the high enantioselectivity offered by enzymes. A review of the 
biocatalytic deracemisation strategies employed will be given, along with a 
comparison with chemical methods where appropriate. 
1.3.2.1. Dynamic Kinetic Resolution 
In the past two decades it has been realised that classical kinetic resolutions could be 
enhanced if the substrate possessed a chirally labile stereogenic centre. In such cases 
the substrate can undergo in situ racemisation, usually by chemocatalysis. To indicate 
the non-static behaviour of the process the term 'Dynamic Kinetic Resolution' was 
coined (figure 1.3.4). 
kR 







A = substrate 
P = product 
Figure 1.3.4: dynamic kinetic resolution 
If the rate of racemisation (k) is much greater than the rate of product formation 
(kR), then a theoretical yield of 100% is possible. A kinetic treatment of dynamic 
resolutions revealed the optimum conditions for efficient resolution processes. 54 For 
maximum efficiency, product formation should be irreversible, the enantiomeric ratio 
17 
Introduction 
(E) should be ~!20 (where E = kR/ks) and krac should be approximately ten times faster 
than kR. 55 
Since the first practical reports of dynamic kinetic resolutions in the 1980s 56 ' 57 
numerous examples of dynamic kinetic resolutions have been published. 48 ' 55' 58 ' 59 
Racemisation of the unreacted starting material can be achieved by a variety of 
techniques, one of the most common being base-catalysed proton abstraction, e.g. the 
ring opening of chirally labile 5(4H)-oxazolones 65 and 66 to produce amino acid 
derivatives 67 and 68 (figure 1.3.5).60.63 
R 	 R 	
Novozyme 
N<r0 	
(Candida antarctica lipase B) 	 R 
ROH, Et2N, 37°C 	 HN 	Co R' 
)-0 
Ph 	 Ph 	 PhO 	
2 
65 R'Me 	 67 R'=Me 
66 R'Pr 68 R'=Pr 
R 	 yield = 69-90% 
a -CH2Ph 	
e.e. = 80-98% 
b -CH2C(CH3)2 
c -CH(CH 3)2 
d indolemethylene 
e -CH2CH2SCH3 
Figure 1.3.5: lipase-catalysed ring opening of 5(4H)-oxazolones 60 
A chemical variation of this racemisationlring opening of racemic azlactones makes 
use of 4-(dimethylamino)pyridine as a planar-chiral catalyst. 64 Although the method 
suffers from low to moderate e.e.'s (50-60%), it is one of only a few examples of 
enantioselective ring opening by a non-enzymatic catalyst. 
The selective ring opening of D-hydantoins (69) by the enzyme D-hydantoinase is the 
basis for a successful industrial scale preparation of D-amino acids (figure 1 . 3 . 6) . 65 
The spontaneous racemisation of hydantoins at pH 8 or above allows a dynamic 
kinetic resolution to occur. 
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Figure 1.3.6: industrial preparation of D-amino acids by dynamic kinetic resolution 
A formal chemical deracemisation for the preparation of enantiomerically pure 
a-amino acids has been performed through a diastereoselective esterification of a 
protected racemic amino acid (figure 1 3•7)•66  The yields of the reaction are very 
good, although the stereoselectivity was found to be R group dependent. The number 
of steps involved in the reaction makes this an unattractive option for the synthesis of 
enantiopure a-amino acids compared with the elegant biocatalytic processes 
available. 
0 0 o 
R 0
C 
N 	 6N HCl R R 	I) soc12  
H2N H2N 
	
o 	Et,N 	 OH ii) 	OH M o 0 	 Me 	 Me e 0 
	 CH3CO,H 	o 




Ph 	 yield = 92-94% 
a R = Me 	 THF, Et3N 	 e.e. =40-98% 
bRCHMe, 	 76 
c R = CH,Ph 
Figure 1.3.7: formal deracemisation via diastereoselective esterification 
When compounds do not possess a chirally labile centre, e.g. secondary alcohols, 
racemisation may be achieved by a decomposition reaction, as can be seen in the 
lipase-catalysed resolution of cyanohydrins (figure 1.3.8).67 
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10 mol% anion 
exchange resin 
OH 	 (OH- form) 	 Pseudomonas sp. lipase 	OAcOH 
fl 	+ 	CN  
R 	H Me'Me 	 R CN 	 vinyl acetate 	R " CN 
78 	79 	 80 	 81 
O—\ 
ço R= oO 
-'0-cl 
Me 
.- — cc 
Figure 1.3.8: lipase-catalysed dynamic resolution of cyanohydrins 
The previous examples often require conditions for racemisation that are incompatible 
with the enzymes used for resolution. A relatively new area in dynamic kinetic 
resolution uses enzymes and transition metals complexes in tandem, 68 where the 
transition metals that bring about racemisation are more compatible with biological 
systems. The dynamic resolution of secondary alcohols can be achieved via 
palladium(U)-catalysed racemisation of allylic acetates (figure 1 •39),69  albeit with 
exceedingly long reaction times. 
	
Ph 	 Ph 
áJ.OAc 	
P. fluorescens lipase 	
OH 
5 mol% PdC12(MeCN) 2 
19 dayS 	 96% e.e. 
82 	 8 1 % yield 
via 	 83 
OAc 	 s 	s. 	.OAc + AcO,- 
= 
Pd" 
Figure 1.3.9: palladium(ll)-catalysed racemisation of allylic acetates 
Benzylic a-substituted primary amines can be racemised by palladium on charcoal at 
elevated temperatures, allowing the preparation of enantiopure chiral amides in >60% 
yield (figure 1.3.10). 0 The mechanism of racemisation is thought to occur via initial 
palladium insertion into an N-H bond, followed by n-elimination of PdH to give a 
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palladium-complexed imine (84).' This is then non-selectively reduced by palladium-
catalysed hydrogenation to give the racemic starting material. 
0 
Nc-c2 	Novozym SP 4350 	NH 	 HNLMe 
+ PhMe 	 PhMe 	Ph"Me ethyl acetate 






Pci/c 	Ph 	Me 
84 
Figure 1.3.10: palladium-catalysed racemisation of benzylic amines 
This process has since been scaled-up by BASF Technologies, and is used for the 
bulk preparation of chiral amines, with an annual capacity of 1000 tonnes per annum. 2 
The lipase enzyme employed by BASF has a broad substrate specificity and accepts 
arylalkyl amines, alkyl amines and cyclic amines. The separation of the amine from 
the reactor is carried out by distillation, therefore the only major requirement of the 
amine to be resolved is that its boiling point falls within the accepted boiling point 
range for the process. 
1.3.2.2. Enantioconvergence 
Enantioconvergence processes are highly specific, as the requirements for successful 
deracemisations via this method are difficult to meet. In fact the only enzymes 
suitable for enantioconvergent processes are the microbial epoxide hydrolases. An 
elegant deracemisation has been described using enantiocomplimentary epoxide 
hydrolases from Aspergillus niger and Beauveria sulfurescens. 72 The organisms 
A. niger and B. sulfurescens exhibit the opposite enantioselectivity towards the 
epoxide 85, therefore allowing production of either enantiomer of 85. Interestingly, 
the absolute configuration of the diol product 86 is the same from each organism, 
indicating that the epoxide hydrolases of the two organisms operate with different 
regioselectivities. This observation was the basis of the enantioconvergent process 
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(R)-85 	 (R)-86 
Figure 1.3.11: deracemisation of styrene oxide 
1.3.2.3. Stereoinversion 
Stereoinversion is a cyclical process where only one enantiomer of a racemic mixture 
is oxidised to form an intermediate, which is then followed by reduction of the 
intermediate by an enzyme with the opposite stereochemical preference. 73 The net 
redox-balance of the system is zero and the necessary redox cofactors, e.g. 
nicotinamide adenine dinucleotide, may be recycled internally. 74 The success of such 
systems relies on at least one of the redox reactions being irreversible. Biocatalytic 
stereoinversions have been successfully used in the preparation of optically pure 
a-amino acids7577 and sec-alcohols. 78 ' 79 The preparation of natural and unnatural 
a-amino acids via a two-enzyme system is exemplified in figure 1.3.1 	D-Amino 
acid oxidase form porcine kidney (pk-DAAO) selectively deaminates the D-amino 
acid from the racemic mixture. The a-keto acid 88 produced from the reaction is then 
converted to the corresponding L-amino acid 90 using a branched-chain 
aminotransferase from Escherichia coli, with L-glutamate (89) as the amine donor. 
Although excellent yields and enantioselectivities are observed, the system suffers 
from a few disadvantages: i) ion-exchange chromatography is required to separate 
L-glutamate from the desired amino acid and ii) the first step is ultimately a kinetic 
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Figure 1.3.12: strereoinversion of a-amino acids 
1.3.2.4. Deracemisation by a cyclic oxidation-reduction sequence 
Perhaps a more general methodology for deracemisation is the use of specific 
enzymatic oxidation to an achiral intermediate followed by non-specific chemical 
reduction to yield the racemic mixture (figure 1.3.13). At first glance, this system 
would appear to be of limited practical use as the first step is basically a kinetic 
resolution with the inherent limitation of 50% yield, and the second step bears no 
chiral induction at all. However, a combination of the two reactions and examination 
of the kinetics show this to be a potentially very versatile and economic technique, 8° 
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Figure 1.3.13: cyclic oxidation-reduction sequence 8° 
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In 1971, Hafner and Weliner demonstrated that the reaction of D-alanine with 
D-amino acid oxidase and sodium borohydride (NaBEL1) resulted in significant 
formation of L-alanine, thus establishing the principle of stereoinversion by a cyclic 
oxidation-reduction sequence. 8 ' However, the yield of the reaction was low and it was 
not until the early 1990s that the practical feasibility of this cyclic sequence was 
demonstrated, when Soda et al. prepared the cyclic a-amino acids proline (92) and 
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NH  C! N x—' 
92 X = CH2 
93 X = CH2C 	 X = CH2 H2 
95 X = CH2CH2 
Figure 1.3.14: deracemisation of cyclic amino acids 
High chemical and optical yields were obtained due to the stability of the cyclic 
imines 94 and 95 in aqueous systems and their susceptibility to chemical reduction. 
The major limitation of the reaction was the large excess of NaBH 4 used for reduction 
(500 equivalents). Research carried out within our group has shown that the 
deracemisation of DL-proline can be successfully carried out using only 6 equivalents 
of sodium cyanoborohydride (NaCNBH3), 84 as NaCNBH3 has greater aqueous 
stability than NaBH4 at pH < 8.85 The method has since been developed to produce 
optically pure acyclic a-amino acids in high yield (75-90%), using either NaBH484 or 
amine:boranes 86 as reducing agent. 
This cyclic oxidation-reduction deracemisation protocol has also received much 
interest by the groups of Camell 87 and Faber, 88 and both groups have published 
examples of this type with reasonable success. However both examples require 
separation of the achiral intermediate before "reduction" can take place. 
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1.4. Oxidase enzymes 
Oxidase enzymes belong to the flavoprotein family and are characterised by the 
ability of the reduced flavin to react rapidly with molecular oxygen to yield hydrogen 
peroxide and the reoxidised co-factor. Amongst these enzymes are the amino acid 
oxidases and the amine oxidases, which are of interest due to the possibility of using 
them in the deracemisation of a-amino acids and amines. 
1.4.1. Amino acid oxidase 
Amino acid oxidases oxidatively deaminate (x-amino acids to produce the 
corresponding a-keto acid, ammonia and hydrogen peroxide (figure 1.4.1). There are 
two classes of enzymes in this family: i) D-amino acid oxidase, which specifically 
oxidises D-amino acids and ii) L-amino acid oxidase, which is L-enantiomer specific. 
R,.CO2H DAAO 	R..CO2H + NH3 
i) 	
0 
02 H202  
R,.CO,H LAAO 	RyCO2H + NH3 
NH, 	( 0 
02 H202 
Figure 1.4.1: oxidation of amino acids by amino acid oxidase 
Amino acid oxidases use flavin adenine dinucleotide (FAD) as a cofactor, which is 
reoxidised by molecular oxygen, thereby eliminating the need for external cofactor 
regeneration. The product released from the active site of the enzyme is an cx-imino 
acid, which is non-enzymatically hydrolysed to the ct-keto acid. 
D-Amino acid oxidases are found mainly in eukaryotic cells, e.g. Trigonopsis 
variabilis,89 Rhodotorula gracilis,9° Fusarium oxysporum, 9' Aspergillus species92 ' 93 
and porcine kidney. D-amino acid oxidase from T variabilis (lv-DAAO) is 
commercially available in bulk quantities as it is used in the production of glutaryl-7- 
aminocephalosporanic acid 97 from Cephalosporin C (96). This is the first step in a 
two-step enzymatic route to 7- aminocephalosporanic acid (98), a valuable building 
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Figure 1.4.2: two-step enzymatic route to 7-aminocephalosporanic acid 
L-Amino acid oxidase is commonly found in the venom of a variety of snakes. 95 ' 96 
Studies have, shown that the H 202 produced by L-amino acid oxidation induces 
apoptosis. 97 L-Amino acid oxidase has also been identified in a number of bacterial 
species, e.g. Cellulomonas, 98 Bacillus, 99 Proteus,'°° as well as in fungi, e.g. 
Trichoderma,'°' Neurospora,'°2 Penicillium'°3 and in cyanobacterium, e.g. 
Synechococcus species.' °4 Recently, an enzyme termed L-amino acid deaminase has 
been isolated from Proteus myxofaciens (pm-LAAD).' °5 As for LAAO, LAAD 
oxidatively deaminates L-a-amino acids to give the corresponding a-keto acid and 
ammonia. However, unlike LAAO hydrogen peroxide is not released. The pm-LAAD 
has been cloned and over-expressed in E. coli, and used to prepare D-a-amino acids 
from their L-counterparts. 86,105 
A great deal of research has been carried out on the mechanism of amino acid 
oxidases,' °6 mainly with D-amino acid oxidases from porcine kidney and the yeasts 
T variabilis and R. gracilis due to the relatively recent discovery of L-amino acid 
oxidases in microbial sources. Although differences have been noted between the 
tv-DAAO and pk-DAAO mechanisms, these are due to the variable kinetics of each 
step rather than actual differences in the catalytic cycle. For instance, the 
rate-determining step in DAAO from R. gracilis is the reductive half-reaction, 
whereas the slow step in pk-DAAO catalysis is product release from the oxidised 
enzyme. Despite the number of studies carried out the mechanism remains 
controversial, and three proposals have been put forward.' °7 The "carbanion" 
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mechanism proposes the existence of a carbanion intermediate by removal of the 
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Figure 1.4.3: "carbanion" mechanism 
However, when FAD is replaced by 5-deaza-FAD, the a-proton of the substrate is 
incorporated into the C(5) position of the 5-deazaflavin, which is consistent with a 
direct hydride transfer (figure 1.4.4). 
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Figure 1.4.4: direct hydride transfer mechanism 
The final proposal suggests a concerted reaction in which a-proton abstraction is 
coupled to the transfer of a hydride from the amino acid nitrogen to the flavin (figure 
1.4.5). This model also fits the experimental evidence for a carbanion mechanism. 
R 	 R 
I I 
N0 
)aiOçH _:aN Y 
X  
(H 	
0 	 0 
- RcO3 NH3 
B: 
Figure 1.4.5: direct hydride transfer mechanism 
The problem with clarification lies mainly in the versatility of the flavin cofactors as 
they can accept or donate redox equivalents via hydride transfer, radical steps or 
formation of covalent adducts. It is clear that until the crystal structures of the 
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non-reduced enzymes are published the debate on amino acid oxidase mechanism will 
continue. The important point with regards to deracemisation experiments is that all 
three proposals show release of the a-imino acid from the oxidised enzyme. 
1.4.2. Monoamine oxidase 
Amine oxidases oxidatively deaminate amines to give the corresponding aldehyde, 
hydrogen peroxide and ammonia (figure 1.4.6). 
R. 	 A0 	Ry.H + NH3 
NH2 
02 	H202 
Figure 1.4.6: oxidation of amines by amine oxidase 
A number of enzymes belong to the amine oxidase family, including diamine 
oxidase,' °8 polyamine oxidase,' °9 copper amine oxidase' 1° and monoamine oxidase. 111 
As the names suggest the first two enzymes are responsible for the oxidation of 
compounds containing more than one amine group, e.g. spermine. These enzymes are 
found in plants and microorganisms. 
The copper amine oxidases are abundant in a variety of organisms, their function 
being to convert primary amines into products that can be utilised as a carbon source, 
a nitrogen source or both. Copper dependent amine oxidase requires the organic 
compound topa-quinone as cofactor, which is produced by the enzyme from a 
peptidyl tyrosine residue by a post-translational modification process. ° As a result of 
the availability of X-ray crystal structures of enzymes from a number of organisms, 112 
the catalytic mechanism of the copper amine oxidases is well understood (figure 
1.4.7). The first step is formation of the imine 100 from the amine and carbonyl group 
of the topa quinone 99. Tautomerism to the aromatic imine 101 is followed by 
hydrolysis to the aldehyde 102. Reoxidation of the cofactor 103 by molecular oxygen 
produces the hydrogen peroxide and ammonia by-products. There is evidence in the 
literature that the enzyme shows stereospecificity,"3' 114  however the mechanism 
reveals that copper amine oxidases are not suitable enzymes for the deracemisation of 
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Figure 1.4.7: mechanism of oxidation by copper dependant amine oxidase 
Monoamine oxidase (MAO) on the other hand is a flavin dependent enzyme, similar 
to the amino acid oxidases. It is found in a variety of mammals, and oxidises 
neurogenic amines such as dopamine and serotonin as well as a variety of xenobiotic 
amines. A great deal of research has been carried out on inhibitors of MAO as they 
are used in the treatment of mental disorders and in slowing the progress of 
Parkinson's disease." 5 The enzyme exists as two isozymes in mammalian systems, 
MAO-A and MAO-B. Both are flavoproteins of the mitochondrial outer membrane, 
and attempts to crystallise the proteins have failed due to their tendency to aggregate 
on removal from the outer membrane. As a result the catalytic mechanism is still 
unclear. Two possible pathways have been proposed for the mechanism of oxidation 
of the MAO-B substrate 1-methyl-4-phenyl-1,2,3,6-terahydropyridine 104 (figure 
1.4.8).h16 The single electron transfer (SET) is the favoured proposal, however some 
experimental evidence suggests the aminyl radical cations 105 may not be obligatory 
intermediates. For this reason the hydrogen atom transfer (HAT) pathway has also put 
forward by Castagnoli et al."6 
HAT 
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LN) 	 N. 	 N SET 	 i 	 I 
Me 	 Me 	 Me 	 Me Me 
104 105 
Figure 1.4.8: proposed mechanism(s) for monoamine oxidase oxidation 
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This mechanism should allow for deracemisation reactions since the imine 
intermediate is not covalently bound to the cofactor, thereby allowing reduction back 
to the amine. In 1995 the first direct evidence of an imine product from the reaction 
with MAO-B was published."7' 118  There is also some evidence that MAO-B shows a 
stereospecific removal of the pro-R hydrogen for several different substrates." 9 
For commercially viable deracemisations of racemic amines, a microbial source of 
flavin dependent monoamine oxidase is required. A number of organisms have been 
reported as having flavoprotein amine oxidases, however almost all are either 
polyamine oxidases or have very narrow substrate specificities, e.g. tyramine oxidase. 
The fungus A. niger is the only reported source to date which has a flavin dependent 
monoamine oxidase (MAO-N).' 2° The authors have since cloned, sequenced and 
expressed the MAO-N gene in E. co/i. 121 The enzyme has been compared with 
MAO-A and MAO-B and has been declared an "evolutionary precursor" to the 
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Figure 1.4.9: comparison of monoamine oxidases from mammalian and fungal 
sources (areas of high sequence identity are shown in bold) 
All three N-termini have the -a-l3  fold necessary for binding the ADP moiety of the 
flavin dinucleotide. However, unlike the mammalian enzymes MAO-N does not 
contain the highly conserved C-terminus pentapeptide, Ser-Gly-Gly-Cys-Tyr, 
responsible for the covalent bonding of FAD. Although the FAD is non-covalently 
bound, it has been shown that MAO-N behaves like a classical flavoprotein oxidase in 
that it has a stabilised anionic semiquinone. The MAO-A and MAO-B enzymes have 
an extended hydrophobic C-terminus compared to MAO-N, which is thought to be 
required for binding to the outer mitochondrial membrane. The lack of a membrane 
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binding sequence in MAO-N should provide improved solubility in vitro, which may 
aid crystallisation studies. Structural information should help clarify the catalytic 
mechanism of the flavin dependent monoamine oxidases, however unfortunately no 
X-ray crystal structure has been reported to date. 
1.5. General conclusions & Aims 
Research into the synthesis of optically active a-amino acids and amines over the last 
few decades has been extensive. However, there is still a need for increased research 
and optimisation in most areas, especially for the synthesis of enantiopure chiral 
amines, as a generic method for their production in high yields has not yet been 
realised. 
The recent work by Soda et al. 82 ' 83 on the deracemisation of cyclic amino acids is a 
promising route to both enantiopure a-amino acids and amines in high yields. In order 
to successfully employ this deracemisation as a generic method, oxidase enzymes 
with high enantioselectivity and substrate specificity are required. In the last few 
decades, work has focused on the production of unnatural D-amino acids, which are 
important building blocks in the pharmaceutical industry.' 23 Commercially available 
D-amino acids are generally more expensive than their L-counterparts as their 
production by fermentation is not often possible. Deracemisation reactions would 
provide an efficient route to D-amino acids, either from the racemate or from the 
more readily available L-enantiomer. However, L-amino acid oxidase is only 
commercially available from snake venom (Sigma), which raises issues with toxicity 
and cost. In order to successfully use the deracemisation reaction in the production of 
D-amino acids an alternative, microbial source of L-amino acid oxidase will be 
required. The deracemisation of racemic amines using this cyclic oxidation-reduction 
strategy is a potentially cheap and efficient method for their production, assuming an 
enantioselective monoamine oxidase can be found. 
The aims of this work were to develop the deracemisation of a-amino acids to 
incorporate unnatural a-substituted a-amino acids as substrates and to extend the 
methodology to include the deracemisation of racemic amines. 
31 
R&D: Synthesis 
2. Results & Discussion: Synthesis of unnatural 
a-amino acids 
One of the initial aims of this project was to prepare racemic - and y-substituted 
a-amino acids for use as substrates in the deracemisation reaction. Thereafter, work 
would be directed towards preparation of a-amino acids containing stereochemically 
defined centres at the 3- or y-position and a mixture of R- and S- at the a-position. 
2.1. Strecker synthesis 
The Strecker synthesis was first reported in 1850 and is one of the oldest known 
methods for the synthesis of a-amino acids. 7 The reaction is carried out at room 
temperature, on an equimolar scale under aqueous conditions, and is a popular choice 
for the large-scale synthesis of a-amino acids. In the reaction an aminonitrile 108 is 
formed through addition of a cyano donor to an imine 107 derived from an aldehyde 
106 and ammonia. The aminonitrile is then hydrolysed to the corresponding amino 
acid 109 under acidic conditions (figure 2.1 .1). 
o 	
CN 	
NH 	 NH3 
R1 	 HCI 02- RJL NH4CI 	 ______ _ 
R 	 R 	 R 	 R 
106 	 107 	 108 109 
Figure 2.1.1: Strecker synthesis of an a-amino acid 
2.1.1. Synthesis of (2RS,3R5)-2-amino-3-phenylbutanoic acid 
Me 	 Me 	 c.HC1 
Ph'( + NH4CI + KCN 	 Ph 
IyCN Bw  




110 	 111 	 112 
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A suspension of the aldehyde 110 in water was treated with ammonium chloride and 
potassium cyanide. The resulting aminonitrile 111 was extracted into ether and then 
into dilute HC1. It was found that the volume of aqueous acid used for extraction was 
crucial to obtaining even a reasonable yield (table 2.1.1). The low yield of 111 was 
probably due to the reversible nature of the imine formation reaction when carried out 
in water. Excess ammonia and cyanide donor may drive the reaction to completion. 
Table 2.1.1 
aq. HC1 extraction volume Yield! % d.r. a 
1 50m1 9 70:30 
2 165 ml 26 70:30 
a) calculated from integration of HPLC peak areas 
Hydrolysis of 111 proceeded in 70% yield to produce the amino acid 112 with an 
overall yield of 18%. The diastereomeric excess (40%) observed by ' 3C NMR and 
HPLC is most likely due to a preference for the (2R,3R) and (2S,38) enantiomers 
(figure 2.1.2),124  these being the diastereomers with the least unfavourable steric 
interactions. HIPLC analysis showed a ratio of 35:35:15:15 (L:D:L:D), where Land D 
are the configuration at the a-centre and assigned by their behaviour with D-amino 
acid oxidase. Following the above argument the elution order would be (2S,3S), 
(2R,3R), (2S,3R), (2R,3S). 
Me 	 i)CN 	Me 	 Me 
Ph(H 
	 10 	 Ph I _CO2 	+ 	Ph ' (CO2 H 
NH 	ii)H30+ NH2 	 NH2 
50% (3R) 	 35% (2R,3R) 	15% (2S,3R) 
Me 	 i)CN 	Me 	 Me 
Ph'( 2 	+ 	Ph !, CO2 Ph 
NH 	ii)H30+ 	 NH2 NH2 
50% (35) 	 35% (2S,3S) 	15% (2R,3S) 
Figure 2.1.2: diastereoselectivity of the Strecker reaction 
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Following the optimised reaction conditions used in § 2.1.1, the desired amino acid 
115 was recovered in 23% yield. Again IIPLC analysis showed 40% d.e., but with an 
elution order of (2S,3R):(2S,3S):(2R,38):(2R,3R) (15:35:15:35). 
Although sufficient material for deracemisation experiments was obtained via the 
Strecker synthesis, it was decided that the low yield of the reaction and the high 
toxicity of the potassium cyanide warranted research into other methods for the 
synthesis of a-amino acids. 
2.2. Alkylation of N-(diphenylmethylene)aminoacetonitrile 
The alkylation of glycine anion equivalents has received much attention in the 
asymmetric synthesis of a-amino acids (§ 1.1.1). However, it is also a useful 
methodology for the synthesis of racemic a-amino acids. The alkylation of an imine 
glycinate developed in the late 1970s by O'Donnell etal. (figure 2.2.1),125 126 offers 
an attractive alternative to the Strecker synthesis, as the methodology uses cheap and 
readily available starting materials. 
R 
base 	 HC1 	
R 
R 	
NC ' N _______  
+ 	 II 	
. 	R 	. 	
R 
R'Br 	 CPh2 	 N 
PhC 	 NH, 
116 	117 	 118 	 119 
Figure 2.2.1: alkylation of 117, N-(diphenylmethylene)aminoacetonitrile 
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2.2.1. Synthesis of (2RS,3R5)-2-amino-3-phenylbutanoic acid 
Me 










120 117 121 112 
Initially, the reaction was attempted under phase-transfer catalysis (PTC) conditions, 
due to the attractive reaction and separation conditions this method offers, i.e. room 
temperature, catalytic and bi-phasic. Benzyltributylammonium bromide was 
employed as the PT catalyst in aqueous NaOH:DCM (1:1). However, upon work-up a 
mixture of both starting materials and the desired iminonitrile intermediate 121 was 
recovered. A search of the literature revealed that refluxing in acetonitrile in the 
presence of potassium carbonate should be sufficient for alkylation to occur. 127 After 
24 h, excess base was removed and 121 was recovered in 78% yield. Hydrolysis 
proceeded quantitatively to yield the corresponding amino acid 112 as a colourless 
solid in 65% overall yield. The diastereomeric excess of the reaction was 40%, the 
same as observed in the Strecker reaction (§ 2.1.1), indicating the diastereoselectivity 
of the reactions was a result of thermodynamic equilibration. For successful alkylation 
five equivalents of base were required,' 28 less than five equivalents resulted in 
remaining starting material, which could be removed by chromatography. The 
O'Donnell alkylation methodology provided a higher yielding, less toxic route to the 
amino acid, 2-amino-3-phenylbutanoic acid 112. 
2.2.2. Synthesis of (2RS,3RS)-2-amino-3-ethylhexanoic acid 
Me Me 








CPh 	 NH3 
122 	 117 	 123 	 124 
The preparation of 2-amino-3-ethylhexanoic acid 124 was attempted via the 
alkylation methodology used in § 2.2.1. The bromide 122 and imine 117 were 
refluxed for 24 h, and then for 48 h in acetonitrile, in the presence of potassium 
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carbonate. After separation only the imine glycinate starting material 117 was 
observed by 'H NMR. The reaction was repeated with a reaction time of 5 days, 
excess base was removed and the solution concentrated under vacuum to leave an oil 
with a 'H NMR spectrum consistent with the intermediate aminonitrile 123. However, 
after hydrolysis the 'H NMR spectrum of the product showed only aromatic protons. 
This spectrum was consistent with benzophenone, which is the other product of 
hydrolysis. It is probable that the amino acid 124 was not soluble in chloroform, the 
solvent used for analysis, whereas benzophenone is. Regardless, the long reaction 
times required to drive the reaction to completion made this an unattractive method 
for the synthesis of a-amino acid 124. 
The reaction was next attempted using the PT catalyst cetyltrimethylammonium 
bromide (125) 129  and sodium hydroxide as base. After isolation 'H NMR showed a 
spectrum consistent with 125 and benzophenone. The PTC experiments showed that 
the unactivated halide 122 was not effectively alkylated under the alkylation 
conditions attempted. However, activation of the bromide by in situ iodine exchange 
looked to be a viable alternative.' 30 The PT catalyst tetrabutylammonium iodide (126) 
was chosen as the iodine exchange reagent, but with no success. Only 126 and 
benzophenone were isolated from the reaction mixture. 
Me\Me Br 
(CH2) 15CH3 	 Bu 
125 	 126 
The literature available on the O'Donnell alkylation methodology revealed that 
alkylation of glycine equivalents by simple alkyl halides such as methyl- and 
ethylbromide could be achieved by using n-butyllithium for the deprotonation of the 
imine glycinate 117.125  When this was attempted with bromide 122, the intermediate 
123 was obtained in 67% yield, after chromatography. Hydrolysis of the intermediate 
proceeded with only 50% yield, to give 2-amino-3-ethylhexanoic acid 124 (32% 
overall yield). 13C NMIIR and HPLC showed no diastereomeric excess, probably due to 
the similar steric bulk of the two alkyl groups. The low yield of the hydrolysis step, 
compared with the quantitative hydrolysis of compound 121, could be a result of 
steric hinderance by the p3-ethyl group. 
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Me 	 CPh, 	 Me Me 
127 	 117 	 128 	 129 
It was hoped that primary bromides would be more reactive under the milder PlC or 
potassium carbonate conditions (§ 2.2.1) compared with the secondary bromide 122. 
However, as in the synthesis of 2-amino-3-ethylhexanoic acid, only the starting 
materials were observed. Switching to the use of n-butyllithium at -78 °C yielded the 
desired amino acid 129, in 87% yield. Hydrolysis proceeded quantitatively and 13C 
NMR showed a diastereomeric ratio of 55:45. The lower diastereoselectivity 
compared with the n-substituted a-amino acids a results from the second stereogenic 
centre being one position further away from the reacting centre. 
2.2.4. Preparation of (2RS,4RS)-2-amino-4-phenylpentanoic acid 
Ph CN 	base 
Br + 




Attempts at the synthesis of 2-amino-4-phenylpentanoic acid proved unsuccessful. 
Using n-butyllithium as base yielded an oil with a mass spectrum consistent with the 
intermediate 131 and unknown impurities. However, upon chromatography the 
compound decomposed and no intermediate was recovered. Attempts at alkylation 




2.2.5. Preparation of (2RS,4S)-2-amino-4-methylhexanoic acid 
Me 	Br + 	
CN base 	Me'j") 	
Me'10 	
c.HC1 	 co:




CPh2 	 CPh2 	 Me NH3 
132 	 117 	 133 	 134 
One of the aims of this work was to synthesise a-amino acids with epimeric a-centres 
and stereochemically defined 3- or y-centres. Conceivably this could be achieved by 
using an enantiomerically pure bromide in the O'Donnell alkylation reaction. 
However, the reaction may suffer from epimerisation at the stereochemically defined 
centre. In an attempt to realise this goal, the commercially available enantiomerically 
pure bromide 132 was used in the alkylation of 117. It was hoped that a primary 
bromide would be more reactive than a secondary bromide and that racemisation of 
the bromide would be less likely to occur if the stereogenic centre was positioned beta 
to the reacting centre. The reaction was first attempted with n-butyllithium as 
previous reactions had shown most success with this base. The intermediate 133 was 
recovered in 67% yield after chromatography, with aD = +14.3 ' (c = 1.0, CHC1 3). 
Hydrolysis proceeded to give a-amino acid 134 as a white solid in 65% yield, with 
aD = +7.0 ° (c = 1.0, H 20). The 13C NMR spectrum showed diastereomeric signals, 
indicating that some epimerisation at the y-centre had occurred. This was confirmed 
by IF{PLC analysis as integration of the HPLC peak area showed a d.e. of 88%. 
Combining the high cost and limited availability of optically active bromides with the 
racemisation problems observed makes the alkylation methodology unsuitable for the 
preparation of 3- and y-substituted a-amino acids bearing optically active centres at 
the - and y-positions. 
2.3. Conclusions & Future Work 
Studies into the preparation of - and y-substituted a-amino acids have concentrated 
on the Strecker synthesis and alkylation of glycinate imines as developed by 
O'Donnell et al. However, both syntheses have their limitations. The Strecker 
synthesis suffers from low yields and highly toxic reagents. A recent paper has shown 
an improvement in yield for the Strecker synthesis (>90%) by using lithium 
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perchlorate/diethyl ether solution and trimethylsilylcyanide. 13 ' However, the synthesis 
still involves the use of highly toxic chemicals. The O'Donnell methodology is not 
effective when using certain bromides, especially non-activated bromides. However, 
further optimisation of the reaction by alteration of the glycine equivalent may yield 
the desired amino acids. 
Another area that requires study is the synthesis of a-amino acids with non-
stereochemically defined a-centres and stereochemically defined 13-centres. To date 
no reports have been made on such compounds, and their synthesis will be 
challenging. A recent method reported in the literature may prove interesting, where 
allylation of aziactones is achieved under catalytic conditions (figure 2.3.1). 132 
+ 	
7.5 mol% 138 ~HO 
 
Oft 	N( 
Ph 	 2.5 mol% Pd" 
Ph 
135 	136 	 137 
R = CH31  CH2PII 	
01, 	
0 O h, Ph,P 
138 
Figure 2.3.1: allylation of azlactones 
The diastereomeric ratio in this reaction can be up to 19:1, with e.e.s of 99%. It may 
be possible to modify this reaction to maintain selectivity at the 13-position but to have 
R = H, resulting in a mixture of R- and S- at the a-position. 
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3. Results & Discussion: Deracemisation of 
a-amino acids 
The ultimate aim of this project was to develop a general system for the 
deracemisation of racemic chiral amines and a-amino acids using oxidase enzymes 
(§ 1.4) and chemical reduction in a cyclic oxidation-reduction sequence. Soda et al. 
demonstrated the practical feasibility of this method for a-amino acids in the early 
1990s. 82 ' 83 This was recently further developed in Edinburgh to include acyclic 
natural and unnatural a-amino acids. 84 ' 86 Initial work on the deracemisation strategy 
focused on further modification of the method to encompass other natural a-amino 
acids and 1- and y-substituted a-amino acids, and to examine the use of D-amino 
acid oxidase from T. variabilis in the deracemisation reaction. 
3.1. Deracemisation of natural a-amino acids 
3.1.1. Deracemisation using pk-DAAO 
In order to establish reproducibility, the reaction was first carried out using 
pk-DAAO and sodium cyanoborohydride as developed in Edinburgh. 84 The amino 
acids proline 92 and phenylalanine 139 were used as substrates, at a concentration of 
2.5 mlvi. Reactions were incubated with catalase and FAD in an orbital shaker, at 
37 °C, until no further reaction was observed (table 3.1.1). One unit of enzyme 
catalyses the oxidation of 1 tmol of D-alanine per minute under standard conditions. 
From entries 1-3 it can be seen that the amount of pk-DAAO must be> 0.8 U to 
achieve high yields, and that the reaction appears reproducible (entries 2&3). 
However, the use of excess enzyme and reducing agent lowers the yield of the 
reaction (entry 4). Acyclic a-imino acids are not as stable in aqueous conditions as 
their cyclic counterparts and as a result lower yields are observed for phenylalanine 
compared with proline (entry 5). To avoid competing hydrolysis of the a-imino acid 
(140) to the a-keto acid (141), i.e. kH > kR (figure 3.1.1), sodium borohydride was 
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used as the reducing agent as it has a higher reactivity towards imines compared with 
sodium cyanoborohydride. It has been shown that in reactions with NaCNBH 3 the 
reduction of the imine is the rate-limiting step. 84 
COH DAAO 
Ph 	





NH2 	 NH2 	 NH 
139 139 140 




kH 	 0 
141 
Figure 3.1.1: deracemisation of DL-phenylalanine 
Table 3.1.1 
§ no. Sub. U 
a LHI (eq.) Time! h Yield! % e.e.I % 
1 8.2.1.1 92 0.80 NaCNBH3 (6.4) 6.0 58 >99 
2 8.2.1.1 92 1.60 NaCNBH 3 (12.8) 24.0 94 >99 
3 8.2.1.1 92 1.60 NaCNBH3 (6.4) 2.5 94 >99 
4 8.2.1.1 92 2.60 NaCNBH3 (25.6) 2.5 82 >99 
5 8.2.1.3 139 1.60 NaBH4 (31.6) 20.0 74 >99 
a) 1 U = 1 j.xmol of D-alanine oxidised per minute 
The success of the reaction with proline prompted us to try the reaction on a larger 
scale (§ 8.2.1.2). A 25 mM solution of DL-proline in ammonium formate buffer, 
pH 6.5, was incubated at 37 °C with pk-DAAO (13 U), NaCNBH 3 (10 eq.), FAD 
(0.4 mM) and catalase for 20 h. After this time HPLC analysis showed a yield of 
94% of L-proline with an e.e. >99%. 
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Figure 3.1.2: deracemisation of DL-proline (25 mM) 
3.1.2. Deracemisation using tv-DAAO 
The use of DAAO from porcine kidney would be problematic when performing 
large-scale reactions. Although commercially available, the enzyme is expensive in 
bulk quantities, being from a mammalian source, and it also requires the addition of 
an external cofactor, FAD, raising the cost of the reaction further. tv-DAAO was 
chosen as an alternative enzyme as it is readily available in bulk quantities as a whole 
cell preparation, therefore eliminating the need to add the external cofactor. This 
commercially available enzyme has the added advantage that it is supplied in 
immobilised form, thereby simplifying recovery from the reaction. 
For comparison purposes, the deracemisation of natural a-amino acids using 
tv-DAAO was initially attempted (table 3.1.2). Reactions were carried out at 30 °C as 
this was found to be the optimum temperature for the enzyme. One unit of enzyme 
catalyses the oxidation of 1 jmol of cephalosporin C per minute under standard 
reaction conditions. 
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Table 3.1.2 
§ no. Sub. U 
a [H] (eq.) Time! h Yield! % e.e.I % 
1 8.2.2.3 142 1.70 NaCNBH3 (10.0) 22.0 59 >99 
2 8.2.2.3 142 1.70 NaCNBH3 (20.0) 22.0 66 >99 
3 8.2.2.3 142 1.70 NaCNBH3 (30.0) 22.0 75 >99 
4 8.2.2.3 142 1.70 NaCNBH3 (40.0) 22.0 77 >99 
5 8.2.2.3 139 1.70 NaCNBH3 (40.0) 22.0 66 >99 
6 8.2.2.3 139 3.40 NaCNBH3 (63.5) 22.0 66 >99 
7 8.2.2.2 139 0.68 NaBH4 (42.1) 3.5 64 >99 
8 8.2.2.2 b 139 0.68 NaBH4 (42.1) 3.5 54 >99 
9 8.2.2.2 C 139 0.68 NaBH4 (42.1) 3.0 54 >99 
a) 1 U = 1 .tmol of cephalosporin C oxidised per minute; b) 0.34 U added after 1 h; 
c) 5 eq. NH4CO2 added 
The deracemisation of DL-leucine 142 was attempted with NaCNBH 3 and was 
optimised to yield optically pure L-leucine in 77% (entries 1-4). However, the 
deracemisation of DL-phenylalanine gave only low yields of L-phenylalanine, 
irrespective of the reducing agent used or the amount of enzyme added (entries 5-8). 
It is known that the a-keto acid hydrolysis products are inhibitors of amino acid 
oxidases, especially when in a highly conjugated state, e.g. the enol tautomer of 
phenylpyruvic acid 141 (figure 3.1.3). 133  Previously NT-L4CO2 was successfully used 
to increase the yield of deracemisation by reversing the hydrolysis step. 86 However, 





Figure 3.1.3: tautomerism of phenylpyruvic acid 141 
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Reactions with DL-proline showed that it is a poor substrate for tv-DAAO. 
Incubation of DL-proline with tv-DAAO at 30 °C resulted in incomplete oxidation of 
D-proline after 6 h (e.e. = 86%). By comparison, oxidation of D-proline by 
pk-DAAO is complete within 80 min and oxidation of D-phenylalanine by tv-DAAO 
is complete within 30 mm. This suggests that for the successful deracemisation of a 
wide range of substrates a set of enzymes with complementary and overlapping 
substrate specificities will be needed. 
The deracemisation of DL-phenylalanine, DL-leucine and DL-methionine 143, using 
tv-DAAO and NaCNBH3 was attempted on a 25 mM scale (table 3.1.3). The high 
enantiomeric excesses (>94%) indicated that the enzyme was capable of oxidising 
the substrates at this concentration. However, the low yields showed that more 
reducing agent is required to bring about successful deracemisation. 
Table 3.1.3 
§ no. Sub. U 
a [H] (eq.) Time! h Yield/ % e.e.! % 
1 8.2.2.4 139 17.0 NaCNBH3 (10.2) 22.0 46 94 
2 8.2.2.4 142 17.0 NaCNBH3 (10.2) 22.0 52 >99 
3 8.2.2.4 143 17.0 NaCNBH3 (10.2) 22.0 48 >99 
a) 1 U = 1 tmo1 of cephalosporin C oxidised per minute 
3.2. Deracemisation of unnatural a-amino acids 
After the success of the reactions using natural a-amino acids, our attention turned to 
the 3- and 'y-substituted a-amino acids synthesised in chapter 2. These compounds 
are important in the studies of peptidomimetics and enzyme inhibitors, 31, 134 as they 
introduce conformational constraint to the secondary structure of polypeptides. It was 
first necessary to determine if such compounds would be accepted as substrates by 
tv-DAAO (table 3.2.1). 
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Table 3.2.1 
§ no. Sub. Conc./ mM U 
a Time/ h Yield! % d.e.! % 
1 8.3.1.1 112 2.5 0.68 2.0 48 20 
2 8.3.1.1 115 2.5 0.68 3.0 52 16 
3 8.3.1.5 112 25.0 6.8 5.0 61 33 
4 8.3.1.5 112 25.0 8.5 22.0 44 20 
5 8.3.1.5 134 25.0 8.5 22.0 47 >99b 
a) 1 U = 1 p.mol of cephalosporin C oxidised per minute; b) e.e. quoted 
Although incomplete oxidation of the major 2R-diastereomer, i.e. 2R,3R, was 
observed in both cases, the n-substituted a-amino acids 2-amino-3-phenylbutanoic 
acid 112 and 2-amino-3-methylhexanoic acid 115 appear to be substrates for 
tv-DAAO, albeit with lower activity than the natural a-amino acids. The 
7-substituted a-amino acid 2-amino-4-methylhexanoic acid 134 was also a substrate 
for tv-DAAO. However, attempts at oxidation of the amino acid 2-amino-3-
ethylhexanoic acid 124 proved difficult. In the first attempt (§ 8.2.1.2), using 0.68 U 
of tv-DAAO, the first three chromatographic peaks were approximately 75% of their 
original integration, and the fourth chromatographic peak had completely 
disappeared. Using 1.7 U of tv-DAAO in an attempt to drive the reaction to 
completion, the first two peaks showed approximately 135% of their original 
integration, the third peak was approximately 80% and the fourth peak had 
disappeared. This unexpected result would appear to indicate a problem with the 
integration of the chromatographic peaks. Due to the negligible UV absorbance of 
the amino acid the peak area is very small, resulting in large errors in integration. No 
further reactions were attempted with this amino acid. Similar problems with HPLC 
analysis were observed for the amino acid (2RS,4RS)-2-amino-4-ethyloctanoic acid 
and no oxidation studies were attempted. 
The deracemisation of the - and 7-substituted a-amino acids was next attempted 
(table 3.2.2). Theoretically the four diastereoisomers should be converted to a single 
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pair of enantiomers in a 1:1 ratio. Figure 3.2.1 shows that after only three cycles the 
majority of the amino acid bears S-specificity at the a-position, with an 





























Figure 3.2.1: interconversion of stereoisomers of n-substituted a-amino acids 
Table 3.2.2 
§ no. Sub. U 
a [H] (eq.) Time! h Yield! % e.e./ % 
1 8.3.1.3 b 115 0.68 NaCNBH3 (25.4) 18.0 63 >99 
2 8.3.1.3 115 0.68 NaBFL (42.1) 3.0 94 >99 
3 8.3.1.3 115 0.68 NaBH4 (42.1) 3.5 99 >99 
4 8.3.1.3 112 0.68 NaCNBH3 (25.4) 2.0 69 33 C 
5 8.3.1.4 112 1.70 NaCNBH 3 (38.1) 22.0 68 48 C 
6 8.3.1.4 112 3.40 NaCNBH3(63.5) 22.0 86 SOC 
7 8.3.1.3 112 0.68 NaBH4 (42.1) 6.0 71 >99 
8 8.3.1.4 134 1.70 NaCNBH3  (3 8. 1) 22.0 66 >99 
9 8.3.1.4 134 3.40 NaCNBH3 (63.5) 22.0 60 >99 
a) a) 1 U = 1 p.mol of cephalosporin C oxidised per minute; b) 5 eq. NH4CO2 added; 
c) diastereomeric excess quoted 
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Not all the reactions proceeded to completion and the quoted yield is the sum of any 
diastereoisomers remaining at the end of the reaction. For 2-amino-3 -phenylbutanoic 
acid, the 2R,3S isomer was completely depleted, however some 2R,3R isomer 
remained, i.e. incomplete oxidation of the R-enantiomer was observed. In these cases 
the d.e. is quoted instead of e.e. For 2-amino-3-methylhexanoic acid and 2-amino-4-
methylhexanoic acid, only the stereoisomers with S-configuration at the 2-position 
remain at completion of the reaction. 
The reactions with sodium cyanoborohydride were not efficient and in the case of 
2-amino-3-phenylbutanoic acid resulted in incomplete oxidation of the R-enantiomer 
(entries 4-7). Addition of excess NaCNBH3 and enzyme actually resulted in a lower 
yield of (2S,45)-2-amino-4-methylhexanoic acid (entries 8&9). Replacing NaCNBH 3 
with NaBH4 allowed the amino acids 2-amino-3-methylhexanoic acid and 2-amino-
3-phenylbutanoic acid to be prepared in optically pure form in good to excellent 
yields (entries 2,3&7). Once again the amino acid with its a-keto acid in a 
conjugated state resulted in a lower yield (entry 7, figure 3.2.2). 
Me 0 	 Me 0 
fff" OH 
144 
Figure 3.2.2: tautomerism of 2-keto-3-phenylbutanoic acid, 144 
Attempts at deracemisation on a 25 niM scale resulted in only oxidation of the 
R-enantiomer due to insufficient reducing agent present (table 3.2.3). 
Table 3.2.3 
§ no. Sub. u 
a [H] (eq.) Time! h Yield! % e.e./ % 
1 8.3.1.6 112 25.5 NaCNBH3 (5.1) 26.0 58 24 
b 
2 8.3.1.6 112 17.0 NaCNBH 3 (10.2) 42.0 60 
3 1 8.3.1.6 134 25.5 NaCNBH3 (5.1) 28.0 50 >99 
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- § no. Sub. U 
a IHI (eq.) Time! h Yield! % e.e.! % 
4 8.3.1.6 134 17.0 NaCNBH3 (10.2) 42.0 45 >99 
5 8.3.1.6 115 42.5 NaCNBH3 (10.2) 22.0 58 >99 
6 8.3.1.6 115 17.0 NaBH4 (10.0) 22.0 46 >99 
a) a) 1 U = 1 pLmol of cephalosporin C oxidised per minute; b) d.e. quoted 
3.3. Conclusions & Future Work 
The deracemisation of 13-substituted a-amino acids using tv-DAAO and borohydride 
reducing agents has been demonstrated. NaCNBH 3 has been successfully used in the 
deracemisation of acyclic a-amino acids for the first time. Certain aromatic a-amino 
acids are not deracemised as efficiently as aliphatic a-amino acids due to the 
inhibition of the enzyme by the a-keto acid by-product. The scale-up of the reaction 
remains to be optimised, however, the alternative reducing agents now developed for 
the production of D-amino acids may improve the success of the deracemisation of 
a-amino acids bearing two stereogenic centres. 86 
In previous work the cyclic oxidation-reduction sequence has been successfully used 
in the stereoinversion of a-amino acids from the R- to the S-enantiomer and vice 
versa.84 ' 86 Asymmetric hydrogenation (§ 1.1.3) is often used to prepare 13-substituted 
a-amino acids with both centres stereochemically defined. The drawback of this 
approach is that, due to the nature of the catalyst, hydrogen can only be added in a 
syn fashion. A combination of asymmetric hydrogenation and stereoinversion should 
allow access to all four diastereomers of 13-substituted a-amino acids (figure 3.3.1). 
R' 	 1) H21 cat*Rh 	 tv-DAAO 
H <COH 
NH-P 	 2) HC1 	 NH, 	 NaCNBH3 	 NH2 
Figure 3.3.1: chemoenzymatic synthesis of 13-substituted a-amino acids 
R&D: Oxidase enzymes 
4. Results & Discussion: Screening for oxidase 
enzymes 
In order to broaden the scope of the deracemisation reaction to include production of 
D-a-amino acids and chiral amines, it is necessary to have access to a wider range of 
oxidase enzymes. The production of D-a-amino acids from the racemic mixture is 
dependent on finding commercially viable sources of L-amino acid oxidase. To 
prove the concept of amine deracemisation, flavin-dependent monoamine oxidases 
exhibiting stereoselectivity are required. Examination of the literature revealed a 
variety of organisms displaying amino acid and amine oxidase activities (§ 1.4), 
therefore it was decided to screen randomly selected organisms in an attempt to find 
novel LAAO and MAO activities. 
4.1. Development of high-throughput assay 
Screening a large library of organisms requires an efficient assay method in order to 
maximise the probability of identifying a "hit". The production of a dye via 
enzymatic reaction is a common method for the measurement of enzyme activity,' 35 ' 
136 as it allows quick and easy identification of possible hits and can also be adapted 
to quantitative methods using a spectrophotometer in conjunction with a kinetics-
measuring programme. Hydrogen peroxide is a product in the oxidation of amines 
and L-amino acids by monoamine oxidase and L-amino acid oxidase respectively. A 
number of assays have been developed that allow measurement of enzymatic activity 
based on hydrogen peroxide production.'37' 138  Hydrogen peroxide is reduced to 
water in the presence of horseradish peroxidase (HRP) and a proton donor (e.g. 
4-aminoantipyrine, AAP, 145). The proton donor for this peroxidase reaction is 
oxidised in the process and subsequently reacts with an acid, in this case vanillic acid 
(146), to form a soluble dye 147 (figure 4. 1.1).137  The absorbance change at 500 nm 
can be measured and used to calculate the activity of the oxidase enzyme. 
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LAAO or MAO 
SUBSTRATE 
Figure 4.1.1: peroxidase-coupled colorimetric assay * 
Activity (U.mr 1 ) = initial rate(Au.s 1 ) x ('/) x 60 x (t/s.v)  x ixiO3 . 
where s = molar extinction coefficient (M' .cm') 
t.v. = total reaction volume 
s.v. = sample volume 
4.1.1. Validation of assay 
A series of experiments were carried out using a Cobas Mira discrete data analyser 
(§ 9.1). The optimum reagent concentrations were determined and linearity and 
reproducibility of the assay proved (table 4.1.1). Benzylamine was used as the 
substrate, which reacts with MAO to give benzaldehyde. The HIRP, AAP and vanillic 
acid were pre-mixed in a 1:1:1 ratio (§ 9.5.17). Plasma amine oxidase (PAO, Sigma 
#M4636, 1.1 U.mr') was used as the standard for monoamine oxidase assay and a 
3% H202 solution was prepared for use as positive control. 
exact structure of dye has not been determined. 
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Table 4.1.1 
T/ °C [BzNH2 ] Sample a Activity (U.mr') b 
1 30 0.2 mM H202 (0.04%) -0.18 
2 30 0.2 mM PAO (0.015 U) 0.01 
3 30 0.4 mM H202 (0.04%) -0.18 
4 30 0.4 mM PAO (0.015 U) 0.03 
5 37 0.4 mM H202 (0.04%) -0.23 
6 37 0.4 mM PAO (0.015 U) 0.05 
7 37 1.6 mM H202 (0.40%) 0.00 
8 37 1.6 mM H202 (0.08%) -0.07 
9 37 1.6 mM H202 (0.04%) -0.18 
10 37 1.6 mM H202 (0.02%) -0.36 
11 37 1.6 mlvi PAO(0.015U) 0.11 
12 37 3.2 mlvi PAO (0.015 U) 0.14 
13c 37 3.2mM PAO(0.015U) 0.16 
14 37 3.2 mM PAO (0.075 U) 0.42 
15 37 3.2mM PAO(0.015U) 0.18 
16 37 3.2mM PAO(0.010U) 0.12 
17 37 3.2 mM PAO (0.008 U) 0.09 
18 37 3.2 mM PAO (0.005 U) 0.06 
19 37 3.2 mM PAO (0.004 U) 0.05 
a) 1 U = 1 tmol of benzylamine oxidised per minute; b) negative activity is a result 
of non-linear change in absorbance; c) reagent concentration halved 
Concentrations of hydrogen peroxide above 0.08% show a very low change in 
absorbance. This is probably due to denaturation of the HRP at high H 202 
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concentrations. The concentration of benzylamine was varied until no significant 
variation in activity was observed (entries 2,4,6,11&12). When the concentration of 
reagent was halved (entry 13) no difference in activity was observed showing that the 
HRP reaction or dye-formation were not rate limiting. Linearity (entries 14-19) has 
been proved within the range 0.025 to 0.1 (figure 4.1.2) and reproducibility 
experiments showed c.v. <2% (calculated by Cobas Mira), i.e. within the acceptable 
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Figure 4.1.2: linearity of MAO assay 
L-Amino acid oxidase purified from snake venom (Sigma #A8390, 1.0 U.mr) was 
used as the standard for the L-amino acid oxidase assay. L-Phenylalanine was used 
as substrate, which reacts with LAAO to give phenylpyruvic acid and hydrogen 
peroxide. Linearity and reproducibility experiments, using optimised concentrations 
from monoamine oxidase assay, were within acceptable limits of ± 5%. 
4.2. Screening of culture collections 
4.2.1. Monoamine oxidase 
Both copper and FAD dependent amine oxidases (AO) are prevalent in microbial 
sources. The copper dependent AO is mainly found in bacteria and yeast, whereas 
the flavin dependent AO is present in a number of fungi. Although copper dependent 
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AO is not a viable enzyme for amine deracemisation due to the covalent binding of 
the imine to the active site of the enzyme, the screening of bacterial and yeast 
sources was undertaken as it has been shown that the fungus A. niger produces both a 
copper dependent AO and a flavin dependent form of MAO.' 2° 
The organisms used in the screening program were chosen from the literature and 
from a random selection of the GlaxoSmithKline biotransformation collection. 
Organisms were selected from fungal, bacterial and yeast species, and grown until 
sufficient biomass was obtained. Fungal strains were grown in FS media (§ 9.5.4), 
yeast strains were grown in YEPD media (§ 9.5.5) and bacterial species were grown 
in SV2 media (§ 9.5.3). The biomass was harvested and then used to inoculate 
induction media (growth media + 0.1% butylamine). After incubation the cells were 
harvested and disrupted by sonication. Both the media supematant and the cleared 
cell lysate were assayed for monoamine oxidase activity. 
Seventy-four organisms were assayed using the colorimetric assay outlined in § 4.1 
(§ 11.1, entries 1-74), including a number that were cited as monoamine oxidase 
producers. However, the assay showed zero absorbance change from any of the 
organisms. It was thought that production of catalase by the organisms might be 
preferentially reacting with the hydrogen peroxide, or the amount of H 202 produced 
by the organism is denaturing the horseradish peroxidase. In view of this an 
alternative assay method was sought. Monoamine oxidase reacts with benzylamine to 
form benzaldehyde. Benzylamine has a molar extinction coefficient (E) of zero at 
250 nm, whilst benzaldehyde has c = 12500 M 1 .cm'. In 1954, Tabor etal. used this 
information to assay monoamine oxidase from beef plasma.' 39 A solution of 
benzylamine with enzyme was monitored at 250 nm for 10 minutes. Activity 
(U.mr') can be calculated using the same format as before. A number of organisms 
were assayed using this method (§ 11.1, entries 75-143), with some showing a 
change in absorbance at 250 nm (table 4.2.1). 
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Table 4.2.1 




1 Penicillium chrysogenum Q176 wisco 0.009 - 
2 S. carisbergensis ncyc 530 0.028 - 
3 Schizosaccharomyces 
ombe 
ncyc 380 - 0.008 
4 Zygosaccharomyces 
rermen tatai 
cbs 67.72 0.009 - 
5 Curvularia lunata nrrl 2434 0.008 - 
6 Absidia cylindrospora nrrl 2796 0.009 - 
7 Streptomyces lavendulae cbs 414.59 - 0.008 
8 Streptomyces griseus nrrl 3851 - 0.008 
9 Streptomycespunipalis nrrl 3529 - 0.012 
10 Mucorracemosus - 0.011 - 
11 A. ochraceus imi 16264 0.002 0.032 
12 Septomyxaaffinis atcc 6737 - 0.064 
13 Verticillium lecanii imi 68689 0.044 0.025 
14 A. terreus imi 045543 - 0.068 
15 A. alliaceus atcc 10060 - 0.010 
16 Xylariapolymorpha F5755 0.016 - 
17 Pichia angusta atcc 76722 0.012 - 
18 Providencia rustigianii atcc 13159 0.002 0.008 
19 Serratia marcesens atcc 274 0.008 - 
20 Erwinea aroideae atcc 25206 - 0.008 
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The change in absorbance at 250 nm was non-linear in all these cases, and it was not 
possible to say if the absorbance change was due to monoamine oxidase activity or 
as a result of some artefact. In an attempt to overcome any ambiguity samples were 
submitted for LC/MS analysis. However, this proved unsuccessful because 
electrospray ionisation does not ionise benzaldehyde, either in the positive or 
negative mode. Finally, an HPLC method was developed to separate benzylamine 
and benzaldehyde. This method was used to screen organisms that had shown an 
absorbance change in the spectrophotometric assay method (§ 9.4.1). Analysis was 
performed at t = 1 h, t =24 h, and t =48 h. Unfortunately, none of the organisms 
screened in this way showed a peak assignable to benzaldehyde. 
From these results it appears that the organisms screened do not produce monoamine 
oxidase. However, the fact that some of these organisms are known producers of 
MAO suggests that lack of sensitivity in the assays is the reason for the lack of hits. 
Further optimisation of the HPLC assay may reveal novel monoamine oxidase 
sources. 
4.2.2. L-Amino acid oxidase 
L-Arnino acid oxidases documented in the literature are mainly found in bacteria and 
fungi. As before, the organisms used in the screening program were chosen from the 
literature and from a random selection of the GlaxoSmithKline biotransformation 
collection. Organisms were selected from fungal, bacterial and yeast species and 
these organisms grown as for the monoamine oxidase assay. The biomass was then 
used to inoculate induction media (growth media + 0.1% L-Phe). After incubation 
the cells were harvested and disrupted by sonication. Both the media supernatant and 
the cleared cell lysate were assayed for L-amino acid oxidase activity. 
The organisms were first assayed based on hydrogen peroxide production (§ 11.1, 
entries 1-74). However, as with the MAO screen, no activity was found, most likely 
due to production of catalase and an alternative assay was sought. Again a 
spectrophotometric method was available, where the absorbance change at 320 nm 
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was measured over 10 minutes, i.e. measurement of phenylpyruvic acid production. 
Activity (U.mr') was calculated as before. A number of organisms were assayed 
using this method (§ 11.1, entries 75-143), with some showing a change in 
absorbance at 320 nm (table 4.2.2). 
Table 4.2.2 




1 Proteus vulgaris atcc 13315 0.029 - 
2 Pseudomonasputida ncimb 12190 0.033 - 
3 Bacillus cereus ncimb 11617 0.029 - 
4 E. coli atcc 9637 0.056 - 
5 Kiebsiella oxytoca - 0.075 - 
6 Corynebacterium equi ifo 3730 - 0.012 
7 Nocardioides simplex atcc 6946 0.008 - 
8 Mucorracemosus - - 0.016 
9 Cylindrocarpon radicicola atcc 11011 0.003 0.015 
10 Septomyxaaffinis atcc6737 - 0.019 
11 Giberellafujikuroi atcc 12616 - 0.016 
12 Verticillium lecanii imi 68689 - 0.007 
13 P. angusta atcc 76722 0.013 - 
14 P. angusta atcc 76723 0.009 0.006 
15 Providencia rustigianii atcc 13159 - 0.015 
The absorbance change at 320 nm was non-linear and LC/MS in negative ionisation 
mode was used to confirm production of phenylpyruvic acid (§ 11.3). Five organisms 
were found to show an LC/MS spectrum corresponding to phenylpyruvic acid, 
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indicating possible L-amino acid oxidase activity (table 4.2.3). However, these 
organisms will need further study to determine if they indeed contain L-amino acid 
oxidases as the deaminase family of enzymes would also produce phenylpyruvic 
acid. 
Table 4.2.3 




1 Septomyxa affinis atcc 6737 10 % PPA 3 % PPA 
2 Verticillium lecanii imi 68689 3 % PPA n 
3 Proteus vulgaris atcc 13315 5 % PPA 2 % PPA 
4 Pseudomonasputida ncimb 12190 n 1 % PPA 
5 Providencia rustigianii atcc 13159 9 % PPA 4 % PPA 
a) % PPA calculated from MS intensity 
4.3. Conclusions & Future Work 
The random screening program adopted for identifying novel oxidase activities has 
proved relatively unsuccessful. In general, the assays employed lack the sensitivity 
required to identify activity against the background activity of the organisms. The 
exception appears to be the LC/MS assay used in screening for L-amino acid oxidase 
activity, however this could not be extended to encompass screening for monoamine 
oxidase activity. 
The five organisms identified as having L-amino acid oxidase activity require further 
purification and characterisation to positively identify them as L-amino acid 
oxidases. The two fungi, Septomyxa affinis and Verticillium lecanii, have not been 
previously reported as containing L-amino acid oxidases. 
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5. Results & Discussion: Monoamine oxidase from 
Aspergillus niger 
As no monoamine oxidase activity was found through the screening program, 
attention turned to the monoamine oxidase recently identified by Schilling et al. in 
the fungus A. niger (MAO-N).' 2° The gene has been isolated, sequenced and 
subcloned in pET3a to produce the expression vector pECME3. 12 ' Although 
extensive characterisation of the enzyme had been reported, the stereospecificity of 
the enzyme with respect to chiral substrates had not been examined. 122 
5.1. Oxidation of RS-AMBA by E. coil BLR(DE3) [pECME3] 
5.1.1. Growth of E.coli BLR(DE3) fpECME3J 
The plasmid MAO-N [pECME3] was transformed into E. coli BLR(DE3) competent 
cells and incubated in LB/amp50 media (10 x 50 ml in 250 ml flasks) at 37 °C, 
250 rpm for 24 h (013600 = 3.5). The saturated media was used to inoculate 
LB/amp50 media (10 x 400 ml in 2 L florence flasks), which were incubated at 
37 °C, 200 rpm for 14.5 h (013600 = 3.5). The cells were harvested (wet weight 
36 g), resuspended in phosphate buffer (100 mM, 110 ml) and disrupted. The cleared 
cell lysate had an activity of 0.20 U.mr 1 towards benzylamine (§ 9.4.3). 
5.1.2. Oxidation of RS-AMBA by cell free extract 
a-Methylbenzylarnine is a valuable compound in organic synthesis and is produced 
on a multi-kilogram scale via a resolution process. 2 It is often used as a model 
substrate in the development of new processes for the synthesis of enantiomerically 
pure amines. 2 ' 3 ' 39 ' 51 ' 70  The cell free extract of BLR(DE3) [pECME3] was examined 
for activity and stereoselectivity towards RS-AMBA, using HPLC for analysis 
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(§ 8.6.7). The extract was incubated with a solution of AMBA in 50 mM phosphate 
buffer, pH 7.4 at 30 °C until no further reaction was observed (table 5.1.1). 
Table 5.1.1 
§ no. Conc.I mM U 
a Time/ h Yield (R)/ % e.e./ % 
1 8.4.1.1 0.9 0.2 95.0 28 16 
2 8.4.1.1 0.8 0.4 96.0 26 8 
3 8.4.1.1 0.7 0.6 97.0 23 10 
4 8.4.1.1 4.5 0.2 74.0 39 2 
a) 1 U = 1 .tmol benzylamine oxidised per minute 
The enzyme appeared to act with some stereoselectivity towards the S-enantiomer of 
AMBA. However, the amount of enzyme used did not significantly affect the yield 
or enantiomeric excess of the reaction (entries 1-3). Increasing the substrate 
concentration resulted in negligible stereoselectivity (entry 4). In an effort to evaluate 
the stereoselectivity of the reaction the lysate of BLR(DE3) [pECME3] was 
incubated separately with each enantiomer of AMBA at a concentration of 0.9 mM 
(table 5.1.2). Only a slight preference for the S-enantiomer was observed. 
Table 5.1.2 
§ no. Substrate u 
a Time/ h Yield (R)/ % e.e./ % 
1 8.4.1.2 R-AMBA 0.1 96.0 67 100 
2 8.4.1.2 S-AMBA 0.1 96.0 63 100 
a) 1 U = 1 tmol benzylamine oxidised per minute 
When using biocatalysts in organic synthesis the main advantages are that the 
reactions can be carried out under mild conditions, i.e. room temperature, pH 7, and 
that they offer an environmentally friendly alternative as the reactions are carried out 
in water. However, the poor solubility of many organic compounds in aqueous 
systems can limit the practicality of the reaction. An accepted method to overcome 
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this problem is to perform the reaction in either bi-phasic systems or in organic 
solvents with low water content. 140 Recently it had been shown that using different 
amine oxidases in organic solvents is a convenient method for the oxidation of 
poorly soluble amines.' 4 ' It is also known that the MAO-B isozyme efficiently 
catalyses the oxidation of amines in organic solvent.'17' 118  It was decided to perform 
the oxidation of AMBA in the presence of organic solvent in an attempt to increase 
the efficiency of the oxidation reaction. The cell free extract (0.1 U, BzN}1 2) was 
incubated with 1 mM RS-AMBA in 50 mM buffer containing hexane as co-solvent 
(table 5.1.3). 
Table 5.1.3 
§ no. % Hexane pH Time! h Yield (R)/ % e.e.! % 
1 8.4.1.3 10 7.4 94 13 40 
2 8.4.1.3 15 7.4 95 16 22 
3 8.4.1.3 10 5 96 32 19 
4 8.4.1.3 10 6 96 26 16 
5 8.4.1.3 10 7 96 23 17 
6 8.4.1.3 10 8 96 29 14 
7 8.4.1.3 10 9 96 28 .18 
Initial reactions looked promising, with approximately four-fold increase in e.e. 
observed and a concomitant decrease in yield (entry 1), indicating an improvement in 
the rate of oxidation. However, this result was not reproducible and the best e.e. 
obtained thereafter was <20%. The effect of pH on the reaction was found to be 
negligible (entries 3-7). 
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5.1.3. Purification studies 
E. coli is a known producer of monoamine oxidase' 42 and we considered that the 
E. coli enzyme may be interfering with the stereoselectivity of the reaction. In order 
to discount interference from the indigenous enzyme, purification of the MAO-N 
enzyme encoded by pECME3 was undertaken. Sablin et al. recently isolated the 
enzyme in pure form 122 and stated that the E. coli monoamine oxidase can be 
removed in the first stage of the purification (DEAE-sepharose anion exchange 
chromatography). The cell free extract obtained in § 5.1 was dialysed against 
Tris/HC1 buffer (25 mM, pH 7.8) containing 1 mM DTT and subjected to FPLC 
purification on a DEAE-sepharose column (§ 9.3.1.3). The fractions were assayed 
against benzylamine using the colorimetric assay 9.4.1.2. Active fractions were 
diluted in ammonium sulfate (1.7 M in 50 mM phosphate buffer, pH 7.2) and eluted 
through a phenyl-sepharose hydrophobic interaction resin (§ 9.3.2.1). The 
colorimetric assay showed no activity in any of the fractions collected or in the flow-
through from loading the column. The absorbance at 280 nm was measured and it 
was discovered that approximately half the protein loaded was in the flow-through, 
i.e. protein had not bound to resin, and the remainder was spread throughout the 
fractions. This loss of activity is in contrast to the published work, which observed 
very little loss in the total activity (437 U c.f. 499 U at start). 
The MAO-N enzyme appeared to suffer from problems of stability during and after 
purification, e.g. CFE activity t(0) = 0.20 U.mr 1 , t(5d, 4 °C) = 0.006 U.mr'. Thus it 
was decided to investigate the effect of different inhibitors on the stability of the 
enzyme during purification and storage. The whole cells were disrupted (5 mm, 30 s) 
in the presence of three different inhibitor cocktails (ci, c2 & 6) and then purified 
on a MonoQ anion exchange column (§ 9.3.1.4). The activity of each enzyme 
preparation was assayed using hydrogen peroxide based method using benzylamine 
as substrate (table 5.1.4). 
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Activity (ci) a 
/ U.ml' 
Activity (c2) a 
/ U.mi' 
Activity (6) a 
I U.ml' 
CFE - 0 0.241 0.229 0.199 
CFE 4 1 0.082 0.106 - 
CFE 4 2 0.171 0.144 0.089 
CFE -80 12 - - 0.108 
Purified" - 0 0.307 0.655 - 
Purified 4 1 0.285 0.596 - 
Purified -80 12 0.420 0.618 - 
a) ci = 1 mM PMSF, 1 mM EDTA, 1 mM DTT c2 = Sigma general use protease 
inhibitor cocktail c3 = Sigma mammalian cell protease inhibitor cocktail + 1 mlvi 
EDTA; b) CFE in presence of ci was overloaded on column, therefore purification 
was not as efficient as for CFE in presence of c2 
The addition of a cocktail of commercial inhibitors did not offer any great advantage, 
and it was therefore decided to perform purification in the presence of PMSF, EDTA 
and DTT. The cell free extract showed a considerable drop in activity with 
benzylamine when stored at 4 °C, however the purified enzyme appeared more stable 
at 4 °C. Storage of the purified enzyme at -80 °C showed good stability. The effect of 
glycerol on the activity of purified MAO-N towards benzylamine was investigated 
(table 5.1.5) and the best storage conditions were at -80 °C, when no glycerol was 
present. In both investigations the hydrogen peroxide assay showed some problems 
with reproducibility. Loss of HRP activity was ruled out as the probable cause, 
therefore the fluctuations may have been to do with aeration differences between 
assays. 
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Table 5.1.5 
Conditions Activity! U.m1 1 
t=Od 
Activity! U.m1 1 
t = 7 d 
Activity! U.mr' 
t=19d 
0%glycerol,4°C 0.023 0.030 - 
0% glycerol, -20 °C 0.023 0.017 0.012 
0% glycerol, -80 °C 0.023 0.044 0.050 
20% glycerol, -20 °C 0.023 0.015 - 
20% glycerol, -80 °C 0.023 0.011 negative rate 
50% glycerol, -20 °C 0.023 0.010 - 
50% glycerol, -80 °C 0.023 0.036 0.026 
5.1.4. Oxidation of RS-AMBA by partially purified MA 0-N 
BLR(DE3) [pECME3] was grown in LB/amp 50 media at 37 °C and harvested to 
yield 5.6 g of cells. The cells were resuspended in lysis buffer (1 mM DTT, 1 mlvi 
PMSF and 1 mM EDTA), disrupted by sonication (10 mm, 30 s period) and the cell 
free extract was subjected to purification on Q-Sepharose anion-exchange resin 
(§ 9.3.1.1). The fractions collected were assayed by the hydrogen peroxide based 
method (§ 9.4.1.2), with the most active fraction having 0.32 U.mg' activity towards 
benzylamine. The partially purified extract (0.46 U) was incubated at 30 °C with RS-
AMBA (0.9 mM) in 100 mM buffer, pH 8 and monitored by HPLC (§ 8.6.8). After 
94 h HPLC showed 37% yield of the R-enantiomer and 37% yield of the S-
enantiomer, indicating that the stereoselectivity observed previously must have been 
due to the native E. co/i monoamine oxidase enzyme. 
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5.2. Oxidation of RS-AMBA byE. coil BL2I(DE3) [pMAO-N] 
5.2.1. Growth of E.coli BL2I(DE3) fpMAO-NJ 
Analysis of the protein purification by SDS-PAGE showed that the expression of 
MAO-N from pECME3 was poor (data not shown). Therefore, in an attempt to 
improve expression of the protein, the gene encoding monoamine oxidase from 
A. niger was subcloned into the plasmid pET 16b by Marina Alexeeva to produce the 
plasmid pMAO-N. 
Experiments by M. Alexeeva showed that in this new construct MAO-N acted with 
some stereoselectivity towards RS-AMBA.' 43 BL2 1 (DE3) [pMAO-N] was grown in 
LB/amplOO media at 30 °C until 0D600 = 3.8. Aliquots (12 x 1 ml) of the growth 
media were spun down (14000 g, 3 mm) and the frozen pellets stored at -20 °C. The 
remainder of the culture media was harvested to yield 10.4 g of cells and stored at 
-20 °C. The activity of the whole cells towards amylamine was 0.15 U.mr 1 (§ 9.4.2). 
5.2.2. Oxidation of RS-AMBA by whole cells and CFE 
The thawed pellets ofBL2l(DE3) [pMAO-N] were incubated at 30 °C with AMBA 
in 100 mlvi buffer, pH 8 (table 5.2.1). The reaction was followed by HPLC analysis 
(§ 8.6.8). Increasing the amount of enzyme relative to the substrate did not have an 
appreciable effect on the yield or stereoselectivity of the reaction (entries 1-3). 
Increasing the reaction time showed no difference in the e.e. (entries 4&5), indicating 
that both enantiomers were being oxidised to the same extent. A significant effect 
was observed when the buffer concentration was reduced to 20 mM, with the 
enantiomeric excess increasing to 58% (entry 6). This result may offer an alternative 
explanation to the lack of selectivity observed in the oxidation of RS-AIvIIBA by the 
purified fraction of BLR(DE3) [pECME3] (§ 5.1.3) as this reaction was also 
performed in 100 mM buffer. Increasing the amount of enzyme increased the 
reaction rate but lowered the selectivity of the reaction (entry 7). 
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Using E. coli BL21(DE3) [pETl6b] cells showed that AMBA was oxidised by the 
E. coli cells without MAO-N present to almost the same extent as when the gene is 
present but without the same selectivity (entry 8). This indicates that the selectivity 
previously observed in the reaction was probably due to the recombinant monoamine 
oxidase, MAO-N. 
Table 5.2.1 
§ no. Conc.! mM U 
a Time! h Yield (R)/ % e.e./ % 
1 8.4.3.1 0.9 010b 54 10 
2 8.4.3.1 0.7 0.29" 47 56 10 
3 8.4.3.1 0.5 0.48 b 47 46 10 
4 8.4.3.1 0.9 0.10" 89 45 10 
5 8.4.3.1 0.9 010b 94 42 14 
6 8.4.3.1 	C 0.9 0.08 99 78 58 
7 8.4.3.1 	C 1.0 0.16 97 34 26 
8 8.4.2.1 c,d 0.9 10% 89 40 8 
a) 1 U = 1 tmol amylamine oxidised per minute; b) cells provided by M. Alexeeva 
(0.20 U.mF') c) 20 mM buffer, pH 8; d) plain BL21(DE3) [pET 16b] cells 
The frozen cells of MAO-N [pET16b] (10.4 g) were resuspended in lysis buffer 
(1 mM PMSF) and disrupted (10 mm, 30 s). The CFE was incubated with RS-AMBA 
in 20 mM buffer, pH 8 at 30 °C (table 5.2.2). 
65 
R&D: Oxidase enzymes 
Table 5.2.2 
§ no. Conc./ mM u 
a Time! h Yield (R)/ % e.e.I % 
1 8.4.3.2 0.9 0.19 99 48 24 
2b 8.4.3.2 0.9 0.19 99 70 50 
3 8.4.3.2 0.9 0.27 97 50 46 
4C 8.4.3.2 1 0.9 0.27 97 15 96 
a) 1 U = 1 tmol amylamine oxidised per minute; b) catalase added; 
c) reaction vial 4 x usual size 
The cell free extract showed a similar reactivity and selectivity towards RS-AMBA 
as the whole cells (entry 1). Addition of catalase slowed the reaction but increased 
the selectivity (entry 2). Surprisingly, increasing the amount of MAO-N did not 
affect the yield of the reaction but improved the selectivity (entry 3). The most 
interesting effect was noted when the size of the reaction vessel was increased 
relative to the reaction volume (entry 4), i.e. the volume of oxygen present in the 
vessel was increased. The yield of the R-AIMIBA was much lower indicating a faster 
reaction rate and the reaction was almost completely enantioselective. The oxidation 
of amines by the isozyme MAO-B is known to be sensitive to 02 concentration and 
Sablin et al. have demonstrated that, in this respect, MAO-N resembles the behaviour 
of MAO-B.' 22 
5.3. Production of a MAO-N mutant 
In all experiments with BLR(DE3) [pECME3] or BL21(DE3) [pMAO-N], either 
whole cell, CFE or purified extract, the rate of AMBA oxidation was very slow and 
the enantioselectivity was variable. This led to the conclusion that the wild type 
MAO-N would not be a viable enzyme for the deracemisation of chiral amines. In 
recent years, the activity and selectivity of enzymes have been modified using a 
"directed evolution" approach."' 46 The amino acid residues in the enzyme are 
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randomly mutated, and the mutated enzyme library is screened for enhanced activity. 
Marina Alexeeva used E. coli XL1-Red mutator strain to randomly mutate the 
plasmid containing MAO-N [pET16b]. This mutator strain offers the advantage that 
all parts of the plasmid are subject to mutation, not only the gene of interest. A 
library of approximately one million variants was obtained, a fraction of which was 
screened against S-AMBA. The assay method was based on the hydrogen peroxide 
colorimetric method. However, the AAP proton donor was replaced by 
3,3'-diaminobenzidine, which results in an insoluble dye more appropriate to the 
screening of agar plates as the colour does not diffuse from the active colony. 
Twenty-four colonies were identified as having increased activity towards S-AMBA, 
which were subsequently grown on a small scale and one clone was shown to be 
superior in terms of its selectivity and activity towards S- versus R-AMBA. This 
clone was sequenced and one specific mutations identified: N336S. After 
purification of the selected mutant kcat for S- and R-AMBA was measured, which 
revealed that the activity of the mutant towards S-AMBA ('( cat = 8.0 min) was 
47-fold higher than the wild type (kcat = 0.17 min
1 ). 147 Moreover the selectivity of 
the mutant for the S-enantiomer versus the R-enantiomer (ca. 100:1) was also 
increased relative to the wild type (Ca. 17:1).147  Oxidation reactions of AMBA by 
this mutant (BL21(DE3) [pMAO-Nmut.]) were carried out and compared to the 
reactions with the wild type enzyme. 
5.3.1. Investigation into background activity of E. coli cells 
BL21(DE3) [pETl6b], BL21(DE3) [pMAO-N] and BL21(DE3) [pMAO-Nmut.] 
were grown in LB/amp 100 media (300 ml) at 30 °C. Aliquots (12 x 1 ml) were spun 
down (14000 g, 3 mm) and stored at -20 °C. The remainder of the growth media was 
harvested and stored at -80 °C. The BL21(DE3) [pETl6b] cells had zero activity 
towards amylamine, BL2 1 (DE3) [pMAO-N] had an activity of 0.15 U.mF 1 and 
BL2 1 (DE3) [pMAO-Nmut.] had an activity of 0.20 U.mr'. The cells were incubated 
at 30 °C with RS-AMBA (0.9 mM) in 20 mM buffer, pH 8 and the results shown in 
table 5.3.1. 
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Table 5.3.1 
§ no. Strain U 
a Time! h Yield (R)! % e.e.! % 
1 8.4.2.1 BL21 [pET16b] 10% 99 58 76 
2 8.4.3.1 BL21 [pMAO-N] 0.08 99 78 58 
3 8.4.4.1 BL21 [pMAO-Nmut.] 0.10 99 86 74 
a) 1 U = 1 mo1 amylamine oxidised per minute 
After 20 h the mutated enzyme showed approximately a 10-fold increase in 
enantioselectivity relative to the wild type MAO-N enzyme and BL21(DE3) 
[pET 16b] control, both of which oxidised RS-AMBA to the same extent. However, 
as the reaction progressed, the BL2 1 (DE3) [pET 1 6b] cells increased in selectivity to 
the point that they showed the greatest selectivity relative to the MAO-N enzymes 
(figure 5.3.1). 
Figure 5.3.1: oxidation of RS-AMBA by whole cells 
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5.2.1. Purification of BL.21(DE3) [pMAO-N] and BL2I(DE3) 
[pMA O-Nmut.] 
The question of interference by the native E. coli monoamine oxidase had obviously 
not yet been frilly resolved. In an attempt to eliminate this background activity, we 
decided that 131_2I(DE3) [pMAO-N] and BL2I(DE3) [pMAO-Nmut] needed to be 
purified. The plasmid encodes six histidyl residues at the C-terminus of MAO-N. 
This hexahistidine motif is often introduced as an aid to purification, as metal affinity 
chromatography can be used as a one-step purification technique (§ 9.2.8). The 
purification relies on the hexahistidine motif binding to Ni 2 ions on the resin and 
imidazole is then used as a competitive chelator to elute the protein. However, 
attempts at purification ofBL2l(DE3) [pMAO-N] and BL2I(DE3) [pMAO-Nmul.] 
using this method were unsuccessful. On elution from the resin the protein was 
active (1.57 U.nii' against amylamine) and partially purified (figure 5.3.2). 
However, the protein precipitated over time, even when stored at -80 °C, and activity 
towards amine substrates was lost. The precipitation may have been due to the high 
salt and imidazole concentration of the eluted fractions. 
1 	234 	567 
kDa 	 1) molecular weight marker 
62 -  
	
'L 	 2) insoluble fraction 16 
47.5 -  3) insoluble fraction 15 
32.5 
- 	 4) insoluble fraction 14 
5) soluble fraction 16 
25 - 	 6) soluble fraction 15 
16.5 - 	
7) soluble fraction 14 
MW(MAO-N) = 55.5 kDa 
Figure 5.3.2: SDS-PAGE analysis of His-Tag purification of MAO-N [pETl6b] 
It was decided to purify the monoamine oxidase using the proven method of anion 
exchange chromatography (§ 9.3.1.2). The frozen cells ofBL2l(DE3) [pET16b], 
BL2I(DE3) [pMAO-N] and BL2I(DE3) pMAO-Nmut] were resuspended in lysis 
buffer (1 mM PMSF), disrupted by sonication (5 mm, iS s) and dialysed against 
TrisIHCl buffer (25 mM, pH 7.8). Purification of all three cell free extracts was 
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performed on a ResourceQ anion exchange colunm (§ 11.4). The activity of the CFE 
and partially purified extracts was measured against amylamine, benzylamine and R- 
and S-AMBA (table 5.3.2). 
Table 5.3.2 
Activity/ 	U.mg' 
Amylamine Benzylamine S-AMBA 	I R-AMBA 
BL2I(DE3) CFE - - n.d. n.d. 
BL2I(DE3) p.p. - - - - 
MAO-N CFE 0.43 n.d. n.d. n.d. 
MAO-N p.p. 7.07 4.16 - - 
MAO-N mut. CFE 0.02 n.d. n.d. n.d. 
MAO-N mut. p.p. 0.97 1.76 0.14 0.008 
a) n.d. = not determined 
SDS-PAGE analysis showed a high concentration of MAO-N in the purified 
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Figure 5.3.3: SDS-PAGE analysis of purified extracts (fractions 15&16) 
The CFE of each preparation was incubated at 30 °C with RS-AMBA (0.9 mM) in 
20 mM buffer, p1-I 8 (table 5.3.2, figure 5.3.4). After the first twenty hours, 
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BL21(DE3) [pMAO-Nmut.] showed approximately double the selectivity of 
BL21(DE3) [pMAO-N] and a four-fold increase in selectivity over BL21(DE3) 
[pETl6b]. However, the E. coli monoamine oxidase acts with sufficient 
stereoselectivity, 26% e.e. of R-enantiomer, to cause interference with the 
deracemisation reaction. Therefore we concluded that the CFE could not be used for 
deracemisation studies. 
Table 5.3.2 
§ no. Strain U 
a Time! h Yield (R)/ % e.e./ % 
1 8.4.2.2 [pETl6b] 10% 20 54 26 
2 8.4.2.2 [pET16b] 10% 96 46 98 
3 8.4.3.2 [pMAO-N] 0.30 20 56 44 
4 8.4.3.2 [pMAO-N] 0.30 96 48 >99 
5 8.4.4.2 [pMAO-Nmut.] 0.02 20 45 >99 
a) 1 U = 1 tmol amylamine oxidised per minute 
Figure 5.3.4: oxidation of RS-AMIBA by cell free extracts 
The partially purified extracts of the three different preparations were incubated at 
30 °C with RS-AMBA (0.9 mM) in 20 mM buffer, pH 8 (table 5.3.3, figure 5.3.5). 
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After 20 h BL21(DE3) [pMAO-Nmut.] had fully oxidised only the S-enantiomer and 
BL21(DE3) [pET16b] and BL21(DE3) [pMAO-N] showed only 5% e.e. As the 
partially purified extract ofBL2l(DE3) [pMAO-Nmut.] showed no interference from 
the native E. co/i monoamine oxidase an enzyme suitable for study of the 
deracemisation of amines has been obtained, the first such enzyme reported. 
Table 5.3.3 
§ no. Enzyme u a Time! h Yield (R)! % e.e.! % 
1 8.4.2.3 BL21(DE3) 10% 20 53 4 
2 8.4.2.3 BL21(DE3) 10% 96 31 38 
3 8.4.3.3 MAO-Nw.t. 0.27 20 52 6 
4 8.4.3.3 MAO-Nw.t. 0.27 96 46 38 
5 8.4.4.3 MAO-N mut. 0.04 7 51 94 
6 8.4.4.3 MAO-N mut. 0.06 20 47 >99 
a) 1 U = 1 p.mol amylamine oxidised per minute 
Figure 5.3.5: oxidation of RS-AMBA by partially purified extract 
72 
R&D: Oxidase enzymes 
5.4. Oxidation of RS-AMBA by the MAO-N mutant 
Optimisation of the oxidation of RS-AMBA by partially purified BL21(DE3) 
[pMAO-Nmut.] was undertaken. Incubation of the enzyme with RS-AMBA (0.9 
mlvi) at three different temperatures (table 5.4.1) showed that the enzyme worked 
efficiently at room temperature or 30 °C but the rate of reaction was reduced at 
37 °C. All future experiments were therefore performed at 30 °C. 
Table 5.4.1 
§ no. Temp./ °C U 
a Time! h Yield (R)! % e.e./ % 
1 8.4.4.3 rt. 0.004 18 56 >99 
2 8.4.4.3 30 0.004 18 52 >99 
3 8.4.4.3 37 0.004 18 67 72 
a) 1 U = 1 p.mol amylamine oxidised per minute 
To continue with the oxidation and deracemisation studies fresh enzyme was 
required. BL21(DE3) [pMAO-Nnut.] was grown in LB/amp 100 media at 30 °C, 
harvested, disrupted and purified as before (§ 5.3.2). The protein expression was 
lower than previously and consequently an increase in enzyme concentration and 
reaction time was required for successful oxidation of S-AMBA. The effect of pH on 
the reaction with RS-AMBA (0.9 mM) was studied next (table 5.4.2) and the 
optimum was found to be pH 8. 
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Table 5.4.2 
§ no. pH U 
a Time! h Yield (R)I % e.e.! % 
1 8.4.4.3 6 0.03 22 55 2 
2 8.4.4.3 7 0.03 22 47 86 
3 8.4.4.3 8 0.03 22 54 92 
4 8.4.4.3 9 0.03 22 48 74 
5 8.4.4.3 10 0.03 22 56 16 
a) 1 U = 1 j.imol amylamine oxidised per minute 
Finally, the limits of concentration for both the enzyme and substrate were studied 
(table 5.4.3). The enzyme has a low tolerance for RS-AMBA (entry 2) and it will be 
necessary to modify the enzyme further to accept higher substrate concentrations as, 
for the deracemisation to be commercially viable, a substrate concentration of 
100 g.F' is desirable. Reducing the enzyme concentration by a third did not affect the 
rate of reaction (entry 3). 
Table 5.4.3 
§ no. Conc.I mM u a Time! h Yield (R)I % e.e.! % 
1 8.4.4.3 0.90 0.03 25 59 96 
2 8.4.4.3 4.50 0.03 25 56 2 
3 8.4.4.3 0.90 0.01 24 61 96 
a) 1 U = 1 imo1 amylamine oxidised per minute 
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5.5. Investigation into the substrate specificity of the 
MAO-N mutant 
The mutant was assayed against a range of aromatic substrates using the hydrogen 
peroxide based assay (table 5.5.1). Chromogemc solution 2 (§ 9.5.18, 990 p1), 
substrate (6 p.!) and HIRP (5 p.!) were placed in the spectrophotometer, which was 
zeroed. The solution was monitored at 500 nm for 10 mm, at 3 s intervals before 
BL21(DE3) [pMAO-Nmut.] (10 p.!) was added and the assay mixture monitored at 
500 nm for a further 10 mm. Addition of the substrate to the chromogenic solution 
sometimes resulted in an increase in absorbance at 500 nm, which was a result of 
oxidised amine reacting with TBHBA, i.e. impurities were present in the substrate. 
Table 5.5.1 
Substrate Rate 1/ Au.s' a Rate 2/ Au.s1 b Relative rate 
Me negative 2.0x10 100 
Me 
CHNH2 
negative negative - 
Me 3.5 xl O not measured - 
Br—.s-_< 
MeO—f
2.0 xl0 5 6.3 xi0 5 32 
MeO—
C~~ 




5 . 9 x 10 4 c 2.3x10 5 11  
Me negative negative - Me—
CHNF, 
a) rate without enzyme present; b) rate with enzyme present; c) rate levelled off 
before enzyme was added 
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Surprisingly aliphatic substrates showed increased activity relative to the aromatic 
substrates (table 5.5.2). As the mutant was evolved towards AMBA it was expected 
that the substrate range would be narrow. However, the mutant showed a similar 
specificity as the wild type, which favours the aliphatic amines such as amylamine 
and hexylamine.' 22 This suggests that the mutation has increased the size of the 
active site to allow the enzyme to accept an (x-methyl group. Gratifyingly the enzyme 
acted with the same stereospecificity on all substrates, oxidising only the 
S-enantiomer. 
Table 5.5.2 
Substrate Rate 1/ Au.s' a Rate 2/ Au.s' b Relative rate 













!1e negative 7.4 x1O 37 
Me 
Me 




a) rate without enzyme present; b) rate with enzyme present 
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5.6. Conclusions & Future Work 
The activity and stereoselectivity of BLR(DE3) [pECME3] and BL2 1 (DE3) 
[pMAO-N] towards a-methylbenzylamine was very low. The use of a monoamine 
oxidase obtained by in vitro evolution has resulted in the enantioselective oxidation 
of RS-AMBA. Monoamine oxidase present in E. coli has been shown to act 
stereoselectively on RS-AMIBA with preference for the S-enantiomer. However, the 
rate of reaction is much slower than for BL21(DE3) [pMAO-Nmut.] (96 h cf. 20 h) 
and partial purification ofBL2l(DE3) [pMAO-Nmut.] removed any interference 
from the native E. coli enzyme. 
A preliminary study into the substrate specificity of the mutated MAO-N showed 
that the enzyme accepts both aromatic and aliphatic substrates, with preference for 
the S-enantiomer in all cases. Further characterisation will need to be carried out and 
the amine substrates purified to eliminate interference in the assay. 
The success of the in vitro evolution experiment should allow access to a wide 
variety of mutated enzymes with different substrate specificities. It will be especially 
important to evolve an enzyme with preference for the R-enantiomer in order to 
prepare both enantiomers of chiral amines. 
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6. Results & Discussion: Deracemisation of 
RS-cc-methylbenzylamine 
6.1. Deracemisation reaction 
With the availability of the mutated MAO-N enzyme, the oxidation of RS-AMBA 
could now be performed enantioselectively within a reasonable time frame. 
Therefore application of the enzyme to deracemisation of racemic amines was 
attempted. Initially, the reaction was performed with sodium borohydride as for the 
deracemisation of a-amino acids (chapter 3). Purified BL21(DE3) [pMAO-Nmut.] 
(0.04 U) was incubated with RS-AMBA (0.9 mM) and NaBH4 (58.5 eq.) for 20 h, 
after which time HPLC analysis showed 50% yield R-AMBA and e.e. = 12%, i.e. 
almost zero oxidation of the S-enantiomer. It is known that a Schiff base can form 
between key protein amino acid residues and the ketone hydrolysis products of the 
amino acid oxidation by amino acid oxidase. The Schiff base formed is then 
irreversibly reduced by sodium borohydride, thereby inactivating the enzyme. It is 
conceivable that a similar inactivation is occurring with the monoamine oxidase 
catalysed oxidation of RS-AMBA, thereby affecting the deracemisation reaction. 
The animonia:borane reducing agent developed for the deracemisation of a-amino 
acids offered an attractive alternative to sodium borohydride. 86 Ammonia:borane is 
stable in water at neutral or basic pH, soluble and unreactive towards a range of 
protic and aprotic solvents.' 48 Initial studies on the deracemisation of RS-AMBA 
using N}13BH3 were promising. After 72 h, R-AMBA was observed in 69% yield, 
74% e.e. (table 6.1.1, entry 1). Further optimisation of the reaction was then 
undertaken. Addition of the enzyme and reducing agent in four aliquots did not 
improve the yield or e.e. (entry 2). Increasing the enzyme concentration resulted in 
optical purity after 24 h, however, the yield of R-AMBA was only 52% (entry 3). 
The yield and optical purity of R-AMIBA were adversely affected by increasing the 
NH3 :BH3 concentration (entries 4&8), probably as a result of inactivation of the 
enzyme. Decreasing the NH 3 :BH3 concentration resulted in optical purity at the 
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expense of yield (entries 11-14). Addition of catalase or ammonium formate did not 
improve the reaction (entries 5&7). The best result was obtained with 0.04 U of 
enzyme and 178 eq. reducing agent, yielding R-AMBA in 79% with e.e. = 94% 
(entry 6). 
Table 6.1.1 
Cone.! mM NH3BH3/ eq. U a Time! h Yield (R)/ % e.e./ % 
1 b 0.9 44.4 0.04 72 69 74 
2 C 0.9 44.4 0.01 45 59 72 
d 0.9 88.9 0.04 24 52 >99 
4e 0.9 177.8 0.02 96 58 68 
5 0.9 177.8 0.04 23 53 44 
6 0.8 177.8 0.04 24 79 94 
g 0.8 177.8 0.04 17 63 12 
8 h 0.8 177.8 0.02 48 74 78 
9 0.8 100 0.02 48 69 98 
IOJ 0.75 120 0.02 48 62 >99 
11 0.8 100 0.02 24 63 88 
12 0.8 50 0.02 24 58 >99 
13 0.8 25 0.02 24 58 >99 
14 0.8 25 0.02 24 54 >99 
a) 1 U = 1 tmol amylamine oxidised per minute; b) 44.4 eq. added at 3 h; c) 44.4 eq. 
and 0.01 U added at 1.5, 3 & 19 h; d) 88.9 eq. and 0.04 U added at 4 h; e) 177.8 eq. 
and 0.02 U added at 2 h; catalase added; g) 1 M ammonium formate added; 
h) 177.8 eq. and 0.02 U added at 26 h; i)100.0 eq. and 0.02 U added at 26 h; 
j) 133.0 eq. and 0.02 U added at 26 h 
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A study of the time-course of the reactions showed that in the initial stages of the 
reaction the "typical" deracemisation plot was observed, i.e. an increase in 
R-enantiomer with a concomitant decrease in S-enantiomer (figure 6.1.1). However, 
after a few hours the yield of R-enantiomer became variable. Analysis of the HPLC 
chromatograms revealed formation of a by-product at r.t. = 34 min, which was 
preventing the yield of R-AMBA reaching 100%. To obtain high yields and optical 
purity, it will be necessary to identify the unknown by-product and attempt to 
eliminate its formation. The obvious by-product is the hydrolysis product 
acetophenone, however analysis of pure acetophenone by HPLC showed this 
compound to have a retention time of 73 mm. 
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Figure 6.1.1: representative time-course of deracemisation experiment (entry 9) 
Although the by-product did not appear to be acetophenone, it may be Schiff base 
149, the result of condensation between AMBA and acetophenone, or even the 
reduced form of the Schiff base 150 (figure 6.1.2). 
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Figure 6.1 .2: condensation of a-methylbenzylamine and acetophenone 
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Extraction of acetophenone into an organic solvent may improve the yield of the 
reaction. Therefore deracemisation of 1 mlvi RS-AMBA using 1% organic co-solvent 
was attempted (table 6.1.2). Although oxidation of S-AMBA was not adversely 
affected, except in the case of dioxane, the addition of organic solvent did not 
improve the yield of the deracemisation. 
Table 6.1.2 
Solvent NH3BH3/ eq. U a Time! h Yield (R)I % e.e./ % 
1 DMSO 80.0 0.02 24 55 80 
2 dioxane 80.0 0.02 21 51 46 
3 acetonitrile 80.0 0.02 21 61 88 
4 hexane 80.0 0.02 21 57 96 
5 hexane 20.0 0.02 23 51 99 
a) 1 U = 1 j.imol amylamine oxidised per minute 
6.2. Stereoinversion reaction 
The definitive proof of deracemisation is to convert a single enantiomer into its 
antipode, i.e. stereoinversion (figure 6.2.1). 
Me 	MAO-N mut. e NH, Do NH3BH3 
S-AMBA 
Me e NH, 
R-AMBA 
Figure 6.2.1: stereoinversion of S-a-methylbenzylamine 
Each enantiomer of AMBA was separately incubated with BL21(DE3) 
[pMAO-Nmut.] and NH3:BH3 at 30 °C (table 6.2.1, figure 6.2.2). The S-enantiomer 
was converted to the R-enantiomer in 18% yield, 99% e.e. whereas no conversion of 
R&D: Deracemisation II 
R- to S-AMBA was observed under identical conditions. As for the standard 
deracemisation reaction, the low yield of the reaction is due to the formation of the 
unknown by-product at r.t. = 34 mm. 
Table 6.2.1 
Substrate NH3BH3/ eq. U a Time! h Yield (R)/ % e.e.I % 
1 S-AMBA 20.0 0.02 23 18 >99 
2 1 R-AMBA 20.0 0.02 23 98 >99 
a) 1 U = 1 p.mol amylamine oxidised per minute 
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Figure 6.2.2: time-course of stereoinversion reaction (entry 1) 
6.3. Conclusions & Future Work 
The deracemisation of racemic amines using a cyclic oxidation-reduction sequence 
has been demonstrated for the first time. The success of the reaction was dependent 
on the availability of an enantioselective monoamine oxidase, BL2 1 (DE3) 
[pMAO-Nmut.], which was obtained by in vitro evolution. However the 
deracemisation reaction was not as efficient as the deracemisation of a-amino acids 
MN 
R&D: Deracemisation II 
(chapter 3). One possibility for the reduced efficiency of the reaction would be 
decreased activity of the monoamine oxidase compared with tv-DAAO. Presently 
Marina Alexeeva is carrying out further work on the directed evolution of the 
enzyme in an attempt to improve the catalytic efficiency of the mutated monoamine 
oxidase. 
Decreasing the electron density of an imino bond increases the reactivity of the C=N 
bond towards reduction.' 49 Therefore the reactivity of the imine towards reduction is 
less than for the a-imino acid in the amino acid deracemisation. Further optimisation 
of the reduction conditions will be required to achieve an efficient deracemisation. 
Unfortunately there are limited options for reducing imines under aqueous 
conditions. Other possible reducing agents include cyanoborohydride anion, 
palladium on charcoal and pyridine:borane. These reducing agents all bring their 
own problems: cyanoborohydride produces cyanide gas at low pH, therefore an 
alternative analysis system will be required; palladium on charcoal can be poisoned 
by the amine substrate and pyridine:borane is a toxic compound. 
After optimisation of the deracemisation conditions the key aim of the work would 
be to develop the system for other racemic amines. It is hoped that from initial 
studies on the substrate specificity of the mutated MAO-N (5.5) the enzyme could 
be used without further modification to deracemise other racemic amines. However it 
may be necessary to further evolve the enzyme to cope with all the amines of 
interest. Evolution of the enzyme to accept the R-enantiomer will definitely be 
required. In order to analyse the deracemisation reactions of other amines a new 
analysis system will be needed as many of these amines have no chromophore and 
cannot therefore be analysed using UV detection. Other analysis options include 
LC/MS, GC/MS or derivatisation followed by fluorescence detection. This last 
option is obviously the least attratcive as another analysis step has been introduced. 
General discussion 
7. General Discussion 
The increase in demand for enantiomerically pure a-amino acids and amines has 
caused resurgence in the development of new methodologies for their preparation. 
One such growth area has been in the use of enzymes to bring about chemical 
transformations. Enzymes offer the advantages of high stereo- and regiospecificity, 
whilst being perceived as a "green" alternative to conventional organic reactions. 
The deracemisation of enantiomerically pure a-amino acids and amines using 
enzymes in combination with chemical reducing agents has the potential to provide 
an efficient, cost-effective route towards the preparation of these sought after 
compounds. Initial research into this area has shown that natural racemic a-amino 
acids could be transformed into their enantiomerically pure L-enantiomers using the 
enzyme D-amino acid oxidase in combination with a hydride reducing agent, either 
sodium borohydride or sodium cyanoborohydride. 84 
The aim of this work was to further develop the technique to encompass the 
preparation of enantiomerically pure 13-substituted a-amino acids and chiral amines. 
13-Substituted a-amino acids are currently receiving a great deal of attention in the 
field of peptidomimetics as well as in the study of enzyme mechanistics. Chiral 
amines are of interest because of their use as chiral auxiliaries in asymmetric 
synthesis and for their use as building blocks for drug molecules in the 
pharmaceutical industry. There were a number of obstacles to be overcome in order 
to achieve our goals. Firstly, the synthesis of 13-substituted a-amino acids was 
required to test their suitability as substrates for the deracemisation reaction. 
Secondly, if enantiomerically pure D-a-amino acids were to be prepared a 
commercially viable L-amino acid oxidase had to be identified and, similarly, for the 
preparation of enantiopure chiral amines a monoamine oxidase of the flavin family 
was required. 
General discussion 
Sufficient quantities of 13 - and y-substituted a-amino acids were obtained using 
conventional synthetic methods, albeit in low overall yields. These compounds were 
then tested as substrates for the D-amino acid oxidase from Trigonopsis variabilis 
and found to be suitable, although longer reaction times were necessary than for the 
non-13-substituted amino acids. The deracemisation of these compounds was then 
shown to be effective using the enzyme with the hydride reducing agents. Further 
optimisation of the system will be needed to allow the deracemisation of all a-amino 
acids of interest and to reach the concentrations and yields required for industrial 
scale reactions. Subsequent research within our group has identified further reducing 
agents suitable for use in the deracemisation reaction, 86 which may prove more 
effective in the deracemisation of the 1- and y-substituted a-amino acids. 
The production of D-a-amino acids requires the use of an L-amino acid oxidase. As 
the commercially available LAAO's are prepared from snake venom there is a need 
for less expensive and less toxic sources. To this end a random screening program 
was adopted in an attempt to identify novel L-amino acid oxidases. Five organisms 
were found that were capable of transforming L-phenylalanine to phenylpyruvic 
acid. Further work on the characterisation of these organisms is required to prove the 
identity of an oxidase enzyme. 
Research into preparation of D-a-amino acids using an L-amino acid oxidase with 
chemical reducing agents was also being carried out elsewhere within our group 86 
therefore it was decided to focus our attention on the preparation of enantiomerically 
pure chiral amines. The initial plan of work was to attempt the identification of a 
novel monoamine oxidase for use in the deracemisation reaction. Towards this aim a 
random screening of a variety of organisms was undertaken, in parallel to the LAAO 
screening program, with both spectrophotometric and chromatographic techniques 
being used for detection of products. The sensitivity of these assays proved to be 
insufficient and no new sources of monoamine oxidase were identified. 
General discussion 
An existing monoamine oxidase from the fungus Aspergillus niger has been 
previously identified, sequenced and cloned by Schilling et al. 120,121  The plasmid 
was kindly donated by Dr. B. Schilling (Givaudan-Roure Research Ltd., 
Switzerland) and transformed into various vectors by Marina Alexeeva (University 
of Edinburgh). Studies into the deracemisation using the wild type enzyme were 
ineffective, with any enantioselectivity observed perhaps due to either a native 
E. co/i monoamine oxidase or to the production in the reaction mixture of another 
enzyme capable of transforming an amine, e.g. transaminase. To overcome these 
difficulties M. Alexeeva performed random mutagenesis on the plasmid and 
identified a mutant with increased stereospecificity towards the model substrate, 
S-a-methylbenzylamine. With this mutated enzyme in hand it was then possible to 
attempt the deracemisation of RS-a-methylbenzylamine. Experiments showed that 
the deracemisation system was suitable for the production of one enantiomer of a 
chiral amine from a racemic mixture. The conclusive proof for the deracemisation 
reaction is in the ability to perform the stereoinversion on one enantiomer into its 
antipode as shown by the conversion of S-AIvIBA to R-AIv[BA in 18% yield, 
99% e.e. As with the deracemisation of a-amino acids it will be necessary to 
optimise the reaction further in order to compete with the industrial processes already 
established for the production of a-amino acids and amines. It may be that for bulk 
chemicals the deracemisation reaction cannot compete. However, for the production 
of specialist chiral compounds the deracemisation may offer an attractive alternative. 
Experimental: Synthesis 
8. Experimental: Synthesis of a-amino acids 
8.1. General Techniques 
'H and 13C NMR were recorded on Varian Gemini 200 or Brucker AC 250 
instruments. Chemical shifts (H)  are reported in parts per million (ppm) downfield 
of tetramethylsilane and were referenced to residual undeuterated solvent present in 
the deuterated sample, e.g. CHC13 in CDC1 3 . Assignments were made on the basis of 
chemical shift and coupling data. Abbreviations used in the descriptions of 
multiplicities are s (singlet), d (doublet), t (triplet), m (multiplet) and br (broad). 
Coupling constants (J) are quoted in hertz. Where diastereomeric signals are 
observed, * denotes the minor diastereomer. Chemical shifts (sc)  are quoted in parts 
per million (ppm) downfield of tetramethylsilane and are referenced to residual 
undeuterated solvent present in the deuterated sample. Assignments were made by 
comparison with the data obtained from similar structures. Carbon multiplicity was 
established by DEPT (distortionless enhancement by polarisation transfer). Where 
diastereomeric signals are observed, * denotes minor diastereomer. 
Electrospray ionisation (ESI) mass spectrometry was carried out on a Micromass VG 
Platform II instrument from a mixed solvent system (MeCN:H 20, 1:1) in +ve scan 
mode, using flow injection analysis. Mass Lynx version 2.3 software in open access 
mode was used for analysis of the data. m/z values are reported in Daltons and are 
followed by their percentage abundances in parentheses. 
Thin layer chromatography was performed on Merck DC-Alufolien Kieselgel 60F 254 
0.2 mm pre-coated plates or Merck 60F 254 0.25mm glass backed silica gel plates. 
Components were visualised by the quenching of u.v. fluorescence (A max. = 254 nm). 
Flash column chromatography was performed by the method of Still et al.'5° using 
silica gel (Merck 9385, particle size 0.04-0.063mm). The solvent system follows in 
parentheses. 
Experimental: Synthesis 
All solvents and reagents for chemical synthesis were of standard laboratory grade 
and were used as supplied from commercial sources. All non-aqueous experiments 
were carried out under N2 atmosphere unless specified otherwise, using oven-dried 
glassware (T 150 °C). Solvents and commercially available reagents were dried or 
purified, where appropriate, using standard procedures. THF was obtained dry and 
oxygen-free by distillation from sodium benzophenyl ketyl under nitrogen. In each 
experimental procedure the work-up was performed at room temperature unless 
reported otherwise. Brine refers to a saturated aqueous solution of sodium chloride, 
and ether refers to diethylether 
Optical rotations were measured on an Optical Activity AA-1000 polarimeter with a 
cell path length of 1 dm and concentrations (c) quoted in g.100 mr' (sodium 589 nm 
detection). 
8.2. Synthesis of unnatural DL-a-amino acids 
8.2.1. Strecker Synthesis 




A solution of RS-2-phenylpropanal (13.3 ml, 100.0 mmol, 1.0 eq.), ammonium 
chloride (5.35 g, 100.0 mmol, 1.0 eq.), and potassium cyanide (6.55 g, 100.0 mmol, 
1.0 eq.) in water (100 ml) was stirred at room temperature for 24 h. The mixture was 
extracted with ether (3 x 75 ml), and the combined organic phase washed with water 
(100 ml), then extracted with dilute HC1 (165 ml). The aqueous phase was 
concentrated under vacuum to give a white solid (4.12 g, 25.8 mmol, 26%); m/z 
(ESI+) 201.6 (100%), 178.6 (5), 160.5 (M 58) (required 160). 
Experimental: Synthesis 
The aminobutyronitrile intermediate 111 (4.12 g, 25.8 mmol) was refluxed in conc. 
HC1 (25 ml) for 16 h, and then concentrated under vacuum. The residue was 
triturated in MeCN to leave a white solid (3.18 g, 17.8 mmol, 18%); 5H  (200 MHz, 
DMSO-d6) 1.30-1.38 (311, m, CH3CH), 3.30-3.37 (1H, m, CH 3CH), 3.94-3.97 (1H, 
m, CHCR), 7.25-7.30 (5H, m, Ph), 8.53 (3H, br s, NH3); 6C  (63 MIHz, DMSO-d6) 
16.2 (q*),  17.7 (q), 40.6 (d), 57.7 (d), 57.9 (d*),  127.4 (d), 128.1 (2 x d), 128.6 
(2 x d), 140.3 (s), 140.5 (s*),  169.9 (s); d.e. = 40%, from the integration of HPLC 
peak area; m/z (ESI+) 220.6 (66%) 179.5 (M 100), 142.6 (70), 134.7 (18) (required 
179). 





A solution of RS-2-methylpentenal (10.0 g, 100.0 mmol, 1.0 eq.), ammonium 
chloride (5.36 g, 100.0 mmol, 1.0 eq.), and potassium cyanide (6.57 g, 100.0 mmol, 
1.0 eq.) in water (100 ml) was stirred at room temperature for 24 h. The mixture was 
extracted with ether (3 x 75 ml), and the combined organic phase washed with water 
(100 ml), then extracted with dilute HC1 (165 ml). The solution was concentrated 
under vacuum, and the residue triturated in ether to leave an off-white solid (6.35 g, 
50.4 mmol, 50%); m/z (ESI+) 167.6 (100%), 126.4 (M 28) (required 126). 
The resultant solid (6.35 g, 50.4 mmol) was refluxed in cone. HC1 (25 ml) for 18 h, 
concentrated under vacuum, and the residue triturated in MeCN to leave a white 
solid (3.29 g, 22.7 mmol, 23%); SH (200 MHz, DMSO-d6) 0. 84-0.92 (2 x 311, m, 
CH3CH2 + CH3CH), 1.15-1.39(2 x 211, m, CH3CH2CH2), 2.01 (111, br s, CH3CH), 
3.73 (1H, br s, CH3CHCH), 8.37 (3H, br s, NH3); 8c (63 MHz, DMSO-d) 14.0 (q), 
14.9 (q), 19.8 (t), 33.6 (d), 34.6 (t), 56.3 (d), 170.2 (s); d.e. = 40%, from the 
MI 
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integration of HPLC peak area; m/z (ESI+) 186.5 (100%), 145.7 (M 92) (required 
145). 
8.22. Alkylation of N-(diphenylmethylene)aminoacetonitrile 





N-(Diphenylmethylene)aminoacetonitrile (0.50 g, 2.3 mmol, 1.0 eq.), potassium 
carbonate (1.60 g, 11.6 mmol, 5.0 eq.) and 1-bromo-1-phenylethane (0.41 ml, 
3.0 mmol, 1.3 eq.) were refluxed in acetonitrile (10 ml) for 24 h. Excess base was 
removed by filtration, and the mother liquor dried over anhydrous Mg504 then 
concentrated under vacuum to leave an orange oil. (0.58 g, 1.8 mmol, 78%); 
6H(250 MHz, CDC13) 1.51 (3H, d, J 7.0, CH*3CH),  1.55 (3H, d, J 7.0, CH3CH), 
3.37 (114, q, J 7.0, CH 3CH), 4.25 (1H, d, J 7.5, CH3CHCH), 4.28 (1H, d, J 7.5, 
CH3 CHCH*), 7.12-7.66 (15H, m, Ph); oc (63 MHz, DMSO-d6) 16.4 (q*),  17.0 (q), 
44.2 (d*),  44.3 (d), 59.0 (d*), 60.0 (d), 126.1-129.1 (15 x d), 130.9 (d), 131.0 (d*), 
135.0 (s), 138.4 (s), 140.9 (s), 172.9 (s*),  173.4 (s). 
The resultant solid (0.48g, 1.5 mmol) was refluxed in conc. HC1 (15 ml) for 6 h, 
concentrated under vacuum, and the residue triturated in MeCN to leave a white 
solid (0.26 g, 1.5 mmol, 65%); 8H(250 MHz, DMSO-d6) 1.36 (3H, d, J 7.0, CH3CH), 
1.38 (3H, d, J 7.0, CH*3CH),  3.39 (1H, br s, CH3 CH), 3.96 (1H, br s, CH3CHCH), 
7.22-7.33 (5H, m, Ph), 8.55 (3H, br s, NH3); oc (63 MHz, DMSO-d6) 16.1 (q), 17.8 
(q*), 40.6 (d), 57.7 (d*),  58.0 (d), 127.3 (d), 127.4 (d*),  128.1 (2 x d), 128.6 (2 x d), 
140.3 (s*),  140.6 (s), 169.7 (s), 169.8 (s*);  d.e. = 40%, from the integration of HPLC 
peak area. 
Experimental: Synthesis 




N-(Diphenylmethylene)aminoacetonitrile (1.00 g, 4.6 mmol, 1.0 eq.) in anhydrous 
THF (15 ml) was cooled to -78 °C under a nitrogen atmosphere. n-Butyllithium 
(3.20 ml of 1.6 M solution, 5.1 mmol, 1.1 eq.) was added over 5 minutes and the 
suspension stirred at -78 °C for 1.5 h, after which 3-bromohexane (0.80 ml, 
5.7 mmol, 1.2 eq.) was added and the reaction stirred at room temperature for 20 h. 
The reaction was quenched with THF (1 ml) and concentrated under vacuum to leave 
an orange-brown oil which was resuspended in water (20 ml), then extracted with 
ether (3 x 25 ml). The combined organic phase was washed with brine (30 ml), then 
dried over anhydrous MgSO 4 and concentrated under vacuum to leave an orange oil 
(1.32 g). 
The oil was chromatographed on silica (5% EtOAc/hexane). The relevant fractions 
were combined and reduced to leave a colourless oil (0.95 g, 3.1 mmol, 67%), which 
was refluxed in conc. HO (30 ml) for 17 h. The solution was concentrated under 
vacuum and the residue triturated in ether to leave a white solid (0.23 g, 1.5 mmol, 
32%); 8H(250  MHz, MeOH-d4) 1.01-1.16 (611, m, 2 x CH3), 1.43-1.62 (6H, m, 3 x 
Cl-I2), 1.98-2.04 (1H, m, CR), 4.11 (1H, m, Cl!); 8C (63 MHz, MCOH-d 4) 10.1 (q), 
12.4 (q), 19.4 (t), 21.8 (t), 30.8 (t), 40.3 (d), 54.0 (d), 169.7 (s); m/z (ESI+) 200.9 
0 	 + (100/o), 159.8 (M 67) (required 159). 
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N-(Diphenylmethylene)aminoacetonitrile (1.00 g, 4.6 mmol, 1.0 eq.) in anhydrous 
THF (15 ml) was cooled to -78 °C under a nitrogen atmosphere. n-Butyllithium 
(3.20 ml of 1.6 M solution, 5.1 mmol, 1.1 eq.) was added over 5 minutes and the 
suspension stirred at -78 °C for 1 hour, after which 3-bromomethyiheptane (1.00 ml, 
5.6 mmol, 1.2 eq.) was added and the reaction stirred at room temperature for 18 h. 
The solution was concentrated under vacuum to leave a brown oil, which was 
resuspended in water (20 ml) and extracted with ether (4 x 25 ml). The combined 
organic phase was washed with brine (25 ml), then dried over anhydrous MgSO 4 and 
concentrated under vacuum to leave an orange oil (1.71 g); m/z (ESI+) 332.5 (M'1 
18%), 250.9 (75), 209.4 (100) (required 332). 
The resultant oil was purified by chromatography on silica (5% EtOAc/hexane). The 
relevant fractions were combined and reduced to leave a colourless oil (1.21 g, 3.6 
mmol, 78%); 8H(200 MHz, CDC13) 0.62-1.90 (17H, m, 2 x CH3, 5 x CH2 , CR), 4.21 
(1H, t, J 7.5, CR), 7.12-7.59 (1011, m, 2 x Ph). 
The oil (1.21 g, 3.6 mmol) was refluxed in conc. HC1 (30 ml) for 17 h, then 
concentrated under vacuum and triturated in ether to leave a white solid (0.74 g, 
4.0 mmol, 87%); 5H(250 MHz, MeOH-cL) 0.99-1.05 (6H, m, 2 x CH3), 1.41-1.51 
(811, m, 4 x CH2), 1.82-2.02 (2H, m, CH2), 3.38-3.42 (1H, m, CR), 3.99-4.07 (1H, m, 
CR); 8c (63 MHz, MeOH-cL) 8.3 (q*),  8.7 (q), 12.5 (q), 22.1 (t), 24.1 (t), 24.5 (t*), 
27.3 (t), 27.6 (t*),  31.2 (t), 31.4 (t*),  34.2 (d), 34.3 (t), 50.5 (d), 170.4 (s); d.e. 	10%, 








N-(Diphenylmethylene)aminoacetonitrile (0.10 g, 0.5 mmol, 1.0 eq.) in anhydrous 
THF (2 ml) was cooled to -78 °C under a nitrogen atmosphere. n-Butyllithium 
(0.30 ml of 1.6 M solution, 0.5 mmol, 1.1 eq.) was added over 5 minutes and the 
suspension stirred at -78 °C for 1.5 h, after which 2-bromo-l-phenylpropane 
(1.00 ml, 0.6 mmol, 1.2 eq.) was added and the reaction stirred at room temperature 
for 16 h. The solution was concentrated under vacuum to leave an orange residue, 
which was resuspended in water and extracted with ether (3 x 5 ml). The combined 
organic phase was washed with brine (7 ml), then dried over anhydrous MgSO 4 and 
concentrated under vacuum to leave an orange oil (0.32 g); m/z (ESI+) 339.0 (M 
100%), 215.7 (29), 181.5 (36), 174.6 (26) (required 339). Chromatography (5% 
EtOAc/hexane) did not yield the desired product. 
N-(Diphenylmethylene)aminoacetonitrile (0.10 g, 0.5 mmol, 1.0 eq.), potassium 
carbonate (0.35 g, 2.5 mmol, 5.0 eq.) and 2-bromo-1-phenylpropane (0.38 ml, 
2.5 mmol, 5.0 eq.) were refluxed in acetonitrile (5 ml) for 28 h. Further potassium 
carbonate (0.10 g, 0.7 mmol, 1.5 eq.) and 2-bromo-1-phenylpropane (0.08 ml, 0.5 
mmol, 1.0 eq.) were added and the suspension refluxed for 18 h. Excess base was 
removed by filtration, and the mother liquor concentrated under vacuum to leave an 
orange oil, consistent with starting material and benzophenone. 
93 
Experimental: Synthesis 
8.2.2.5. Synthesis of (2RS,4S)-2-amino-4-methylhexanoic acid 
Me NH3 
134 
N-(Diphenylmethylene)aminoacetonitrile (1.21 g, 5.5 mmol, 1.0 eq.) in anhydrous 
THF (20 ml) was cooled to -78 °C under a nitrogen atmosphere. n-Butyllithium 
(4.00 ml of 1.6 M solution, 6.1 mmol, 1.1 eq.) was added over 5 minutes and the 
suspension stirred at -78 °C for 1 hour, after which (2S)- 1 -bromo-2-methylbutane 
(1.00 g, 6.6 mmol, 1.2 eq.) was added and the reaction stirred at room temperature 
for 18 h. The solution was concentrated under vacuum to leave a red-brown oil 
(2.80 g), which was resuspended in water (30 ml) and extracted with ether (4 x 
35 ml). The combined organic phase was washed with brine (50 ml), then dried over 
anhydrous MgSO4 and concentrated under vacuum to leave an orange-red oil 
(1.45 g); m/z (ESI+) 336.1 (65%), 309.0 (37), 290.9 (M 100), 236.9 (30), 211.9 (33) 
(required 290). 
The resultant oil was purified by chromatography (5% EtOAc/hexane). The relevant 
fractions were combined and reduced to leave a pale-yellow oil (1.07 g, 3.7 mmol, 
67%); 8H(200 MHz, CDC1 3) 0.65-0.90 (6H, m, 2 x CH3), 0.95-2.15 (5H, m, 2 x CH2 , 
1 x Cl!), 4.20-4.40 (1H, m, CR), 7.15-7.70 (1OH, m, 2 x Ph); aD +14.3 ° (c = 1.0, 
CHC13). 
The oil (0.98 g, 3.4 mmol) was refluxed in conc. HC1 (30 ml) for 22 h, then 
concentrated under vacuum and triturated in ether to leave a white solid (0.65 g, 
3.6 mmol, 65%); 6H(250  MHz, DMSO-d6) 0.78-0.86 (6H, m, 2 x CH3), 1.07-1.79 
(5H, m, 2 x CH2 , CR), 3.75 (1H, br s, CR), 8.52 (3H, br s, NH3); oc (63 MHz, 
DMSO-d6) 11.0 (q), 18.7 (q*),  19.0 (q), 28.7 (t), 28.8 (t*),  29.9  (d*),  30.0 (d), 
37.3 (t), 37.3 (t*),  50.5 (d), 171.4 (s), 171.5 (s*);  d.e. = 88%, from the integration of 
ITPLC area; m/z (ESI+) 186.6(45%), 145.5 (M 100) (required 145); aD +7.00 
(c = 1.0 , H20). 
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9. Experimental: Deracemisation 
9.1. General Techniques 
HPLC analysis was carried out using a Waters 486 Tuneable Absorbance Detector 
and a Waters 600E Pump and Controller. Injection was through either a Rheodyne 
7522i valve or Waters 717 Autosampler. Waters Millennium Chromatography 
Manager software was used for analysis of the data. Chiral HPLC analysis was 
performed on one of three different stationary phases: i) Chirex 3126 colunm 
(D-penicillamine based stationary phase) which was obtained from Phenomenex; 
ii) Chiralcel OD-H (cellulose based stationary phase) which was obtained from 
Merck Chromatography; iii) Crownpak CR(+) (crown ether based stationary phase) 
also obtained from Merck Chromatography. 
Solvents for HPLC analysis were of the highest grade obtainable, and were filtered 
before use. a-Amino acids and reagents for deracemisation reactions were of 
standard laboratory grade and were used as supplied from commercial sources, 
except for the unnatural a-amino acids, which were synthesised as described in 
chapter 2. Commercial enzymes were used as supplied from Sigma, except for 
D-aminoacid oxidase from Trigonopsis variabilis, which was received as a gift from 
Boehringer Mannheim. The gene encoding monoamine oxidase from Aspergillus 
niger, which was integrated into the plasmid pECME3, was received as a gift from 
Dr. B. Schilling (Givaudan-Roure Research Ltd., Switzerland). The gene was 
subsequently subcloned into pET 16b and subjected to random mutagenesis by 
Marina Alex eeva at the University of Edinburgh. 
An Innova 4430 orbital shaker or Stuart Scientific SI 50 orbital incubator, set at the 
desired temperature, was used for incubation of the biotransformations. 
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9.2. Deracemisation of natural DL-a-amino acids 
9.2.1. Reactions with porcine kidney D-amino acid oxidase 
9.2.1.1. General Procedure I: Deracemisation on 2.5mM scale, pH 8 
A solution of DL-amino acid (100 p1 of 25 mM solution, final concentration = 
2.5 mlvi), FAD (100 p.1 of 0.8 mM solution, final concentration = 80 p.M), catalase 
(1 mg of 21000 U.mg, 21000 U), pk-DAAO and NaCNBH 3 in phosphate buffer 
(800 p.1, 50 mM, pH 8) was incubated at 37 °C. Aliquots of the reaction mixture were 
filtered, and analysed by HPLC at regular intervals until no further reaction was 
observed. 
9.2.1.1.1. Deracemisation of DL-proline 
Following general procedure I, using pk-DAAO (1 mg of 0.8 U.mg 1 = 0.8 U) and 
NaCNBH3  0  mg, 15.9 mM, 6.4 eq.), and analysed by HPLC method 1. R.t. (L-92) = 
7.5 min, r.t. (D-92) = 13.8 mm. At t = 6 h: yield L = 1.45 mM, 58%; e.e. >99%. 
Following general procedure I, using pk-DAAO (2 mg of 0.8 U.mg' = 1.6 U) and 
NaCNBH3 (1 mg, 15.9 mM, 6.4 eq.), and analysed by HPLC method 1. R.t. (L-92) = 
7.8 mm, r.t. (D-92) = 14.4 mm. At t = 2.5 h: yield L = 2.36 mlvi, 94%; e.e. >99% 
Following general procedure I, using pk-DAAO (2 mg of 0.8 U.mg' = 1.6 U) and 
NaCNBH3 (2 mg, 31.8 mM, 12.8 eq.), and analysed by HPLC method 1. R.t. (L-92) 
= 8.6 min, r.t. (D-92) = 16.0 mm. At t =24 h: yield L = 2.36 mM, 94%; e.e. >99%. 
Following general procedure I, using pk-DAAO (2 mg of 1.3 U.mg4 = 2.6 U) and 
NaCNBH3 (4mg, 63.6 mM, 25.6 eq.), and analysed by HPLC method 1. R.t. (L-92) 
= 5.5 min, r.t. (D-92) = 9.1 mm. At t = 2.5 h: yield L = 2.06 mM, 82%; e.e. >99%. 
Experimental: Deracemisation 
9.2.1.2. General Procedure II: Deracemisation on 25 mM scale, pH 6.5 
A solution of DL-amino acid (3 ml of 25 mM solution, final concentration = 25 
mM), FAD (1 mg, 1.2 .tmol, final concentration = 0.4 mM), catalase (3 mg of 21000 
U.mg', 63000 U), pk-DAAO (10mg of 1.3 U.mg' = 13.0 U) and NaCNBH3 
(50 mg, 264.6 mM, 10.6 eq.) in ammonium formate buffer (50 mlvi, pH 6.5) was 
incubated at 37 °C. Reactions were monitored by HPLC analysis, with aliquots 
filtered and injected directly. 
9.2.1.2.1. Deracemisation of DL-proline 
Analysis by HPLC method 1 (254 nm). R.t. (L-92) = 10.1 mm, r.t. (D-92) =21.0 mm. 
At t = 3 h: yield L = 23.5 mM, 94%; e.e. >99%. 
9.2.1.3. General Procedure Ill: Deracemisation on 2.5 mM scale with 
ammonium formate, pH 8 
A solution of DL-amino acid (100 tl of 25 mM solution, final concentration = 
2.5 mlvi), FAD (100 p.1 of 0.8 mM solution, final concentration = 80 p.M), catalase 
(100 p.1 of 21000 U.mr 1 solution, 2100 U), ammonium formate (100 p.1 of 124 mM 
solution, final concentration = 12.4 mM, 5.0 eq.), pk-DAAO (2 mg of 0.8 U.mg' = 
1.6 U) and NaBI-L (3 mg, 79.0 mM, 31.6 eq.) in phosphate buffer (600 p.1, 50 mM, 
pH 8) was incubated at 37 °C. Aliquots of the reaction mixture were filtered, and 
analysed by HPLC at regular intervals until no further reaction was observed. 
9.2.1.3.1. Deracemisation of DL-phenylalanine 
Following general procedure ifi, and analysed by HPLC method 2. R.t. (L-139) = 
15.0 mm, r.t. (D-139) = 19.2 mm. At t = 20 h: yield L = 1.86 mM, 74%; e.e. >99%. 
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Experimental: Deracemisation 
9.2.2. Reactions with D-aminoacid oxidase from T. variabilis 
9.2.2.1. General Procedure IV: Oxidation on 2.5 mM scale, pH 8 
A solution of DL-amino acid (10 l of 250 mM solution, fmal concentration = 
2.5 mM), catalase (1 mg of 21000 U.mg 1 , 21000 U), and tv-DAAO (20 mg of 
34 U.g' = 0.68 U) in phosphate buffer (990 p.!, 50 mM, pH 8) was incubated at 
30 °C. Aliquots of the reaction mixture were filtered, and analysed by HPLC at 
regular intervals until no further reaction was observed. 
9.2.2.1.1. Oxidation of DL-proline 
Analysis by HPLC method 1. R.t. (L-92) = 5.0 mm, r.t. (D-92) = 8.1 mm. At t = 6 h: 
yield L = 1.20 mM, 48%; yield D = 0.10 mM, 4%, e.e. = 86%. 
9.2.2.2. General Procedure V: Deracemisation on 2.5 mM scale, pH 8 
A solution of DL-amino acid (100 p.1 of 25 mM solution, final concentration = 
2.5 mlvi), catalase (100 p.1 of 21000 U.mr' solution, 2100 U), tv-DAAO (20 mg of 
34 U.g = 0.68 U) and NaBH4 (4 mg, 105.3 mM, 42.1 eq.) in phosphate buffer 
(800 p.!, 50 mM, pH 8) was incubated at 30 °C. Aliquots of the reaction mixture were 
filtered, and analysed by HPLC at regular intervals until no further reaction was 
observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
9.2.2.2.1. Deracemisation of DL-phenylalanine 
Following general procedure V and analysed by HPLC method 3. R.t. (L-139) = 18.5 
mm, r.t. (D-139) = 24.1 mm. At t = 3.5 h: yield L = 1.59 mM, 64%; e.e. >99%. 
Experimental: Deracemisation 
Following general procedure V, using ammoniumformate (100 p1 of 124 mM 
solution, final concentration = 12.4 mM, 5.0 eq) and analysed by HIPLC method 3 
(1 ml.min'). R.t. (L-139) = 29.5 mm, r.t. (D-139) = 38.2 mm. At t = 3 h: yield L = 
1.36 mM, 54%; e.e. >99. 
Following general procedure V and analysed by HPLC method 3 (1 ml.min'). 
tv-DAAO (10 mg of 34 Ug' = 0.34U) added after 1 hour. R.t. (L-139) = 29.6 mm, 
r.t. (D-139) = 38.1 mm. At t = 3.5 h: yield L = 1.36 mM, 54%; e.e. >99%. 
9.2.2.3. General Procedure VI: Deracemisation on 2.5 mM scale, pH 8 
A solution of DL-amino acid (2 ml of 2.5 mM solution, final concentration = 
2.5 mM), catalase (1 mg of 21000 U.mg 1 , 21000 U), tv-DAAO and reducing agent 
in phosphate buffer (50 mM, pH 8) was incubated at 30 °C. Aliquots of the reaction 
mixture were centrifuged (14000 rpm, 1 mi, and analysed by HPLC at regular 
intervals until no further reaction was observed. 
9.2.2.3.1. Deracemisation of DL-leucine 
Following general procedure VI, using tv-DAAO (50mg of 34 U.g' = 1.7 U) and 
NaCNBH3 (3 mg, 25.0 mM, 10.0 eq.), and analysed by HPLC method 4. R.t. (L-142) 
= 20.0 min, r.t. (D-142) = 30.1 mm. At t = 22 h: yield L = 1.46 mM, 59%; e.e. >99%. 
Following general procedure VI, using tv-DAAO (50 mg of 34 U.g' = 1.7 U) and 
NaCNBH 3 (6 mg, 50.0 mM, 20.0 eq.), and analysed by IIPLC method 4. R.t. (L-142) 
= 20.0 min, r.t. (D-142) = 30.1 mm. At t = 22 h: yield L = 1.65 mM, 66%; e.e. >99%. 
Following general procedure VI, using tv-DAAO (50 mg of 34 U.g' = 1.7 U) and 
NaCNBH3 (9 mg, 75.0 mM, 30.0 eq.), and analysed by HPLC method 4. R.t. (L-142) 
= 20.0 mm, r.t. (D-142) = 30.1 mm. At t = 22 h: yield L = 1.88 mM, 75%; e.e. >99%. 
Experimental: Deracemisation 
Following general procedure VI, using tv-DAAO (50 mg of 34 U.g 1 = 1.7 U) and 
NaCNBH3 (12 mg, 100.0 mlvi, 40.0 eq.), and analysed by HPLC method 4. R.t. 
(L-142) = 20.0 mm, r.t. (D-142) = 30.1 mm. At t = 22 h: yield L = 1.91 mM, 77%; 
e.e. >99%. 
9.2.2.3.2. Deracemisation of DL-phenylalanine 
Following general procedure VI, using tv-DAAO (50 mg of 34 U.g' = 1.7 U) and 
NaCNBH3 (12 mg, 100.0 mM, 40.0 eq.), and analysed by HPLC method 5. R.t. 
(L-139) = 18.8 mm, r.t. (D-139) = 26.0 mm. At t = 22 h: yield L = 1.65 mM, 66%; 
e.e. >99%. 
Following general procedure VI, using tv-DAAO (100 mg of 34 U.g 1 = 3.4 U) and 
NaCNBH3 (20 mg, 158.7 mM, 63.5 eq.), and analysed by HPLC method 5. R.t. 
(1,139) = 20.4 min, r.t. (D-139) = 28.2 mm. At t =22 h: yield L = 1.64 mM, 66%; 
e.e. >99%. 
9.2.2.4. General Procedure VII: Deracemisation on 25 mM scale, pH 8 
A solution of DL-amino acid (2 ml of 25 mM solution, final concentration = 25 
mlvi), catalase (2 mg of 21000 U.mg 1 , 42000 U), tv-DAAO (500 mg of 34 U.g' 
17.0 U) and NaCNBH 3 (32 mg, 254.0 mM, 10.2 eq.) in phosphate buffer (50 mM, 
pH 8) was incubated at 30 °C. Aliquots of the reaction mixture were centrifuged 
(14000 rpm, 1 mm), and analysed by HPLC at regular intervals until no further 
reaction was observed. 
9.2.2.4.1. Deracemisation of DL-phenylalanine 
Following general procedure VII and analysed by HPLC method 5. R.t. (L-139) = 
18.1 min, r.t. (D-139) = 25.0 mm. At t = 22 h: yield L = 11.38 mlvi, 46%; e.e. = 94%, 
at t = 42 h: yield L = 12.13 mM, 49%; e.e. >99%. 
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Experimental: Deracemisation 
9.2.2.4.2. Deracemisation of DL-Ieucine 
Following general procedure VII and analysed by HPLC method 4. R.t. (L.-142) = 
17.2 mm, r.t. (D-142) = 26.1 mm. At t = 22 h: yield L = 12.88 mM, 52%; e.e. >99%. 
9.2.2.4.3. Deracemisation of DL-methionine 
Following general procedure VU and analysed by HPLC method 4. R.t. (L-143) = 
13.5 min, r.. (D-143) = 17.4 mm. At t = 22 h: yield L = 12.00 mlvi, 48%; e.e. >99%. 
9.3. Deracemisation of unnatural DL-a-amino acids 
9.3.1. Reactions with D-aminoacid oxidase from T. variabilis 
9.3.1.1. General Procedure VIII: Oxidation on 2.5 mM scale, pH 8 
A solution of RS-amino acid (100 tl of 25 mM solution, final concentration = 
2.5 mlvi), catalase (100 p1 of 21000 U.mF' solution, 2100 U), and tv-DAAO (20 mg 
of 34 U.g' = 0.68 U) in phosphate buffer (800 p.1, 50 mM, pH 8) was incubated at 
30 °C. Aliquots of the reaction mixture were filtered, and analysed by HPLC at 
regular intervals until no further reaction was observed. 
9.3.1.1.1. Oxidation of (2RS,3RS)-2-amino-3-phenylbutanoic acid, 112 
Following general procedure Vifi and analysed by HPLC method 2 (2 mM CuSO4. 
R.t. (2S,35) = 9.4 mm, r.t. (2R,3R) = 11.2 min, r.t. (2S,3R) = 16.7 min, r.t. (2R,35) = 
23.1 mm. At t = 2 h: yield 2S,3S = 0.81 mM, 32%; yield 2R,3R = 0.05 mM, 2%; 
yield 2S,3R = 0.36 mM, 14%. 
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Experimental: Deracemisation 
9.3.1.1.2. Oxidation of (2RS,3RS)-2-amino-3-methylhexanoic acid, 115 
Following general procedure Vifi and analysed by HPLC method 4 (2 mM CuSO4. 
R.t. (2S,3R) = 20.3 mm, r.t. (2S,35) = 26.7 mm, r.t. (2R,3S) = 29.0 mm, r.t. (2R,3R) = 
40.9 mm. At t = 3 h: yield 2S,3R = 0.45 mM, 18%; yield 2S,3S= 0.83 mlvi, 33%; 
yield 2R,3R = 0.03 mM, 1%. 
9.3.1.2. General Procedure IX: Oxidation on 2.5 mM scale, pH 6.5 
A solution of RS-amino acid (100 jtl of 25 mM solution, final concentration = 
2.5 mM), catalase (1 mg of 21000 U.mg 1 , 21000 U), and tv-DAAO in ammonium 
formate buffer (900 p1, 50 mM, pH 6.5) was incubated at 30 °C. Aliquots of the 
reaction mixture were filtered, and analysed by HPLC at regular intervals until no 
further reaction was observed. 
9.3.1.2.1. Oxidation of (2RS,3RS)-2-amino-3-ethylhexanoic acid, 124 
Following general procedure IX, using tv-DAAO (20 mg of 34 U.g' = 0.68 U), and 
analysed by HPLC method 5. R.t. (1) = 31.5 mm, r.t. (2) = 37.0 mm, r.t. (3) = 41.0 
mm, r.t. (4) = 54.4 mm. At t = 3 h: %(1) = 76; %(2) = 78; %(3) = 73; %(4) = 0. 
Following general procedure TX, using tv-DAAO (50 mg of 34 U.g' = 1.7 U), and 
analysed by HPLC method 5. R.t. (1) = 29.9 min, r.t. (2) = 35.3 mm, r.t. (3) = 39.3 
min, r.t. (4) = 51.9 mm. At t = 17 h: %(1) = 137; %(2) = 136; %(3) = 81; %(4) = 0. 
9.3.1.3. General Procedure X: Deracemisation on 2.5 mM scale, pH 8 
A solution of RS-amino acid (100 p1 of 25 mM solution, final concentration = 
2.5 mM), catalase (100 p.! of 21000 U.mi' solution, 2100 U), tv-DAAO (20 mg of 
34 U.g' = 0.68 U) and reducing agent in phosphate buffer (800 p.1, 50 mM, pH 8) 
was incubated at 30 °C. Aliquots of the reaction mixture were filtered, and analysed 
by HPLC at regular intervals until no further reaction was observed. 
102 
Experimental: Deracemisation 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
9.3.1.3.1. Deracemisation of (2RS,3RS)-2-amino-3-phenylbutanoic acid, 112 
Following general procedure X, using NaCNBH 3 (4 mg, 63.5 mM, 25.4 eq.) and 
ammoniumformate (100 dat of 124 mM solution, final concentration = 12.4 mM, 
5.0 eq), and analysed by HPLC method 2 (2 mM CuSO4. R.t. (2S,35) = 9.5 mm, r.t. 
(2R,3R) = 11.3 mm, r.t. (2S,3R) = 17.1 mm, r.t. (2R,3S) = 23.5 mm. At t = 2 h: yield 
2S,3S = 0.93 mM, 37%; yield 2R,3R = 0.36 mM, 14%; yield 2S,3R = 0.43 mM, 17%; 
yield 2R,3S = 0.04 mM, 1%. 
Following general procedure X, using NaBH4 (4 mg, 105.3 mM, 42.1 eq.), and 
analysed by I{PLC method 2 (1 ml.min', 2 mM CuSO4. R.t. (2S,35) = 14.6 mm, r.t. 
(2R,3R) = 17.4 mm, r.t. (2S,3R) = 26.2 mm, r.t. (2R,3S) = 36.1 mm. At t = 6 h: yield 
(2S,35) = 1.04 mM, 42%; yield 2S,3R = 0.72 mM, 29%; total yield S-112 = 
1.76 mM, 71%; e.e. >99%. 
9.3.1.3.2. Deracemisation of (2RS,3RS)-2-amino-3-methylhexanoic acid, 115 
Following general procedure X, using NaCNBH 3 (4 mg, 63.5 mM, 25.4 eq.) and 
ammoniumformate (100 dat  of 124 mM solution, final concentration = 12.4 mM, 
5.0 eq.), and analysed by HPLC method 4 (2 mM CuSO4. R.t. (2S,3R) = 19.3 mm, 
r.t. (2S,35) = 24.9 mm, r.t. (2R,3S) = 27.2 mm, r.t. (2R,3R) = 38.5 mm. At t = 18 h: 
yield 2S,3R = 0.69 mM, 28%; yield (2S,3S) = 0.88 mM, 35%; total yield S-uS = 
1.57 mM, 63%; e.e. >99%. 
Following general procedure X, using NaBH4 (4 mg, 105.3 mM, 42.1 eq.), and 
analysed by HPLC method 4 (2 mM CuSO4. R.t. (2S,3R) = 19.6 mm, r.t. (2S,35) = 
25.6 mm, r.t. (2R,35) = 27.9 mm, r.t. (2R,3R) = 39.6 mm. At t = 3 h: yield 2S,3R = 




Following general procedure X, using NaBH4 (4 mg, 105.3 mM, 42.1 eq.), and 
analysed by HPLC method 4(2 mM CuSO 4). R.t. (2S,3R) = 18.9 min, r.t. (2S,35) = 
25.4 mm, r.t. (2R,35) = 27.7 mm, r.t. (2R,3R) = 39.1 mm. At t = 3.5 h: yield 2S,3R = 
1.28 mM, 51%; yield 2S,3S= 1.21 mM, 48%; total yield S-115 = 2.49 mM, 99%; 
e.e. >99%. 
9.3.1.4. General Procedure Xl: Deracemisation on 2.5 mM scale with 
ammonium formate, pH 8 
A solution of RS-amino acid (2 ml of 2.5 mM solution, final concentration = 
2.5 mM), catalase (1 mg of 21000 U.mg', 21000 U), tv-DAAO and reducing agent 
in ammonium formate buffer (50 mM, pH 8) was incubated at 30 °C. Aliquots of the 
reaction mixture were centrifuged, and analysed by HPLC at regular intervals until 
no further reaction was observed. 
9.3.1.4.1. Deracemisation of(2RS,3RS)-2-amino-3-phenylbutanoic acid, 112 
Following general procedure XI, using tv-DAAO (50 mg of 34 U.g' = 1.7 U) and 
NaCNBH3 (12 mg, 95.2 mM, 38.1 eq.), and analysed by HPLC method 5. R.t. 
(2S,35) = 20.2 min, r.t. (2R,3R) = 24.2 min, r.t. (2S,3R) = 41.2 mm, r.t. (2R,3S) 
57.3 mm. At t = 22 h: yield 2S,3S = 9.75 mM, 39%; yield 2R,3R = 4.63 mM, 19%; 
yield 2S,3R = 2.56 mM, 10%. 
Following general procedure XI, using tv-DAAO (100 mg of 34 U.g' = 3.4 U) and 
NaCNBH3 (20 mg, 158.7 mM, 63.5 eq.), and analysed by HPLC method 5. R.t. 
(2S,3S) = 23.0 mm, r.t. (2R,3R) = 27.5 mm, r.t. (2S,3R) = 47.8mm, r.t. (2R,3S) = 65.9 
mm. At t = 22 h: yield 2S,3S= 10.79 mM, 43%; yield 2R,3R = 6.21 mM, 25%; yield 
2S,3R = 4.42 mM, 18%. 
9.3.1.4.2. Deracemisation of (2RS,4S)-2-amino-4-methylhexanoic acid, 134 
Following general procedure XI, using tv-DAAO (50 mg of 34 U.g = 1.7 U) and 
NaCNBH3 (12 mg, 95.2 mM, 38.1 eq.), and analysed by HPLC method 5. R.t. (L) = 
19.4 mm, r.t. (D) = 25.3 mm. At t = 22 h: yield S-134 = 16.56 mM, 66%; e.e. >99%. 
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Experimental: Deracemisation 
Following general procedure XI, using tv-DAAO (100 mg of 34 U.g' = 3.4 U) and 
NaCNBH3 (20 mg, 158.7 mM, 63.5 eq.), and analysed by HPLC method 5. R.t. (L) = 
23.0 mm, r.t. (D) = 29.3 mm. At t =22 h: yield S-134 = 14.96 mM, 60%; e.e. >99%. 
9.3.1.5. General Procedure XII: Oxidation on 25 mM scale, pH 6.5 
A solution of RS-amino acid (1 ml of25 mM solution, final concentration = 25 mTvI), 
catalase (1 mg of 21000 U.mg, 21000 U) and tv-DAAO in ammonium formate 
buffer (50 mM, pH 6.5) was incubated at 30 °C. Aliquots of the reaction mixture 
were filtered, and analysed by HPLC at regular intervals until no further reaction was 
observed. 
9.3.1.5.1. Oxidation of (2RS,3RS)-2-amino-3-phenylbutanoic acid, 112 
Following general procedure XII, using tv-DAAO (200 mg of 34 U.g' = 6.8 U), and 
analysed by HPLC method 5. R.t. (2S,3S) = 24.5 mm, r.t. (2R,3R) = 29.7 mm, r.t. 
(2S,3R) = 50.9 min, r.t. (2R,35) = 71.5 mm. At t = 5 h: yield 2S,3S= 7.84 mM, 31%; 
yield 2R,3R = 3.89 mM, 16%; yield 2S,3R = 3.59 mM, 14%. 
Following general procedure XII, using tv-DAAO (250 mg of 34 U.g = 8.5 U), and 
analysed by HPLC method 5. R.t. (2S,3S) = 20.5 mm, r.t. (2R,3R) = 24.3 mm, r.t. 
(2S,3R) = 40.1 mm, r.t. (2R,35) = 56.8 mm. At t = 22 h: yield 2S,3S= 7.24 mM, 
29%; yield 2R,3R = 0.85 mM, 3%; yield 2S,3R = 2.95 mM, 12%. 
9.3.1.5.2. Oxidation of (2RS,4S)-2-amino-4-methylhexanoic acid, 134 
Following general procedure XII, using tv-DAAO (250 mg of 34 U.g' = 8.5 U), and 
analysed by HPLC method 5. R.t. (2S,3R) = 11.0 min, r.t. (2R,3S) = 17.0 min, r.t. 
(2S,35) = 20.3 min, r.t. (2R,3R) = 25.8 mm. At t = 22 h: yield 2S,3R = 1.19 mM, 5%; 
yield 2S,3S = 10.53 mM, 42%; total yield S-134 = 11.72 mM, 47%; e.e. >99%. 
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Experimental: Deracemisation 
9.3.1.6. General Procedure XIII: Deracemisation on 25 mM scale, pH 6.5 
A solution of RS-amino acid (3 ml of 25 mM solution, final concentration =25 mM), 
catalase (3 mg of 21000 U.mg', 63000 U), tv-DAAO and reducing agent in 
ammonium formate buffer (50 mM, pH 6.5) was incubated at 30 °C. Aliquots of the 
reaction mixture were centrifuged (14000 rpm, 1 mm), and analysed by HPLC at 
regular intervals until no further reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
9.3.1.6.1. Deracemisation of (2RS,3RS)-2-amino-3-phenylbutanoic acid, 112 
Following general procedure Xffl, using tv-DAAO (750 mg of 34 U.g' = 25.5 U) 
and NaCNBH 3 (24 mg, 127.0 mM, 5.1 eq.), and analysed by HPLC method 5. R.t. 
(2S,35) = 20.3 min, r.t. (2R,3R) = 24.3 mm, r.t. (2S,3R) = 40.4 min, r.t. (2R,3S) = 
56.8 mm. At t = 26 h: yield 2S,3S= 8.44 mM, 34%; yield 2R,3R = 1.77 mM, 7%; 
yield 2S,3R = 4.30 mM, 17%. 
Following general procedure Xffl (2 ml amino acid solution, 2 mg catalase), using 
tv-DAAO (500 mg of 34 U.g 1 = 17.0 U) and NaCNBH3 (32 mg, 254.0 mM, 
10.2 eq.), and analysed by HPLC method 5. R.t. (2S,3S) = 20.7 mm, r.t. (2R,3R) = 
24.7 min, r.t. (2S,3R) = 41.0 mm, r.t. (2R,35) = 57.7 mm. At t = 42 h: yield 2S,3S= 
8.10 mM, 32%; yield 2R,3R = 2.14 mM, 9%; yield 2S,3R = 4.65 mlvi, 19%. 
9.3.1.6.2. Deracemisation of (2RS,3RS)-2-amino-3-methylhexanoic acid, 115 
Following general procedure Xffl (5 ml amino acid solution, 5 mg catalase), using 
tv-DAAO (1.25 g of 34 U.g' = 42.5 U) and NaCNBH 3 (80 mg, 254.0 mM, 10.2 eq.), 
and analysed by HPLC method 6. R.t. (2S,3R) = 48.4 mm, r.t. (2S,3S) = 68.6 min, r.t. 
(2R,3S) = 74.4 min, r.t. (2R,3R) = 114.7 mm. At t =22 h: yield 2S,3R = 7.07 mM, 
28%; yield 2S,3S= 7.51 mlvi, 30%; total yield S-uS = 14.58 mlvi, 58%; e.e. >99%. 
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Experimental: Deracemisation 
Following general procedure Xffl (2 ml amino acid solution, 2 mg catalase), using 
tv-DAAO (500 mg of 34 U.g 1 = 17.0 U) and NaBH4 (19 mg, 250.0 mM, 10.0 eq.), 
and analysed by HPLC method 6. R.t. (2S,3R) = 44.8 mm, r.t. (2S,35) = 63.1 mm, r.t. 
(2R,3S) = 68.1 mm, r.t. (2R,3R) = 103.1 mm. At t = 22 h: yield 2S,3R = 3.70 mM, 
15%; yield 2S,3S= 7.76 mM, 31%; total yield S-uS = 11.46 mlvi, 46%; e.e. >99%. 
9.3.1.6.3. Deracemisation of (2RS,4S)-2-amino-4-methylhexanoic acid, 134 
Following general procedure Xffl, using tv-DAAO (750 mg of 34 U.g' = 25.5 U) 
and NaCNBH3 (24 mg, 127.0 mM, 5.1 eq.), and analysed by HPLC method 5. R.t. 
(2S,3R) = 10.3 mm, r.t. (2R,3S) = 15.8 mm, r.t. (2S,3S) = 19.0 mm, r.t. (2R,3R) = 
24.3 mm. At t = 28 h: yield 2S,3R = 0.91 mM, 4%; yield 2S,3S = 11.56 mM, 46%; 
total yield S-134 = 12.47 mM, 50%; e.e. >99%. 
Following general procedure Xffl (2 ml amino acid solution, 2 mg catalase), using 
tv-DAAO (500 mg of 34 U.g' = 17.0 U) and NaCNBH3 (32 mg, 254.0 mlvi, 10.2 
eq.), and analysed by HPLC method 5. R.t. (2S,3R) = 10.9 min, r.t. (2R,3S) = 16.8 
mm, r.t. (2S,35) = 19.9 mm, r.t. (2R,3R) = 25.6 mm. At t = 42 h: yield 2S,3R = 0.68 
mM, 3%; yield 2S,3S= 10.37 mM, 42%; total yield S-134 = 11.05 mM, 45%; e.e. 
>99%. 
9.4. Oxidation of RS-a-methylbenzylamine 
9.4.1. Oxidation by E. coli BLR(DE3) [pECME3] 
9.4.1.1. General Procedure XIV: Oxidation by cell free extract 
BLR(DE3) [pECME3] cell free extract was added to a solution of RS-AMBA in 
animonium formate buffer (50 mM, pH 7.4). A 300 p.l aliquot was mixed with 300 p.1 
NaOH (50 mM) and 300 p.1 hexane, and the hexane layer analysed by HPLC method 
7. The reaction mixture was incubated at 30 °C and monitored at regular intervals by 
HPLC until no further reaction was observed. 
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Following general procedure XIV, using CFE (§ 5.1.1, 1 ml of 0.20 U.mr' = 0.20 U) 
and RS-AMBA (9 ml of 1 mM solution, final concentration = 0.9 mM). 
R.t. (R-AMBA) = 21.2 mm, r.t. (S-AMBA) = 29.4 mm. At t =95 h: yield R-AMBA 
= 0.25 mM, 28%; e.e. = 16%. 
Following general procedure XIV, using CFE (§ 5.1.1, 2 ml of 0.20 U.mr' = 0.40 U) 
and RS-AMBA (8 ml of 1 mM solution, final concentration = 0.8 mM). 
R.t. (R-AMBA) = 21.2 mm, r.t. (S-AMBA) = 29.4 mm. At t =96 h: yield R-AMBA 
= 0.21 mM, 26%; e.e. = 8%. 
Following general procedure XIV, using CFE (§ 5.1.1, 3 ml of 0.20 U.mr' = 0.60 U) 
and RS-AMBA (7 ml of 1 mM solution, final concentration = 0.7 mM). 
R.t. (R-AMBA) = 21.2 min, r.t. (S-AMBA) = 29.4 mm. At t =97 h: yield R-AMBA 
= 0.16 mM, 23%; e.e. = 10%. 
Following general procedure XIV, using CFE (§ 5.1.1, 1 ml of 0.20 U.mi' = 0.20 U) 
and RS-AMBA (9 ml of 5 mM solution, final concentration = 4.5 mM). 
R.t. (R-AMBA) = 20.8 min, r.t. (S-AMBA) = 29.0 mm. At t =74 h: yield R-AMBA 
= 1.77 mM, 39%; e.e. = 2%. 
9.4.1.2. General Procedure XV: Oxidation of single enantiomer 
BLR(DE3) [pECME3] cell free extract (§ 5.1.1, 500 jtl of 0.20 U.mi' = 0.10 U) was 
added to a solution of AMBA (4.5 ml of 1 mM solution, final concentration = 
0.9 mM) in ammonium formate buffer (50 mM, pH 7.4) and the reaction mixture was 
incubated at 30 °C. After 4 days, 5 ml NaOH (50 mlvi) and 5 ml hexane was added 
and the hexane layer was analysed by HPLC method 7. 
Following general procedure XV, R-AIMIIBA. R.t. (R-AIVIBA) = 23.9 mm, yield 
R-AMBA = 0.60 mM, 67%. 
Following general procedure XV, S-AMBA. R.t. (S-AMBA) = 33.1 mm, yield 
S-AMBA = 0.57 mM, 63%. 
Experimental: Deracemisation 
9.4.1.3. General Procedure XVI: Oxidation with hexane as co-solvent 
BLR(DE3) [pECME3] cell free extract (§ 5.1.1, 500 pJ of 0.20 U.m1 1 = 0.10 U) was 
added to a solution of RS-AMBA (50 j.il of 100 mM solution in hexane, final 
concentration = 1 mM) in hexane and ammonium formate buffer (50 mM, pH 7.4). A 
300 l aliquot was mixed with 300 p.1 NaOH (50 mM) and 300 p.1 hexane and the 
hexane layer was analysed by HPLC method 7. The reaction mixture was incubated 
at 30 °C and monitored at regular intervals until no further reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
Following general procedure XVI, using hexane (450 p.1) and buffer (4 ml). R.t. 
(R-AMBA) = 25.2 mm, r.t. (S-AMBA) = 33.1 mm. At t =94 h: yield R-AMBA = 
0.13 mM, 13%; e.e. =40%. 
Following general procedure XVI, using hexane (700 .il) and buffer (3.75 ml). R.t. 
(R-AIv[BA) = 24.5 mm, r.t. (S-AMBA) = 33.7 mm. At t = 95 h: yield R-AMBA = 
0.16 mM, 16%; e.e. = 22%. 
Following general procedure XVI, using hexane (450 p.1) and buffer (4 ml, pH 5). 
R.t. (R-AMBA) = 20.6 mm, r.t. (S-AMBA) = 27.1 mm. At t =96 h: yield R-AMBA 
= 0.32 mM, 32%; e.e. = 19%. 
Following general procedure XVI, using hexane (450 p.1) and buffer (4 ml, pH 6). 
R.t. (R-AMBA) = 20.8 mm, r.t. (S-AMBA) = 27.2 mm. At t =96 h: yield R-AMBA 
= 0.26 mM, 26%; e.e. = 16%. 
Following general procedure XVI, using hexane (450 p.1) and buffer (4 ml, pH 7). 
R.t. (R-AMBA) = 20.8 mm, r.t. (S-AMBA) = 27.2 mm. At t =96 h: yield R-AMBA 
= 0.23 mM, 23%; e.e. = 17%. 
Following general procedure XVI, using hexane (450 p.!) and buffer (4 ml, pH 8). 
R.t. (R-AMBA) = 21.1 min, r.t. (S-AMIBA) = 27.6 mm. At t = 96 h: yield R-AIVIBA 
= 0.29 mM, 29%; e.e. = 14%. 
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Following general procedure XVI, using hexane (450 p.1) and buffer (4 ml, pH 9). 
R.t. (R-AMBA) = 20.5 mm, r.t. (S-AMBA) = 27.0 mm. At t =96 h: yield R-AMBA 
= 0.28 mM, 28%; e.e. = 18%. 
9.4.1.4. General Procedure XVII: Oxidation by partially purified MAO-N 
Partially purified BL21(DE3) [pECME3] (§ 5.1.3, 500 p.1 of 0.92 U.mF' = 0.46 U) 
was added to a solution of RS-AIVIBA (4.5 ml of 1 mM solution, final concentration 
= 0.9 mlvi) in phosphate buffer (100 mM, pH 8). A 100 p.1 aliquot was diluted in 
900 p.1 perchioric acid, pH 1.5 and analysed by HPLC method 8. The reaction 
mixture was incubated at 30 °C and the reaction monitored by HPLC at regular 
intervals until no further reaction was observed. 
R.t. (S-AMBA) = 14.9 mm, r.t. (R-AMBA) = 19.1 mm. At t =94 h: yield R-AMIBA 
= 0.33 mM, 37%; e.e. = 0%. 
9.4.2. Oxidation by E. coil BL2I(DE3) fpET 16bJ 
9.4.2.1. General Procedure XVIII: Oxidation by whole cells of E. coil 
BL2I(DE3) [pET16b] 
Freeze-thawed whole cells ofBL2l(DE3) [pETl6b] (§ 5.3.1, 500 p.1) was added to a 
solution of RS-AMBA (4.5 ml of 1 mM solution, final concentration = 0.9 mlvi) in 
phosphate buffer (100 mM, pH 8). A 100 p.1 aliquot was diluted in 900 p.1 perchioric 
acid, pH 1.5 and analysed by HPLC method 8. The reaction mixture was incubated at 
30 °C and the reaction was monitored by HIPLC at regular intervals until no further 
reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
Following general procedure XVffl. R.t. (S-AMBA) = 14.3 mm, r.t. (R-AMBA) = 
18.3 mm. At t = 89 h: yield R-AMIBA = 0.36 mM, 40%; e.e. = 8%. 
110 
Experimental: Deracemisation 
Following general procedure XVffl (buffer = 20 mM. R.t. (S-AMBA) = 14.8 mm, 
r.t. (R-AMBA) = 19.2 mm. At t = 99 h: yield R-AMBA = 0.52 mM, 58%; e.e. = 
76%. 
9.4.2.2. General Procedure XIX: Oxidation by cell free extract of 
BL2I(DE3) [pET16b] 
BL21(DE3) [pET16b] cell free extract (§ 5.3.2, 100 p1) was added to a solution of 
RS-AMBA (900 jfl of 1 mM solution, final concentration = 0.9mM) in phosphate 
buffer (20 mM, pH 8). A 10 pd aliquot was diluted in 990 p.1 perchloric acid, pH 1.5 
and analysed by HPLC method 8. The reaction mixture was incubated at 30 °C and 
the reaction monitored by HIPLC at regular intervals until no further reaction was 
observed. 
R.t. (S-AMBA) = 13.6 mm, r.t. (R-AMBA) = 17.4 mm. At t =20 h: yield R-AMBA 
= 0.49 mM, 54%; e.e. = 26%. At t = 96 h: yield R-AMBA = 0.41 mM, 46%; e.e. = 
98%. 
9.4.2.3. General Procedure XX: Oxidation by purified BL2I(DE3) 
[pETl6b] 
Partially purified BL21(DE3) [pETl6b] (§ 5.3.2, 100 p.1) was added to a solution of 
RS-AIVIBA (900 p.1 of 1 mM solution, final concentration = 0.9 mM) in phosphate 
buffer (20 mM, pH 8). A 10 p.1 aliquot was diluted in 990 p.1 perchloric acid, pH 1.5 
and analysed by FIPLC method 8. The reaction mixture was incubated at 30 °C and 
the reaction was monitored by HPLC at regular intervals until no further reaction was 
observed. 
R.t. (S-AMBA) = 13.6 mm, r.t. (R-AMBA) = 17.4 mm. At t =20 h: yield R-AMBA 




9.4.3. Oxidation by E. coil BL2I(DE3) fpMA 0-NJ 
9.4.3.1. General Procedure XXI: Oxidation by whole cells of BL2I(DE3) 
[pMAO-N] 
Freeze-thawed whole cells of BL21(DE3) [pMAO-N] was added to a solution of 
RS-AMBA in phosphate buffer (100 mM, pH 8). A 100 p.1 aliquot was diluted in 
900 p.1 perchloric acid, pH 1.5 and analysed by HIPLC method 8. The reaction 
mixture was incubated at 30 °C and the reaction monitored by HPLC at regular 
intervals until no further reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
Following general procedure XXI, using BL21(DE3) [pMAO-N] (§ 5.2.1, 500 p.1 of 
0.19 U.mr' = 0.10 U) and RS-AMBA (4.5 ml of 1 mM solution, final concentration 
= 0.9 mM). R.t. (S-AMBA) = 14.9 mm, r.t. (R-AMBA) = 19.2 mm. At t =94 h: yield 
R-AMBA = 0.38 mM, 42%; e.e. = 14%. 
Following general procedure XXI, using BL21(DE3) [pMAO-N] (§ 5.2.1, 500 p.1 of 
0.19 U.mY 1 = 0.10 U) and RS-AMBA (4.5 ml of 1 mM solution, final concentration 
= 0.9 mM). R.t. (S-AMBA) = 14.3 mm, r.t. (R-AIvIBA) = 18.3 mm. At t = 89 h: yield 
R-AMBA = 0.41 mM, 45%; e.e. = 10%. 
Following general procedure XXI, using BL21(DE3) [pMAO-N] (§ 5.2.1, 2.5 ml of 
0.19 U.mr' = 0.48 U) and RS-AMBA (2.5 ml of 1 mM solution, final concentration 
= 0.5 mM). R.t. (S-AMBA) = 15.2 mm, r.t. (R-AMBA) = 19.6 mm. At t = 47 h: yield 
R-AMBA = 0.23 mM, 46%; e.e. = 10%. 
Following general procedure XXI, using BL21(DE3) [pMAO-N] (§ 5.2.1, 1.5 ml of 
0.19 U.mr 1 = 0.29 U) and RS-AMBA (3.5 ml of 1 mM solution, final concentration 
= 0.7 mM). R.t. (S-AIvIBA) = 15.1 min, r.t. (R-AMBA) = 19.5 mm. At t =47 h: yield 
R-AMBA = 0.39 mM, 56%; e.e. = 10%. 
Following general procedure XXI, using BL21(DE3) [pMAO-N] (§ 5.2.1, 500 p.1 of 
0.19 U.mr' = 0.10 U) and RS-AMBA (4.5 ml of 1 mM solution, final concentration 
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= 0.9 mM). R.t. (S-AMBA) = 15.1 mm, r.t. (R-AMBA) = 19.4 mm. At t =47 h: yield 
R-AMBA = 0.49 mM, 54%; e.e. = 10%. 
Following general procedure XXI, using BL21(DE3) [pMAO-N] (§ 5.3.1, 500 j.il of 
0.16 U.mr 1 = 0.08 U), RS-AMBA (4.5 ml of 1 mM solution, final concentration = 
0.9 mM) and buffer =20 mM. R.t. (S-AMBA) = 14.7 mm, r.t. (R-AMBA) = 19.0 
mm. At t =99 h: yield R-AMBA = 0.70 mM, 78%; e.e. = 58%. 
Following general procedure XXI, using BL21(DE3) [pMAO-N] (§ 5.2.1, 1 ml of 
0.16 U.m1 1 = 0.16 U), RS-AMBA (0.13 tl, final concentration = 1.0 mM) and buffer 
= 20 mM Analysis: 10 1u1 aliquot in 990 ,ul HC104 . R.t. (S-AMBA) = 14.8 min, r.t. 
(R-AMBA) = 19.3 mm. At t = 97 h: yield R-AMBA = 0.34 mM, 34%; e.e. = 26%. 
9.4.3.2. General Procedure XXII: Oxidation by cell free extract of 
BL2I (DE3) [pMAO-N] 
BL21(DE3) [pMAO-N] cell free extract was added to a solution of RS-AMBA in 
phosphate buffer (20 mM, pH 8). A 10 tl aliquot was diluted in 990 p.1 perchloric 
acid, pH 1.5 and analysed by HPLC method 8. The reaction mixture was incubated at 
30 °C and the reaction was monitored by HPLC at regular intervals until no further 
reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
Following general procedure XXII, using BL21(DE3) [pMAO-N] CFE (§ 5.2.1, 100 
p.! of 1.90 U.mi' = 0.19 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM). Analysis: 100 p/in 900 p1 HC10 4 . R.t. (S-AMBA) = 14.8 
min, r.t. (R-AMBA) = 19.2 mm. At t = 99 h: yield R-AIvIIBA = 0.43 mM, 48%; e.e. = 
24%. 
Following general procedure XXII, using BL21(DE3) [pMAO-N] CFE (§ 5.2.1, 100 
p.1 of 1.90 U.mr' = 0.19 U), RS-AIVIBA (900 p.1 of 1 mM solution, final 
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concentration = 0.9 mM) and catalase (1 mg of 21000 Umg' = 21000 U). Analysis: 
100 ,ul in 900 p1 HC104 . R.t. (S-AMBA) = 14.8 mm, r.t. (R-AMBA) = 19.2 mm. At t 
= 99 h: yield R-AMBA = 0.63 mM, 70%; e.e. = 50%. 
Following general procedure XXII, using BL21(DE3) [pMAO-N] CFE (§ 5.2.1, 
100 p1 of 2.68 U.mr' = 0.27 U) and RS-AMBA (900 tl of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 14.5 mm, r.t. (R-AMBA) = 18.8 mm. At 
t = 97 h: yield R-AMBA = 0.45 mM, 50%; e.e. = 46%. 
Following general procedure XXII, using BL21(DE3) [pMAO-N] CFE (§ 5.2.1, 
100 j.il of 2.68 U.mr' = 0.27 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 14.5 mm, r.t. (R-AMBA) = 18.8 mm. At 
t = 97 h: yield R-AMBA = 0.14 mM, 15%; e.e. = 96%. 
Following general procedure XXII, using BL21(DE3) [pMAO-N] CFE (§ 5.3.2, 
100 p.1 of 3.0 U.mi' = 0.30 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 13.6 mm, r.t. (R-AMBA) = 17.4 mm. At 
t = 20 h: yield R-AMBA = 0.50 mM, 56%; e.e. = 44%. At t =96 h: yield R-AMBA = 
0.43 mM, 48%; e.e. > 99%. 
9.4.3.3. General Procedure XXIII: Oxidation by purified BL2I(DE3) 
[pMAO-N] 
Partially purified BL21(DE3) [pMAO-N] was added to a solution of RS-AMBA in 
phosphate buffer (20 mM, pH 8). A 10 p1  aliquot was diluted in 990 p.1 perchioric 
acid, pH 1.5 and analysed by HPLC method 8. The reaction mixture was incubated at 
30 °C and the reaction monitored by HPLC at regular intervals until no further 
reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
114 
Experimental: Deracemisation 
Following general procedure XXffl, using BL21(DE3) [pMAO-N] (§ 5.3.2, 100 p.1 
of 1.60 U.mr 1 = 0.16 U) and RS-AMBA (900 p.! of 1 mM solution, final 
concentration = 0.9 mM). Further MAO-N (100 p.1 of 1.60 U.mr' = 0.16 U) was 
added at t = 68 h and 91 h. R.t. (S-AMBA) = 14.0 mm, r.t. (R-AMBA) = 17.9 mm. 
At t = 96 h: yield R-AMBA = 0.35 mM, 39%; e.e. = 8%. 
Following general procedure XXffl, using BL21(DE3) [pMAO-N] (§ 5.3.2, 100 p.1 
of 1.60 U.mr' = 0.16 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM) at room temperature. Further MAO-N (100 p.1 of 
1.60 U.mF' = 0.16 U) was added at t = 68 h and 91 h. R.t. (S-AMBA) = 14.4 mm, r.t. 
(R-AMBA) = 18.6 mm. At t =96 h: yield R-AMBA = 0.45 mM, 50%; e.e. = 10%. 
Following general procedure XXffl, using BL21(DE3) [pMAO-N] (§ 5.3.2, 100 p.1 
of 2.69 U.mr' = 0.27 U) and RS-AMBA (900 p.1 of 1 mlvi solution, final 
concentration = 0.9 mM). R.t. (S-AMIBA) = 13.6 mm, r.t. (R-AMBA) = 17.4 mm. At 
t =20 h: yield R-AMBA = 0.47 mM, 52%; e.e. = 6%. At t =96 h: yield R-AMBA = 
0.41 mM, 46%; e.e. = 38%. 
9.4.4. Oxidation by E. coli BL2I(DE3) (pMAO-Nmut.J 
9.4.4.1. General Procedure XXIV: Oxidation by whole cells of BL2I(DE3) 
[pMAO-Nmut] 
Freeze-thawed whole cells ofBL2l(DE3) [pMAO-Nmut.] was added to a solution of 
RS-AIvIBA in phosphate buffer (20 mM, pH 8). A 100 p.1 aliquot was diluted in 
900 p.1 perchloric acid, pH 1.5 and analysed by FIPLC method 8. The reaction 
mixture was incubated at 30 °C and the reaction monitored by HPLC at regular 
intervals until no further reaction was observed. 
Following general procedure XXII, using BL21(DE3) [pMAO-Nmut.] (§ 5.3.1, 
500 p.! of 0.20 U.mF' = 0.10 U) and RS-AMBA (4.5 ml of 1 mM solution, final 
115 
Experimental: Deracemisation 
concentration = 0.9 mM). R.t. (S-AMBA) = 14.7 mm, r.t. (R-AMBA) = 19.1 mm. At 
t =99 h: yield R-AMBA = 0.77 mM, 86%; e.e. = 74%. 
9.4.4.2. General Procedure XXV: Oxidation by cell free extract of 
BL2I (DE3) [pMAO-Nmut.] 
BL21(DE3) [pMAO-Nmut.] cell free extract was added to a solution of RS-AMBA in 
phosphate buffer (20 mM, pH 8). A 10 j.il aliquot was diluted in 990 j.il perchioric 
acid, pH 1.5 and analysed by HPLC method 8. The reaction mixture was incubated at 
30 °C and the reaction monitored by HPLC at regular intervals until no further 
reaction was observed. 
Following general procedure XXV, using BL21(DE3) [pMAO-Nmut.] CFE (§ 5.3.2, 
100 j.il of 0.18 U.mi' = 0.02 U) and RS-AMBA (900 tl of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 13.6 mm, r.t. (R-AMBA) = 17.4 mm. At 
t =20 h: yield R-AMBA = 0.41 mM, 45%; e.e. > 99%. 
9.4.4.3. General Procedure XXVI: Oxidation by purified BL2I(DE3) 
[pMAO-Nmut.] 
Partially purified BL21(DE3) [pMAO-Nmut.] was added to a solution of RS-AMBA 
in phosphate buffer (20 mM, pH 8). A 10 p1 aliquot was diluted in 990 j.tl perchloric 
acid, pH 1.5 and analysed by HPLC method 8. The reaction mixture was incubated at 
30 °C and the reaction monitored by HPLC at regular intervals until no further 
reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.3.2, 100 
p1 of 0.62 U.mr' = 0.06 U) and RS-AMIBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 13.6 mm, r.t. (R-AMBA) = 17.4 mm. At 
t =20 h: yield R-AMBA = 0.42 mM, 47%; e.e. > 99%. 
flffli 
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Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.3.2, 
100 p.1 of 0.35 U.mF' = 0.04 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 13.9 mm, r.t. (R-AMBA) = 18.0 mm. At 
t = 7 h: yield R-AMBA= 0.46 mM, 51%; e.e. = 94%. At t = 20h: yield R-AMBA= 
0.43 mM, 48%; e.e. > 99%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 10 p.1 
of 0.35 U.mr' = 0.004 U) and RS-AMBA (90 p.1 of 1 mM solution, final 
concentration = 0.9 mM) at room temperature. R.t. (S-AMBA) = 13.8 min, r.t. 
(R-AMBA) = 17.6 mm. At t = 18 h: yield R-AMBA = 0.50 mM, 56%; e.e. > 99%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 10 p.1 
of 0.35 U.mr' = 0.004 U) and RS-AMBA (90 p.1 of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 13.8 mm, r.t. (R-AMBA) = 17.6 mm. At 
t = 18 h: yield R-AMBA = 0.47 mM, 52%; e.e. > 99%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 10 p.1 
of 0.35 U.mi' = 0.004 U) and RS-AMBA (90 p.1 of 1 mM solution, final 
concentration = 0.9 mM) at 37 °C. R.t. (S-AMBA) = 13.8 mm, r.t. (R-AMBA) = 17.6 
mm. At t = 18 h: yield R-AMBA = 0.60 mM, 67%; e.e. = 72%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 p.1 
of 0.25 U.mr' = 0.03 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM) at pH 6. R.t. (S-AMBA) = 13.5 mm, r.t. (R-AMBA) = 17.4 
mm. At t =22 h: yield R-AMBA = 0.50 mM, 55%; e.e. = 2%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 111 
of 0.25 U.mF' = 0.03 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM) atpH 7. R.t. (S-AMBA) = 13.5 mm, r.t. (R-AIv[BA) = 17.4 
mm. At t =22 h: yield R-AMBA = 0.42 mM, 47%; e.e. = 86%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 p.! 
of 0.25 U.mr' = 0.03 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
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concentration = 0.9 mM) atpH8. R.t. (S-AMBA) = 13.5 mm, r.t. (R-AMBA) = 17.5 
mm. At t =22 h: yield R-AMBA = 0.49 mM, 54%; e.e. = 92%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 tl 
of 0.25 U.mi' = 0.03 U) and RS-AMBA (900 jil of 1 mM solution, final 
concentration = 0.9 mM) at pH9. R.t. (S-AMBA) = 13.5 mm, r.t. (R-AMBA) = 17.4 
mm. At t =22 h: yield R-AMBA = 0.43 mM, 48%; e.e. = 74% 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 p.1 
of 0.25 U.mF' = 0.03 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 niM) in Tris/HC1 buffer pH 10. R.t. (S-AMBA) = 13.5 mm, r.t. 
(R-AMBA) = 17.5 mm. At t = 22 h: yield R-AMBA = 0.50 mM, 56%; e.e. = 16%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 p.1 
of 0.25 U.mF' = 0.03 U) and RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 13.6 mm, r.t. (R-AMIBA) = 17.7 mm. At 
t =25 h: yield R-AMBA = 0.53 mM, 59%; e.e. = 96%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 p.1 
of 0.25 U.mr 1 = 0.03 U) and RS-AMBA (900 p.1 of 5 mM solution, final 
concentration = 4.5 mM). R.t. (S-AMBA) = 13.6 mm, r.t. (R-AMBA) = 17.5 mm. At 
t =25 h: yield R-AMBA = 0.50 mM, 56%; e.e. = 2%. 
Following general procedure XXVI, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 50 p.1 
of 0.20 U.mr 1 = 0.01 U) and RS-AMBA (450 p.1 of 1 mM solution, final 
concentration = 0.9 mM). R.t. (S-AMBA) = 13.3 mm, r.t. (R-AMIBA) = 17.2 mm. At 
t =24 h: yield R-AMBA = 0.55 mM, 61%; e.e. = 96%. 
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9.5. Deracemisation of RS-a-methylbenzylamine 
9.5.1. Deracemisatlon by E. coil BL2I(DE3) fpMAO-Nmut.J 
9.5.1.1. General Procedure XXVII: Deracemisation using NaBH4 
Partially purified BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 j.tl of 0.35 U.mi' = 0.04 U) 
was added to a solution of RS-AMBA (900 tl of 1 mM solution, final concentration 
= 0.9 mM) and NaBH4 (2 mg, 52.7 mM, 58.5 eq.) in phosphate buffer (20 mM, 
pH8). A 10 il aliquot was diluted in 990 pJ perchloric acid, pH 1.5 and analysed by 
HPLC method 8. The reaction mixture was incubated at 30 °C and the reaction was 
monitored by HPLC at regular intervals until no further reaction was observed. 
R.t. (S-AMBA) = 14.0 min, r.t. (R-AMBA) = 18.1 mm, e.e. = 11.5%. At t =24 h: 
yield R-AMBA = 0.45 mM, 50%; e.e. = 23%. 
9.5.1.2. General Procedure XXVIII: Deracemisation using NH3:BH3 
Partially purified BL21(DE3) [pMAO-Nmut.] was added to a solution of RS-AMBA 
and ammonia-borane complex in phosphate buffer (20 mM, pH8). A 10 jtl aliquot 
was diluted in 990 tl perchloric acid, pH 1.5 and analysed by HPLC method 8. The 
reaction mixture was incubated at 30 °C and the reaction was monitored by HPLC at 
regular intervals until no further reaction was observed. 
Reactions were carried out according to the general procedure, with deviations 
indicated in italics. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.1 of 0.35 U.mr' = 0.04 U), RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM) and NH 3BH3 (10 p.1 of 4M solution, final concentration = 
40 mM, 44.4 eq). Further NH3BH3 (10 p.1 of 4M solution, final concentration =40 
mM, 44.4 eq) was added at 3 h. R.t. (S-AIvIIBA) = 14.0 mm, r.t. (R-AMBA) = 18.0 
mm. At t =2 h: yield R-AMBA = 0.59 mM, 65%; e.e. = 47%. At t =4 h: yield 
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R-AMBA = 0.50 mM, 56%; e.e. = 66%. At t =72 h: yield R-AMBA = 0.62 mM, 
69%; e.e. = 74%. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut] (§ 5.4, 
25 p1 of 0.35 U.mr' = 0.01 U), RS-AMBA (900 jtl of 1 mM solution, final 
concentration = 0.9 mM) and NH 3BH3 (10 p.1 of 4M solution, final concentration = 
40 mM, 44.4 eq). Further MAO-N mutant (25 p.1 of 0.35 U.m11 = 0.009 U) and 
NH3BH3 (10 p.1 of 4M solution, final concentration =40 mM, 44.4 eq) were added at 
1.5, 3 and 19 hours. R.t. (S-AMBA) = 12.4 min, r.t. (R-AMBA) = 15.8 mm. At t 
2 h: yield R-AMBA = 0.52 mM, 58%; e.e. = 22%. At t = 3 h: yield R-AMBA = 0.59 
mM, 66%; e.e. = 30%. At t =45 h: yield R-AMBA = 0.53 mM, 59%; e.e. = 72%. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.1 of 0.35 U.mF' = 0.04 U), RS-AMBA (900 p.1 of 1 mM solution, final 
concentration = 0.9 mM) and NH 3BH3 (20 p.1 of 4M solution, final concentration = 
80 mM, 88.9 eq). Further MAO-N mutant (100 p.1 of 0.35 U.mr' = 0.04 U) and 
NH3BH3  (20 p.1 of 4M solution, final concentration = 80 mM, 88.9 eq) was added at 
4 h. R.t. (S-AMBA) = 13.3 min, r.t. (R-AMBA) = 17.0 mm. At t = 3 h: yield 
R-AMBA = 0.70 mM, 78%; e.e. = 52%. At t =24 h: yield R-AMBA = 0.47 mM, 
52%; e.e. > 99%. 
Following general procedure XXVIII, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
50 p.1 of 0.35 U.mr' = 0.02 U), RS-AMBA (450 p.1 of 1 mM solution, final 
concentration = 0.9 mM) and NIH 3BH3 (20 p.1 of 4M solution, final concentration = 
160 mM, 177.8 eq). Further MAO-N mutant (50 p.1 of 0.35 U.mI' = 0.02 U) and 
NH3BH3 (20 p.! of 4M solution, final concentration = 160 mM, 177.8 eci) was added 
at 2 h. R.t. (S-AMBA) = 13.8 mm, r.t. (R-AMBA) = 17.9 mm. At t = 3 h: yield 
R-AMBA = 0.55 mM, 61%; e.e. = 34%. At t =96 h: yield R-AIVIBA = 0.52 mM, 
58%; e.e. 68%. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.1 of 0.35 U.mr' = 0.04 U), RS-AIvIBA (900 p.! of 1 mM solution, final 
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concentration = 0.9 mM), NH3BH3 (40 l of 4M solution, final concentration = 
160 mM, 177.8 eq) and catalase (1 mg of 2800 Umg' =2800 U). R.t. (S-AMBA) = 
13.9 mm, r.t. (R-AMBA) = 18.0 mm. At t = 3 h: yield R-AMBA = 0.43 mlvi, 48%; 
e.e. = 26%. At t = 23 h: yield R-AMBA = 0.48 mM, 53%; e.e. = 44% 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 l of 0.35 U.mF' = 0.04 U), RS-AIv1BA (400 }.1l of 1 mM solution, final 
concentration = 0.8 mlvi) and NH 3BH3 (20 il of 4M solution, final concentration = 
160 mM, 177.8 eq). R.t. (S-AMBA) = 14.0 mm, r.t. (R-AMBA) = 18.2 mm. At t = 
3 h: yield R-AIvIBA = 0.57 mM, 71%; e.e. = 60%. At t =24 h: yield R-AIvIBA 
0.63 mM, 79%; e.e. = 94%. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 .il of 0.35 U.mF' = 0.04 U), RS-AIVIBA (400 il of 1 mM solution, final 
concentration = 0.8 mM), NH3BH3 (20 .il of 4M solution, final concentration = 
160 mM, 177.8 eq) and ammoniumformate (32 mg, 1 M, 1111.1 eq). R.t. 
(S-AMBA) = 13.4 mm, r.t. (R-AIvIIBA) = 17.3 mm. At t = 17 h: yield R-AMBA 
0.50 mM, 63%; e.e. = 12%. 
Following general procedure XXVIII, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.1 of 0.20 U.mr' = 0.02 U), RS-AMBA (400 p.1 of 1 mM solution, final 
concentration = 0.8 mM) and NH 3BH3 (20 p.1 of 4M solution, final concentration = 
160 mM, 177.8 eq). Further MAO-N mutant (100 p.1 of 0.20 U.mr 1 = 0.02 U) and 
NH3BH3 (20 p.1 of 4M solution, final concentration = 160 mM, 177.8 eq) was added 
at 26 h. R.t. (S-AMBA) = 13.3 mm, r.t. (R-AMBA) = 17.1 mm. At t = 5 h: yield 
R-AMBA = 0.64 mM, 80%; e.e. = 36%. At t = 24 h: yield R-AMBA = 0.72 mM, 
90%; e.e. = 52%. At t =48 h: yield R-AMBA = 0.59 mM, 74%; e.e. 78%. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.1 of 0.20 U.mF 1 = 0.02 U), RS-AMIBA (400 p.1 of 1 mM solution, final 
concentration = 0.8 mM) and NH3BH3 (10 p.1 of 4M solution, final concentration = 
80 mlvi, 100.0 eq). Further MAO-N mutant (100 p.1 of 0.20 U.mr' = 0.02 U) and 
NH3BH3 (10 p.1 of 4M solution, final concentration = 80 mM, 100.0 eq) was added at 
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26 h. R.t. (S-AMBA) = 13.2 mm, r.t. (R-AMBA) = 17.0 mm. At t = 5 h: yield 
R-AMBA = 0.62 mM, 77%; e.e. = 58%. At t = 24 h: yield R-AMBA = 0.62 mlvi, 
77%; e.e. = 86%. At t =48 h: yield R-AMBA = 0.55 mM, 69%; e.e. = 98% 
Following general procedure XXVIII, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 jfl of 0.20 U.mr 1 = 0.02 U), RS-AMBA (300 jil of 1 mM solution, final 
concentration = 0.75 mM) and NIH 3BR3 (9 p.1 of 4M solution, final concentration = 
90 mM, 120 eq). Further MAO-N mutant (100 p.1 of 0.20 U.mF' = 0.02 U) and 
NH3BH3 (10 p.1 of 4M solution, final concentration = 100 mM, 133.3 eq) was added 
at 26 h R.t. (S-AMBA) = 13.2 mm, r.t. (R-AMBA) = 17.0 mm. At t = 5 h: yield 
R-AMBA = 0.57 mM, 76%; e.e. = 64%. At t =24 h: yield R-AMBA = 0.60 mM, 
80%; e.e. = 90%. At t =48 h: yield R-AMBA = 0.47 mM, 62%; e.e. > 99%. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.1 of 0.20 U.mr 1 = 0.02 U), RS-AMBA (400 p.1 of 1 mM solution, final 
concentration = 0.8 mM) and NH 3BH3 (10 p.1 of 4M solution, final concentration = 
80 mM, 100.0 eq). R.t. (S-AMBA) = 12.8 min,r.t. (R-AMBA) = 16.5 mm. At t = 5 h: 
yield R-AMBA = 0.50 mM, 63%; e.e. = 64%. At t =24 h: yield R-AMBA = 0.50 
mM, 63%; e.e. = 88%. 
Following general procedure XXVffl, using BL2 1 (DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.! of 0.20 U.mi' = 0.02 U), RS-AMBA (400 p.1 of 1 mlvi solution, final 
concentration = 0.8 mlvi) and NH 3BH3 (5 p.1 of 4M solution, final concentration = 40 
mM, 50.0 eq). R.t. (S-AMBA) = 12.7 mm, r.t. (R-AMBA) = 16.4 mm. At t = 5 h: 
yield R-AMBA = 0.43 mM, 54%; e.e. = 78%. At t =24 h: yield R-AMBA = 0.46 
mM, 58%; e.e. > 99%. 
Following general procedure XXVffl, using BL21(DE3) [pMAO-Nmut] (§ 5.4, 
100 p.1 of 0.20 U.mr' = 0.02 U), RS-AMBA (400 p.! of 1 mM solution, final 
concentration = 0.8 mM) and NH 3BH3 (2.5 p.! of 4M solution, final concentration = 
20 mM, 25.0 eq). R.t. (S-AMBA) = 12.7 mm, r.t. (R-AMIBA) = 16.3 mm. At t = 5 h: 
yield R-AMBA = 0.37 mM, 46%; e.e. = 84%. At t =24 h: yield R-AMBA = 0.46 
mM, 58%; e.e. > 99%. 
122 
Experimental: Deracemisation 
Following general procedure XXVIII, using BL21(DE3) [pMAO-Nmut.] (§ 5.4, 
100 p.1 of 0.20 U.mr' = 0.02 U), RS-AMBA (400 p.1 of 1 mM solution, final 
concentration = 0.8 mM) and NH 3BH3 (2.5 p.1 of 4M solution, final concentration = 
20 mM, 25.0 eq). R.t. (S-AMBA) = 13.0 mm, r.t. (R-AMBA) = 16.8 mm. At t = 5 h: 
yield R-AMBA = 0.45 mM, 56%; e.e. = 80%. At t =24 h: yield R-AMBA = 0.43 
mM, 54%; e.e. > 99%. 
9.5.1.3. General Procedure XXIX: Deracemisation with organic 
co-solvent 
Partially purified BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 p.1 of 0.20 U.mF 1 = 0.02 U) 
was added to a solution of RS-AMBA (100 mM solution in organic co-solvent) and 
ammonia-borane complex in phosphate buffer (20 mM, pH8). A 10 p.1 aliquot was 
diluted in 990 p.1 perchloric acid, pH 1.5 and analysed by HPLC method 8. The 
reaction mixture was incubated at 30 °C and the reaction was monitored by HPLC at 
regular intervals until no further reaction was observed. 
Following general procedure XXIX, using RS-AMBA (5 p.1 in DMSO, final 
concentration = 1.0 mM), buffer (395 p.1) and N}13BH3 (10 p.1 of 4M solution, final 
concentration = 80 mM, 80.0 eq). R.t. (S-AMBA) = 12.8 min, r.t. (R-AMBA) = 16.5 
mm. At t = 5 h: yield R-AMBA = 0.49 mM, 49%; e.e. = 34%. At t =24 h: yield 
R-AMBA = 0.55 mM, 55%; e.e. = 80%. 
Following general procedure XXIX, using RS-AMIBA (5 p.1 in dioxane, final 
concentration = 1.0 mlvi), buffer (395 p.1) and NH 3BH3 (10 p.1 of 4M solution, final 
concentration = 80 mM, 80.0 eq). R.t. (S-AMBA) = 12.6 mm, r.t. (R-AMBA) = 16.2 
mm. At t = 21 h: yield R-AMBA = 0.51 mM, 51%; e.e. = 46%. 
Following general procedure XXIX, using RS-AMIBA (5 p.d in hexane, final 
concentration = 1.0 mlvi), buffer (395 p.1) and NH 3BH3 (10 p.1 of 4M solution, final 
concentration = 80 mM, 80.0 eq). R.t. (S-AMBA) = 12.6 mm, r.t. (R-AMBA) = 16.2 
mm. At t =21 h: yield R-AMBA = 0.57 mM, 57%; e.e. = 96%. 
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Following general procedure XXIX, using RS-AMBA (5 tl in acetonitrile, final 
concentration = 1.0 mM), buffer (395 p.!) and NH3BH3 (10 p.! of 4M solution, final 
concentration = 80 mM, 80.0 eq). R.t. (S-AMBA) = 12.6 mm, r.t. (R-AMBA) = 16.2 
mm. At t = 21 h: yield R-AMBA = 0.61 mM, 61%; e.e. = 88%. 
Following general procedure XXIX, using RS-AMBA (5 p.1 in hexane, final 
concentration = 1.0 mM), buffer (395 p.!) and NH3BH3 (2.5 p.! of 4M solution, final 
concentration =20 mM, 20.0 eq). R.t. (S-AMBA) = 13.0 mm, r.t. (R-AMIBA) = 16.8 
mm. At t = 5 h: yield R-AMBA = 0.52 mM, 52%; e.e. = 86%. At t =23 h: yield R-
AMBA = 0.51 mM, 51%; e.e. > 99%. 
9.5.2. Stereoinversion by E. coil BL2I(DE3) fpMAO-Nmut.J 
9.5.2.1. General Procedure XXX: Stereoinversion by purified BL2I(DE3) 
[pMAO-Nmut.] 
Partially purified BL21(DE3) [pMAO-Nmut.] (§ 5.4, 100 p.! of 0.20 U.mr 1 = 0.02 U) 
was added to a solution of AIv[BA (400 p.! of 0.5 mM solution, final concentration 
= 0.4 mM) and ammonia-borane complex (2.5 p.1 of 4M solution, final concentration 
= 20 mM, 20 eq) in phosphate buffer (20 mM, pH8). A 10 p.1 aliquot was diluted in 
990 p.l perchloric acid, pH 1.5 and analysed by EIPLC. The reaction mixture was 
incubated at 30 °C and the reaction monitored by HPLC at regular intervals until no 
further reaction was observed. 
Following general procedure XXX, using S-AMBA. R.t. (S-AIVIBA) = 12.9 mm, 
r.t. (R-AMBA) = 16.6 mm. At t = 5 h: yield R-AIvIBA = 0.06 mM, 15%; e.e. = 22%. 
At t =23 h: yield R-AMBA = 0.07 mM, 18%; e.e. > 99%. 
Following general procedure XXX, using R-AMBA. R.t. (R-AMBA) = 16.6 mm. At 
t = 5 h: yield R-AMIBA = 0.39 mM, 98%; e.e. > 99%. At t =23 h: yield R-AMBA = 
0.39 mM, 98%; e.e. > 99%. 
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9.6. Analysis conditions 
9.6.1. HPLC method I 
Phenomenex Chirex 3126 stationary phase, 100% CuSO 4 (1.5 mM), 1.5 ml.min 1 , 
242 nm. 
9.6.2. HPLC method 2 
Chirex 3126, 70% CuSO4 (1.5 mM), 30% MeOH, 1.5 ml.min1 , 254 rim. 
9.6.3. HPLC method 3 
Chirex 3126, 85% CuSO4 (2.0 mM), 15% MeOH, 1.5 ml.miii', 254 nm. 
9.6.4. HPLC method 4 
Chirex 3126, 90% CuSO4 (1.5 mM), 10% MeOH, 1.5 ml.min', 254 nm. 
9.6.5. HPLC method 5 
Chirex 3126, 70% CuSO4 (1.5 mM), 30% MeOH, 1.3 ml.miii', 254 nm. 
9.6.6. HPLC method 6 
Chirex 3126, 94% CuSO4 (1.5 mM), 6% MeOH, 1.5 ml.min 1 , 254 rim. 
9.6.7. HPLC method 7 
Chiralcel OD-H stationary phase, 95% hexane, 5% propan-2-ol, 0.5 ml.min', 
215 nm, 5 °C. 
9.6.8. HPLC method 8 
Crownpak CR(+) stationary phase, 100% perchioric acid (pH 1.5), 0.8 m1.min, 
200 nm, 25 °C. 
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10. Experimental: Enzyme production 
10.1. General Techniques 
Reagents for buffers, assay mixtures and culture media were of standard laboratory 
grade and were used as supplied from commercial sources. Commercial enzymes 
were used as supplied from Sigma. Bacterial growth in liquid culture was performed 
in an orbital shaker (Innova 4430 or Innova 4000), set at the desired temperature. For 
static incubation an oven, a dry block heater (Anachem HBS-130) or a water bath set 
at the desired temperature were used. 
Centrifugation of culture media and lysed cells was carried out in a Sorvall RC5C 
plus centrifuge. Speed and rotor size follow in parentheses. Small-scale (< 1.5 ml) 
centrifugation was performed in either an Eppendorf 5G1 5C microfuge or a Hereaeus 
Biofuge pico. 
Sterile procedures were performed either on the bench under flame, or in a SterilGard 
Class II Type A/B3 biological safety cabinet. Equipment and media were sterilised 
using a Monarch 745rh autoclave (121 °C, 20 mm) or an Astell Scientific autoclave 
(121 °C, 15 mm). 
Optical density measurements and Bradford assay measurements were performed on a 
Cecil CE1020s spectrophotometer (132 lamp). Kinetic measurements were carried out 
on a Hewlett Packard 8453 spectrophotometer (13 2 lamp), using HP 845x UV-visible 
system software for analysis or a Unicam UV4 UV-spectrophotometer with integrated 
kinetics software. Automated assays were performed using Cobas Mira S, a 
Roche-Diagnostic discrete analytical analyser. HPLC analysis was performed on a 
Hewlett Packard HP1 100. LC/MS analysis was performed on a Hewlett Packard 
HIP 1100 coupled to a Finnigan LCQ ion trap in electrospray ionisation mode. 
FPLC purification was performed on an Amersham pharmacia biotech AKTA FPLC 
system, using Unicorn v. 3.21 software for analysis. Columns were obtained 
pre-packed from Pharmacia. 
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Three different gels were used for SDS-PAGE analysis; i) Biorad Ready gels 10-20% 
Tris/HC1, 10 wells, 30 tl, ii) Biorad CriterionTM precast gel 10-20% Tris/HC1, 18 
wells, 30 tl, iii) self-poured 15% acrylamide gels (§ 9.5.9 & 9.5.10). 
10.2. General Procedures 
	
10.2.1. 	Growth of organisms for screening 
The appropriate media (§ 9.5.3-5, 50 ml in 250 ml flasks) were inoculated in 
duplicate, from bead. The flasks were incubated for 3 days (28 °C, 250 rpm), or until 
sufficient biomass was obtained. The biomass was harvested by centrifugation 
(2500 rpm, aseptically) and used for inoculation of induction media (§ 9.5.6-7, 50 ml 
in 250 ml flasks). The media was incubated for 18 h (28 °C, 250 rpm) then the cells 
were harvested by centrifugation (2500 rpm), resuspended in minimum buffer 
(phosphate, 100 mM, pH 7.5) and disrupted by sonication (1 ml, 3 x 15 s, 4 °C). 
10.2.2. 	DNA Plasmid Purification 
Plasmid DNA was purified from 10 ml bacterial culture using QlAprep Spin Miniprep 
kits (QIAGEN) following the supplied protocol. Purified plasmids were eluted from 
the spin columns in 30 pl of Tris/HC1 buffer (25 mM, pH 7.8). 
10.2.3. 	Transformation of E. coil with plasmid DNA by heat 
shock 151 
Plasmid DNA (1 .il) was mixed with chemically competent cells (20 tl, Novagen 
BL21(DE3) or BLR(DE3)), placed in ice for 5 minutes, heated at 42 °C for 30 s and 
returned to ice for 2 minutes. Growth medium (LB or SOC, 80 jtl) was added and the 
culture was incubated at 37 °C for 2-4 h before plating on LB agar plates containing 
ampicillin at the appropriate concentration. Plates were incubated at 37 °C overnight. 
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10.2.4. 	Growth of monoamine oxidase from a starting culture 
LB media containing ampicillin (50 jig.mF) (10 ml) in 30 ml tube was inoculated 
with a single colony of E. coli BL21(DE3) [pECME3] and was incubated at 37 °C 
(250 rpm) overnight. The resulting saturated culture was used as a 10% inoculum for 
fresh LB/amp50 and was incubated at 37 °C (250 rpm) for 24 hours when 0D 600 
3.5. 
10.2.5. 	Growth of monoamine oxidase from a single colony 
LB media (300 ml), containing ampicillin at the appropriate concentration, in 1 L 
baffled flasks was inoculated with a single colony ofBL2l(DE3) [pMAO-N], and 
incubated at the desired temperature overnight (250 rpm) until 0D600 4. Cells were 
harvested by centrifugation at 4 °C (7000 rpm, Sorvall SLA 3000 rotor) and washed 
with buffer (20 mM, pH 8) before being stored at -20 °C. 
10.2.6. 	Cell Lysis 
Lysis was performed as close to 4 °C as possible. Frozen biomass from growth media 
was thawed and resuspended in Tris/HC1 buffer (25 mM, pH 7.8) containing the 
appropriate protease inhibitors. The suspension was sonicated (Soniprep 150) on ice 
following an on-off protocol, time and period follows in parentheses. The viscous 
mixture was centrifuged (20000 rpm, Sorvall SS-34 rotor) at 4 °C until a clear 
supematant was obtained. Cell free extracts were stored at -80 °C. 
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10.2.7. 	Purification of proteins by FPLC 
Cell free extract (as prepared in § 9.2.6) was dialysed against starting buffer 
appropriate to column. The cell free extract was filtered through 0.45 tm sterile 
membrane prior to loading on the column using a peristaltic pump (Pharmacia P1). 
Fractions were assayed using a colorimetric hydrogen peroxide based assay (§ 9.4.2) 
and active fractions were stored at -80 °C. 
10.2.8. 	Purification of proteins by imac 
A disposable column was packed with Novagen HisBind ® resin according to supplied 
protocol, and charged with Ni ions. Cell free extract containing 0.5 M NaCl was 
loaded onto the column under gravity and the protein eluted with an imidazole 
gradient (0 M to 1 M). Fractions were assayed using colorimetric hydrogen peroxide 
based assay (§ 9.4.2). 
10.2.9. 	Bradford Assay 
Protein concentrations were measured by mixing Bradford reagent (5 ml, § 9.5.8) with 
enzyme solution (100 il) and standing for 2 minutes. The spectrophotometer was 
zeroed against Bradford reagent (5 ml) and water (100 tl), and then the absorbance of 
the protein sample at 595 nm was measured. If the absorbance exceeded the 
calibration range then the enzyme was diluted accordingly and the assay repeated. The 
protein concentration was obtained by comparison with a pre-determined calibration 
curve derived from known dilutions of BSA. 
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10.210. 	SDS-PAGE protein analysis 
Protein samples were prepared in SDS-reducing buffer (§ 9.5.12) and loaded on 
acrylamide gel and run at a constant voltage of 200 V (Powerpac 200). The gel was 
placed in staining solution (§ 9.5.15) and agitated on a rocking platform until the gel 
was dark blue in colour. The gel was de-stained in the same way using fresh de-stain 
solution (§ 9.5.16) until protein bands were visible and the background gel was clear. 
10.3. FPLC purification protocol 
10.3.1. 	Anion exchange chromatography 
10.3.1.1. Q-Sepharose 
Column = HiFlow QSepharose 26/10 (bed volume = 50 ml) 
Buffer A = Tris/HC1 (25 mM, pH 7.8) 
Buffer B = Tris/HCI (25 mM, pH 7.8) + 1 M NaCl 
Flow rate =4 ml.min 1 
Fraction collect = 10 ml 
Column wash =2 CV 100% buffer A 
Elution = 10 CV 100% buffer A to 100% buffer B 
Column clean =4 CV 100% buffer B 
10.3.1.2. ResourceQ 
Column = ResourceQ (bed volume =6 ml) 
Buffer A = Tris/HC1 (25 mM, pH 7.8) 
Buffer B = Tris/HC1 (25 mM, pH 7.8) + 1 M NaCl 
Flow rate = 3 ml.min' 
Fraction collect = 2 ml 
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Column wash =2 CV 100% buffer A 
Elution =20 CV 100% buffer A to 100% buffer B 
Colunm clean = 4 CV 100% buffer B 
10.3.1.3. DEAE-Sepharose 
Column = HiFlow DEAF-Sepharose 26/10 (bed volume = 50 ml) 
Buffer A = Tris/HC1 (25 mM, pH 7.8) 
Buffer B = Tris/HC1 (25 mM, pH 7.8) + 1 M NaCl 
Flow rate = 8 ml.min' 
Fraction collect = 5 ml 
Column wash =2 CV 100% buffer A 
Elution = 5 CV 100% buffer A to 100% buffer B 
Column clean =2 CV 100% buffer B 
10.3.1.4. MonoQ 
Column = MonoQ (bed volume = 6 ml) 
Buffer A = TrisIHCl (25 mM, pH 7.8) 
Buffer B = TrisfHCl (25 mM, pH 7.8) + 1 M NaCl 
Flow rate = 1 ml.min' 
Fraction collect = 1 ml 
Column wash =3 CV 100% buffer A 
Elution =20 CV 100% buffer A to 100% buffer B 
Column clean = 5 CV 100% buffer B 
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10.3.2. 	Hydrophobic interaction chromatography 
10.3.2.1. Phenyl-Sepharose 
Colunm = HiFlow Phenyl-Sepharose 26/10 (bed volume = 25 ml) 
Buffer A = (NH4)2SO4 (0.85 M in K. Phos. buffer, 50 mM, pH 7.2) 
Buffer B = (N}L)2SO4 (1.7 M in K. Phos. buffer, 50 mM, pH 7.2) 
Flow rate =4 ml.min' 
Fraction collect = 5 ml 
Colunm wash =2 CV 100% buffer A 
Elution = 10 CV 100% buffer A to 100% buffer B 
Column clean =4 CV 100% buffer B 
10.4. Assay methods 
10.4.1. 	Hydrogen peroxide coupled assay using vanillic acid 
10.4.1.1. Automated assay - Cobas Mira robot 
The enzymatic sample (40 tl), water (15 .tl) and chromogenic solution 1 (§ 9.5.17, 
200 p.1, £500 = 4650 M'.cm') were mixed at 37 °C and the absorbance at 500 nm 
measured for 4 minutes. After this time substrate (20 p.!, 48 mM, final concentration 
= 3.3 mlvi) and water (15 p.1) were added and the absorbance (500 nm) measured for a 
further 13 minutes. Cobas mira calculates activity (U.mF') from initial rate. 
Activity calculation: 
Activity (U.mF) = initial rate (Au.s 1 ) x ( 1 /c) X 60 X (t • V/s.v) X lx 106 . 
where c = molar extinction coefficient (lvf 1 .cm') 
t.v. = total reaction volume 
s.v. = sample volume 
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10.4.1.2. Non-automated assay 
The spectrophotometer was zeroed against chromogenic solution 1 (690 tl) and water 
(310 il). Chromogenic solution 1 (§ 9.5.17, 690 p.!), water (100 p.1), amine (70 p.1, 
48 mM, final concentration = 3.4 mM) and enzyme (140 p.!) were mixed and the 
absorbance at 500 nm measured over 10 minutes at 5 s intervals. HP 845x UV-visible 
software was used to calculate the initial rate and the activity was calculated from this. 
	
10.4.2. 	Hydrogen peroxide coupled assay using 2,4,6- 
tribromo-3-hydroxybenzoic acid 
The spectrophotometer was blanked against chromogenic solution 2 (§ 9.5.18, 990 p.!, 
= 29500 M'.cm) and HRP (5 p.! of 12000 U.mr' solution, 60 U). Enzyme 
(10 p.!) was added and the absorbance at 500 nm was measured at 3 s intervals for a 
10 minute period. The initial rate was measured and the activity was calculated from 
this (activity calculation as for 9.4.1). 
10.4.3. 	Product formation assay - monoamine oxidase 
The spectrophotometer was zeroed against water (900 p.1) and enzyme (100 p.!). 
Benzylamine (900 p.1, 2 mM, final concentration = 1.8 mM) and enzyme (100 p.1) 
were mixed in a quartz cuvette at room temperature and the absorbance at 250 nm was 
measured over 3 minutes at 5 s intervals. The initial rate was measured and the 
activity was calculated from this (activity calculation as for method 9.4.1). 
s(PhCHO)250 = 12500 M'.cm 1 . 
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10.4.4. 	Product formation assay - L-amino acid oxidase 
L-Phenylalanine (700 tl, 1 mM, final concentration = 0.7 mlvi) and enzymatic sample 
(300 j.il) were mixed in a quartz cuvette at room temperature and the absorbance at 
320 nm was measured for 10 minutes at 20 s intervals. The initial rate was measured 
and the activity was calculated from this (activity calculation as for method 9.4.1). 
8(PPA) 320 = 1017 M 1 .cm 1 . 
Deviations from assay methods are indicated in italics. 
10.4.5. 	HPLC assay for benzaldehyde production 
Benzylamine (900 tl, 1 mM) and enzymatic sample (100 tl) were left at room 
temperature. An aliquot (100 p.1) was removed at regular time intervals and diluted in 
acetonitrile (900 p.1). The mixture was analysed by IHIPLC. 
HPLC conditions: 	Zorbax Eclipse XDB C8 column (150 x 4.6) 
34% Ammonium acetate (50 mM, pH 6), 66% acetonitrile 
1 ml.min', 254 nm, 5 p.1 injection loop 
R.t. (BzNH2) = 1.50 mm, r.t. (BzCHO) = 2.23 mm 
10.4.6. 	LCIMS assay for phenylpyruvic acid production 
L-Phenylalanine (700 p.1, 1 mM) and enzymatic sample (300 p.1) were left at room 
temperature. An aliquot was submitted for LC/MS analysis. 
MS conditions: electrospray ionisation (es) 50-350 mass units 
scan time —1 s, alternate positive/negative switching 
HPLC conditions: Hypersil HyPurity Elite C18 (50 x 2.1, 3p.) 
Solvent A - 0.1% formic acid in ammonium acetate (10 mM) 
Solvent B - 90% acetonitrile, 10% A 
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1 ml.min 1 
Gradient: t = 0 mm 
t = 11 mm 
t = 15 mm 
t= 15.1 mm 
t =20 mm 
100% A 
40% A, 60% B 
30% A, 70% B 
100% A 
100% A 
10.5. Stock recipes 
10.5.1. 	LB medium 
Per litre: 	Tryptone peptone 	10 g 
Sodium chloride 	10 g 
Yeast extract 	5 g 
pH adjusted to 7 with NaOH 
10.5.2. 	LB agar medium 
LB medium 	100 ml 
Agar 	 1.5g 
10.5.3. 	SV2 medium 
Per litre: 	Glucose 	 15 g 
Glycerol 	 15 g 
Soypeptone 	15 g 
NaCl 	 3g 
CaCO3 	 1 g 
adjusted to pH 7 
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10.5.4. 	FS medium 
Per litre: 	Peptone 	 10 g 
Malt extract 	21 g 
Glycerol solution 	40 g 
JunlonilO 	ig 
glass beads (x 2) 
10.5.5. 	YEPD medium 
Per litre: 	Yeast extract 	10 g 
Peptone 	 20 g 
Glucose 	 20 g 
natural pH 
10.5.6. 	Monoamine oxidase induction media 
Per litre growth medium: 	n-butylamine 	1 ml 
10.5.7. 	L-Amino acid oxidase induction media 
Per litre growth medium: 	L-phenylalanine 	1 g 
10.5.8. 	Bradford reagent 152 
Coomassie Brilliant Blue G-250 	50 mg 
Ethanol (95%) 	 25 ml 
Phosphoric acid (85%) 	 50 ml 
Water 	 425 ml 
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10.5.9. 	SDS stacking gel 
Per 10 ml: 	Acrylamide 1.3 ml 
Water 6.1 ml 
Tris/HC1 (0.5 M, pH 6.8) 2.5 ml 
10% (w/v) SDS 100 jil 
TEMED 20 p.1 
10%APS lOOp.! 
TEMED and 10% APS added immediately before pouring gel 
10.5.10. 	SDS separating gel 
Per 10 ml: 	Acrylamide 5.0 ml 
Water 2.35 ml 
Tris/HC1 (0.5 M, pH 8.8) 2.5 ml 
10%(w/v)SDS 100 p.1 
TEMED 10 p.! 
10%APS lOOp.! 
TEMED and 10% APS added immediately before pouring gel 
10.5.11. 	Acrylamide solution 
30% (w/v) acrylamide/bis-acrylamide (Severn Biotech) 
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10.5.12. 	sos reducing buffer 
TrisfHCl (0.5 M, pH 6.8) 
Glycerol 
10% (w/v) SDS 
2-3-Mercaptoethanol 






10.5.13. 	0.05 (wlv) Bromophenol blue 
0.04% in 20% Methanol, pH 2.8-4.6 
10.5. 14. 	5 xSD5 running buffer 
Per litre 	Tris base 	 15.1 g 
Glycine 	 94 g 
10%(w/v)SDS 	 50m1 
10.5.15. 	Coomassie Blue staining solution 
Methanol 450 ml 
Acetic acid 100 ml 
Water 450 ml 
Coomassie blue G-250 500 mg 
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10.5.16. 	Coomassie Blue de-staining solution 
Methanol 450 ml 
Acetic acid 100 ml 
Water 450 ml 
	
10.5.17. 	Chromogenic solution I 
Vanillic acid 	3 niM 
4-AAP 	 1.5mM 
HRP 	 12 U.mF' 
mixed ma 1:1:1 ratio 
10.5.18. 	Chromogenic solution 2 
Potassium phosphate buffer (1 M, pH 7.6) 	5 ml 
THBHA (2% in DMSO) 	 500 pJ 
4-AAP(1.5M) 	 37.5 tl 
Amine substrate 	 30 p.! 
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12.1. Organisms screened for both MAO and LAAO activity 








1 Streptomyces lavendulae cbs 414.59 - - - n n 
2 ?v!ucorracemosus - 3(1) n n n n 
3 A. niger atcc 16404 3(1) n n n n 
4 Penicillium chrysogenum Q176 wisco 3(1) n n n n 
5 4bsidia cylindrospora nrrl 2796 3(1) n n n n 
6 Rhizopus oryzae cect 2672 3(1) n n n n 
7 Neurospora crassa atcc 10336 3(1) n n n n 
8 Fusarium monolforme imi 58290 5(1) n n n n 
9 Proteus vulgaris atcc 13315 - - - n n 
10 Pseudomonasputida ncimb 12190 - - - n n 
11 Bacillus cereus ncimb 11617 3 n n n n 
12 4rthrobacter simplex atcc 6949 - - - n n 
13 Corynebacterium equi ifo 3730 - - - n n 
14 Tactobacillusplantarum ncimb 40027 - - - n n 
15 Streptomyces 
antibioticus 
ncimb 8504 3(1) n n n n 
16 A. ochraceus imi 16264 5(1) n n n n 
17 4.awamori nrrl3ll2 3(1) n n n n 
18 Penicillium variotii cbs 284.48 3(1) n 0.041 n n 
19 Rhizopus stolonfer atcc 6227B 3(1) n n n n 
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20 Vfucorhiemalis cmi 113134 3(1) n n n n 
21 TVlucor rouxii atcc 24905 3(1) n n n n 
22 Curvularia lunata nrrl 2434 5(1) n n n 0.01 
23 Penicilliumpatulum imi 039809 3(1) n n n n 
24 i4rortierella  isabellina atcc 38063 3(1) n n n n 
25 S. cerevisiae nctc 4614 3(1) n n n n 
26 Rhodotorula glutinis cbs 4406 3(1) n n n n 
27 P. angusta atcc 26012 3(1) n n n n 
28 Pseudomonas 
testosteroni 
atcc 11996 3(1) n n n n 
29 Erwinea aroideae atcc 25206 3(1) n n n n 
30 Rhodococcus 
rhodochrous 
ncimb 9703 3(1) n n n n 
31 Nocardia corallina atcc 31338 3(1) n n n n 
32 4rthrobacter rubellus atcc 21495 3(1) n n n n 
33 E. coli JM109(nfl4) 3(1) n n n n 
34 Bacillus subtilis nrrl 8079 3(1) n n n n 
35 Streptomyces capreolus atcc 31963 3(1) n n n n 
36 A. itaconicus atcc 10021 3(1) n n n n 
37 A. oryzae cmi 44242 - - - - - 
38 Rhizopusjaponicus cmi 21600 3(1) n n n n 
39 Rhizopus circinans atcc 1225 3(1) n n n n 
40 Penicillium islandicum imi 040042 3(1) n n n n 
41 Penicillium digitatum imi 39748 6(1) n n n n 
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42 %lucorplumbeus cbs 111.07 3(1) 
43 %'Iucor circinelloides cbs 108.16 3(1) n n n n 
44 Mortierella isabellina atcc 38063 3(1) n n n n 
45 P. methanolica atcc 58403 3(1) n n n n 
46 4ureobasidium pullulans atcc 16623 3(1) n n n n 
47 Candida guilliermondii atcc 20318 3(1) n n n n 
48 Serratia marcesens atcc 274 3(1) n n n n 
49 4lcaligenesfaecalis atcc 8750 3(1) n n n n 
50 Proteus vulgaris atcc 13315 3(1) n n n n 
51 Pseudomonas 
fluorescens 
ncimb 10586 3(1) n n n n 
52 Lactobacilluspentosus atcc 8041 3(1) n n n n 
53 Nocardioides simplex atcc 6946 3(1) n n n n 
54 Bacillus fusiformis atcc 7055 3(1) n n n n 
55 Streptomyces 
euryt/1ermus 
atcc 14975 3(1) n n n n 
56 Byssochiamysfulva cmi 40021 3(1) n n n n 
57 Beauveria bassiana cbs 209.27 5(1) n n n n 
58 Gongronella lacrispora nrrl 2643 3(1) n n n n 
59 Cladosporium resinae nrrl 2778 3(1) n n n n 
60 Circinella muscae cmi 73461 3(1) n n n n 
61 Cunninghamella 
blakesleeana 
atcc 8688B 6(1) n n n n 
62 Pycnoporus coccineus nrrl 12476 3(1) 1 	n I 	n I 	n n 
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63 Peniophoragigantea F3612 - - - - - 
64 kylariapolymorpha F5755 3(1) n n n n 
65 S.fermentati atcc 36311 3(1) n n n 0.008 
66 Rhodotorula marina ncyc 541 3(1) n n n n 
67 Sporodiobolus 
araroseus 
atcc 11386 3(1) n n n n 
68 lerobacter aerogenes nctc 8017 3(1) n n n n 
69 lrthrobacterparaffineus ncimb 10699 3(1) n n n n 
70 4cinetobacter 
calacoaceticus 
ncimb 9871 3(1) n n n n 
71 4vcobacterium phlei atcc 19249 5(1) n n n n 
72 ?kticromonosora chalcea atcc 12452 5(1) n n n n 
73 Brevibacterium 
sterolicum 
atcc 21387 3(1) n n n n 
74 Streptosporangium 
roseum 
atcc 1450 5(1) n n n n 
75 Proteus vulgaris atcc 13315 3(1) n n 0.029 n 
76 Pseudomonasputida ncimb 12190 3(1) n n 0.033 n 
77 acculs cereus ncimb 11617 3(1) n n 0.029 n 
78 E. coli atcc 9637 3(1) n n 0.056 n 
79 Kiebsiella oxytoca - 3(1) 0.002 n 0.075 n 
80 A. niger atcc 16404 3(1) n n n n 
81 Penicillium chrysogenum Q176 wisco 3(1) 0.009 n n n 
82 Penicillium chrysogenum Q176 wisco 3(1) n n n n 
83 'Jeurospora crassa atcc 10336 3(1) 0.002 n n n 
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84 Veurospora crassa atcc 10336 3(1) n n n n 
85 Fusarium monolforme imi 58290 5(1) 0.002 0.006 n n 
86 Rhodosporidium 
toruloides 
atcc 10657 2(1) 0.006 n n n 
87 S. acidfaciens - 2(1) 0.004 n n n 
88 S. carisbergensis ncyc 530 2(1) 0.028 n n n 
89 S. cerevisiae nctc 4614 2(1) 0.006 n n n 
90 Schizosaccharomyces 
ombe 
ncyc 380 2(1) n 0.008 n n 
91 Sporodiobolus 
araroseus 
atcc 11386 2(1) 0.001 n n n 
92 Rhodotorula rubra atcc 4056 2(1) 0.002 n n n 
93 Zygosaccharomyces 
ermentatai 
cbs 67.72 2(1) 0.009 n n n 
94 P. angusta atcc 26012 2(1) 0.006 n n n 
95 Candida tropicalis cbs 2323 2(1) n n n n 
96 Rhodococcus equi ncimb 12035 5(1) n n n n 
97 Corynebacterium equi ifo 3730 5(1) 0.003 n n 0.012 
98 Pseudomonas 
oleovorans 
atcc 29347 3(1) n n n n 
99 Nocardia autotrophica ifo 12743 5(1) n n n n 
100 Rhizopus stolonifer atcc 6227B 3(1) n n n n 
101 Rhizopus arrhizus atcc 11145 3(1) n n n n 
102 v1ucorhiemalis cmi 113134 3(1) 0.002 n n n 
103 Curvularia lunata nrrl 2434 3(1) 0.008 n n n 
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atcc 8688B 3(1) n n n n 
105 4bsidia cylindrospora nrrl 2796 3(1) 0.009 n n n 
106 Streptomyceslavendulae cbs 414.59 2(1) n 0.008 n n 
107 Streptomyces 
antibioticus 
ncimb 8504 2(1) 0.001 n n n 
108 Streptomyces capreolus atcc 31963 2(1) n n n n 
109 Streptomyces 
eurythermus 
atcc 14975 2(1) n n n n 
110 Streptomyces griseus nrrl 3851 2(1) n 0.008 n n 
111 Streptomyces 
aureofaciens 
atcc 10762 2(1) n 0.002 n n 
112 Streptomycespunipalis nrrl 3529 2(1) n 0.012 n n 
113 Streptomycesfradiae atcc 31664 2(1) n n n n 
114 Streptomyces cirratus atcc 21731 2(1) n n n n 
115 Lactobacilluspentosus atcc 8041 3(1) n n n n 
116 4ureobacterium barkerei atcc 49977 3(1) n n n n 
117 1'Jocardioides simplex atcc 6946 3(1) n n 0.008 n 
118 Wicromonosora chalcea atcc 12452 3(1) n n n n 
119 9revibacterium 
sterolicum 
atcc 21387 3(1) n 0.002 n n 
120 Mucorracemosus - 3(1) 0.011 n n 0.016 
121 A. ochraceus imi 16264 6(1) 0.002 0.032 n n 
122 A. itaconicus atcc 10021 3(1) n 0.005 n n 
123 Penicillium variotii cbs 284.48 3(1) n n n 0.003 
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atcc 11011 6(1) n n 0.003 0.015 
125 Ttlórtierella ramanniana cbs 3 5.044 3(1) n n n n 
126 Paecilomyces variotii cbs 284.48 3(1) 0.002 n n n 
127 Septomyxa affinis atcc 6737 3(1) n 0.064 n 0.019 
128 4ctinomucor elegans atcc 6476 3(1) n n 0.006 n 
129 Giberellafujikuroi atcc 12616 3(1) 0.003 n n 0.016 
130 Verticillium lecanii imi 68689 7(1) 0.044 0.025 n 0.007 
131 A. terreus imi 045543 3(1) n 0.068 n n 
132 A. alliaceus atcc 10060 7(1) n 0.010 n n 
133 kylariapolymorpha F5755 3(1) 0.016 n n n 
134 Kluyveromyces lactis atcc 8585 3(1) n 0.002 n UV 
135 P. angusta atcc76722 3(1) 0.012 n 0.013 n 
136 P. angusta atcc 76723 3(1) n n 0.009 0.006 
137 Providencia rustigianii atcc 13159 3(1) 0.002 0.008 n UV 
138 Serratia marcesens atcc 274 3(1) 0.008 n n n 
139 4lcaligenesfaecalis atcc 8750 3(1) 0.002 n n n 
140 Rhodopseudomonas 
sphaero ides 
atcc 8253 3(1) n n n n 
141 Erwinea aroideae atcc 25206 3(1) n 0.008 n n 
142 Trichoderma viride atcc 20536 3(1) n n n n 
143 Neurospora crassa atcc 24698 3(1) n 0.002 n n 
a) commercial culture collection no.; b) growth in days (induction time in days); 
c) extra-cellular activity (tJ.mr 1 ); d) intra-cellular activity (U.mF'). 
156 
Appendices 
12.2. Organisms screened for MAO activity only 




1 A. ochraceus imi 16264 5(1) n n 
2 A. itaconicus atcc 10021 3(1) n n 
3 Penicillium chrysogenum Q176 wisco 3(1) n n 
4 Curvularia lunata nrrl 2434 3(1) n n 
5 4bsidia cylindrospora nrrl 2796 3(1) n n 
6 Septomyxa affinis atcc 6737 3(1) n n 
7 Verticillium lecanii imi 68689 5(1) n n 
8 Fusarium mono1forme imi 58290 - - - 
9 A. terreus imi 045543 3(1) n n 
10 A. alliaceus atcc 10060 - - - 
11 Xylaria polymorpha F5755 5(1) n n 
12 Streptomyces lavendulae cbs 414.59 3(1) n n 
13 Streptomyces griseus nrrl 3851 3(1) n n 
14 Streptomycespunipalis nrrl 3529 3(1) n n 
15 Serratia marcesens atcc 274 3(1) n n 
16 Erwineaaroideae atcc 25206 3(1) n n 
17 Providencia rustigianhi atcc 13159 3(1) n n 
18 Rhodospiridium toruloides atcc 10657 3(1) n n 
19 S. carisbergensis ncyc 530 3(1) n n 
20 Schizosaccharomycespombe ncyc 380 3(1) n n 








22 P. angusta atcc 76722 3(1) n n 
F23 P. angusta atcc 76723 3(1) n n 
a) commercial culture collection no.; b) growth in days (induction time in days); 
c) extra-cellular activity (U.mr'); d) intra-cellular activity (U.mi'). 
123. Organisms screened for LAAO activity only 




1 Rhizopus stolonifer atcc 6227B 3(1) n n 
2 Septomyxa affinis atcc 6737 3(1) y y 
3 Verticillium lecanii imi 68689 5(1) y n 
4 DrQtuS vulgaris atcc 13315 3(1) y y 
5 Pseudomonas putida ncimb 12190 3(1) n y 
6 9acillus cereus ncimb 11617 3(1) n n 
7 E. coli atcc 9637 3(1) n n 
8 Klebsiella oxytoca - 3(1) n n 
9 Providencia rustigianii atcc 13159 3(1) y y 
a) commercial culture collection no.; b) growth in days (induction time in days); 




11.4. PurificatiOn of BL2I(DE3) [pET16b], BL2I(DE3) 
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